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DNA VACCINES 
 
Immunization is regarded as one of the most significant successes in medical 
development of the past two hundred years. When Edward Jenner, in 1786, 
performed the first vaccination on an eight year old boy, he deliberately applied 
the first live attenuated vaccine. Since then other remarkable developments have 
resulted in successful vaccines against small pox, polio, measles and rubella. In 
total, twenty-six infectious diseases are preventable by vaccination, leading to an 
estimated 10 - 15 years longer average lifetime of men in the 20th century.  
Live attenuated vaccines still represent the most successful vaccines. They often 
induce a life long protection by an active infection of the attenuated pathogen 
resulting in the development of an effective immunologic memory. However, 
infectious diseases, such as malaria, tuberculosis and especially HIV, cannot be 
controlled using these vaccines. This is either due to by the possibility of 
restored pathogen virulence, the difficulty to vaccinate immunodefficient 
patients or the frequent mutation of some pathogens, thereby escaping anterior 
immunizations.  
Developments of the past 30 years have led to vaccines, such as subunit 
vaccines (Fluad®, Chiron Behring), recombinant protein vaccines (Engerix-B®, 
GlaxoSmithKline) and protein-polysaccharide conjugate based vaccines 
(Meningitec®, Wyeth). Despite the new potentials arising from the broader 
possibilities to immunize safely compared to live vaccines, these vaccines are 
less immunogenic. Especially the reduced capacity to induce cell mediated 
immune responses of the protein and peptide antigens could not be completely 
overcome by adjuvant systems. Therefore, the challenges remain to develop 
potent, but safe vaccines against infectious diseases, cancer and autoimmune 
diseases, whereas the latter are mostly dependent on a cytotoxic T-cell response. 
The potential of using DNA as a vaccine was discovered by gene therapists. 
They detected immune responses against the proteins that had been genetically 
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delivered in the form of plasmid DNA. This knowledge was only used for the 
purpose of DNA vaccination in the early 90´s. Several studies in mice then 
revealed protection against pathogen challenge, mainly influenza.  
The mechanisms of the induction of cellular and humoral immune response are 
summarized in Figure 1. 
 
 
 
 
 
 
Fig.1: Mechanism of antigen-specific humoral and cellular immune response 
[1]. (a) Recognition of exogenous antigen by APC and activation of a humoral 
immune response. (b) T-helper cell activation by antigen presentation via MHC 
II molecules of the transfected APC. (c) Activation of cytotoxic T- lymphocytes 
(CTL) by the presentation of foreign peptides synthesized and processed by the 
transfected cell.   
 
a 
b 
c 
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The levels of immune response generated by the different immunization 
strategies are summarized in Table 1. The similarity of the immune response 
obtained by DNA -and live attenuated vaccines, as well as the increased safety 
of DNA vaccines are highlighted in the Table 1. 
 
Immune 
response  
DNA 
vaccine 
Live 
attenuated 
vaccine 
Protein/ 
Subunit/ 
Inactivated 
Humoral 
 
Cellular 
B cells 
CD4+ 
CD8+ 
+++ 
++ 
++ 
+++ 
+/- Th1 
+++ 
+++ 
+/- Th1 
- 
Antigen 
presentation 
  
 
 
Humoral 
Cellular 
MHC I / II 
+++ 
++ 
MHC I / II 
+++ 
+++ 
MHC II 
+++ 
+/- 
Manufacturing  
Ease of 
development 
Costs 
Transport /storage  
 
++++ 
++ 
++ 
 
+ 
+ 
+ 
 
++ 
+ 
+++ 
Safety  +++ ++ ++++ 
 
Table 1: Quality of immune responses obtained with DNA vaccines, live 
attenuated vaccines and protein / subunits or inactivated vaccines.  
 
The great advantage of DNA vaccines is their ability to induce a humoral as well 
as a cellular type of immune reaction. 
The encoded antigenic protein can be either processed via the intrinsic 
presentation pathway and presented by MHC I (major histocompatibility) 
molecules. Alternatively the antigen can be presented by MHC II molecules, 
which are specific for antigen presenting cells and some endothelial cells. This 
provides the opportunity of a vaccine corresponding better to a live vaccine type 
of response without the dangers associated with an infection of attenuated 
bacteria or viruses. The ability of DNA vaccines to generate potent cytotoxic T-
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lymphocyte (CTL) responses is a major advantage. The activation of CTL 
depends on in-situ protein synthesis and subsequent presentation via the MHC I 
molecule. The in-situ synthesis results in posttranslational modifications, such as 
glycosylation, proteolytic processing, as well as lipid conjugation. Thus, the 
“naïve” form of the antigenic protein is produced and leads to a better 
recognition of the upcoming antigen after pathogen infection. The generation of 
T-cell responses by genetic vaccines was identified as a promising strategy to 
act against intracellular bacteria and parasites, as well as viral infections and 
cancer.  
DNA immunizations were performed by either direct intra-muscular injection of 
naked DNA or by the use of a gene gun, with DNA coated gold microprojectiles 
(Fig.2) [2-6]. 
  
Fig.2: Application and T-cell activation mechanisms of DNA vaccines [1]. (a) 
Gene gun application or injection of naked plasmid DNA into the skin or the 
muscle. Direct transfection of antigen presenting cells (APC), either dendritic 
cells or dendritic cells of the skin, Langerhans cells, and presentation to T-cells. 
(b) Transfection of myocytes and ‘cross priming’, the transfer of the antigen to a 
APC, and further activation of T-cells. 
 a 
b 
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It has not been clear for some time by which mechanism DNA immunization 
occurred. 
The two possibilities for the induction of a CTL response consist of either direct 
DNA uptake into antigen presenting cells and the expression of the antigen. 
Alternatively, the protein synthesis occurs in non-antigen presenting cells with 
subsequent uptake into antigen presenting cells, referred to as ‘cross priming’ 
[7-9]. A third pathway comprising of the simple transfection of muscle cells 
could be ruled out. This mechanism would not induce humoral, antibody based 
reactions, because of the lack of MHC II presentation and because the lack of 
co-stimulatory molecules. The MHC II antigen presentation is restricted to 
antigen presenting cells and some endothelial cells. 
In vitro studies have demonstrated the difficulty of transfecting antigen 
presenting cells and other phagocytes [10,11]. Still, Denis-Mize et al. 
demonstrated gene expression in dendritic cells by reverse transcriptase-PCR 
and by measuring the activation of an epitope-specific T-cell hybridoma by Il-2 
expression [12]. This mechanism is of great importance as antigen presenting 
dendritic cells have the ability to prime naïve T-lymphocytes, resulting in 
significantly stronger T-cell responses [13]. Moreover, dendritic cells can 
directly activate CTL by the MHC I antigen presentation of phagocytosed 
apoptotic bodies [14].However, this mechanism is not fully understood and will 
have to be elucidated to effectively use plasmid DNA for vaccination. A 
protective immunization of small animal models, as well as some non-human 
primates has shown promising results.  
Human clinical trials, including several against HIV and cancer have been 
initiated. An example of current human clinical trials is given in Table 2. The 
results of completed trials, however, could not confirm the effectiveness of 
DNA vaccines unless very high DNA doses were used [15,16]. Viral gene 
delivery has been used most frequently for gene therapy and has shown 
promising effects for DNA vaccination, as well. 
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Vaccine/ 
Condition Clinical Phase Plasmid Dose Administration 
HIV / 
healthy 
volunteers 
Phase I 
NIAID 
Study: HVTN048 
EP HIV-1090 
21 specific 
CTL epitopes 
 
3 x 
i.m. injection + PVP 
protects / facilitates 
DNA uptake 
 
Phase I  
NIAID 
Study: AVEG 031 
APL 400-047 
+ Bupivacaine 
HCL 
0.1 mg 
0.3 mg 
1 mg 
3 mg 
 
i.m. by needle or 
Biojector 2000 
Needle-Free Jet 
Injection 
 
Phase I  
NIAID 
Study: HVTN 044 
VRC-
HIVDNA009-
00-VP 
 + IL-2/ 
Ig DNA 
adjuvant 
 
4 x 
needle-free i.m. 
injection 
DNA encoding IL-2 
fused to the Fc 
portion of IgG for 
enhanced stability.  
 
Phase I 
NIAID 
Study: N01-
AI05394 
 
HIV-1 DNA 
vaccine with 
protein vaccine 
boost 
3 x 
DNA 
2 x 
protein 
Polyvalent HIV-1 
DNA plasmid 
prime/env protein 
boost vaccine 
Melanoma 
Neoplasm 
Metastasis 
Phase I  
NCI 
Study: 980086; 98-
C-0086 
 
gp100 DNA 
 
4 x + IL-2 
Leukemia, 
Chronic 
Phase I/II 
M.D. Anderson 
Cancer Center 
Study: DM99-412 
 
plasmid vector 
and DNA  
fragments 
 
containing the 
sequence of their own 
immunoglobulin gene 
Ebola / 
healthy 
volunteers 
Phase I 
Vical / 
NIAID 
VRC-
EBODNA012-
00-VP 
 
  
 
Table 2: Examples of current clinical trials of DNA vaccines consisting 
predominantly of Phase I trials for immunization against HIV and cancer. The 
adjuvants used are IL-2, polyvinylpyrrolidone (PVP) and bupivacaine. The DNA 
is applied via i.m. injection or a Biojector®. Gene delivery via bacteria, viruses, 
and ex vivo transfection of cells were not analysed. 
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However, viral delivery systems have led to fatal adverse immune reactions in a 
patient [17]. Therefore, we will focus on non viral adjuvants and delivery 
systems. Many other trials were conducted using viruses, which have not been 
found to be extensively effective [18]. 
Despite the disappointing results in humans until now, great successes in small 
animals and the theoretical possibilities, arising from the use of DNA vaccines 
legitimate further research and developments. 
 
 
 
Table 3: Advantages and drawbacks of DNA vaccines. 
 Advantages  Drawbacks 
 
• 
 
 
 
• 
 
 
• 
 
 
 
• 
 
 
• 
 
• 
 
 
• 
 
 
• 
 
 
• 
 
 
• 
 
 
Possibility to immunize against obligate 
intracellular bacteria such as Myco-
bacterium tuberculosis and Listeria m.  
 
Supports CTL priming despite deficient 
T helper cells 
 
Antigens are equal to the antigenic 
proteins of a viral infection, due to post- 
translational modifications  
 
Plasmid are easily manufactured in 
large amounts  
 
DNA is more stable than proteins 
 
Fast adaptation of DNA vaccines is 
possible  
 
Mixtures of plasmids encoding for 
multiple protein fragments are possible 
 
Only the protein of interest is 
expressed.  
 
No immune reaction against naked 
DNA or synthetic vectors. 
 
Antigen does not have to be a pathogen 
surface characteristic for CTL response. 
 
• 
 
 
 
 
• 
 
 
• 
 
 
• 
 
• 
 
Potential integration of the 
plasmid into host genome leading 
to insertional mutagenesis  
 
 
Induction of autoimmune responses 
(e.g. pathogenic anti-DNA antibodies)  
 
Effects of long-term expression 
unknown  
 
Concept restricted to protein antigens  
 
Induction of immunologic tolerance  
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Therefore, DNA vaccines have to be improved. This is achieved using diverse 
possibilities such as genetic adjuvants, immuno-stimulatory agents encoded by 
the plasmid vector or the development of molecular adjuvants, such as 
cytokines. 
Another promising tool to improve the immune response of DNA vaccines is the 
development of delivery systems that enhance the efficiency of gene delivery 
and provide a targeting of antigen presenting cells. 
 
VACCINE ADJUVANTS 
 
Adjuvants, e.g. substances that can enhance an immune response without being 
immunognic themselves, have been used since the early 1920 to improve 
vaccine efficacy [19,20]. Adjuvants demonstrate several properties. They 
 
- increase the immune response of weakly immunogenic antigens 
- decrease the dose necessary for successful immunization and reduce the 
number of boosts needed 
- prolong the duration and speed-up the onset of the immune response  
- modulate the immune response inducing different antibody isotypes or 
inducing mucosal immunity 
- stimulate cytotoxic T lymphocytes  
- facilitate the immunization with combined vaccines 
- allow the immunization of elderly 
 
The immune reaction induced by simple injection of plasmid DNA cannot 
achieve a sufficient immune response for protection against pathogenic 
challenge. Therefore, very early in the development of DNA vaccines the co-
application of adjuvants was investigated.  
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Non-Particulate Adjuvants 
The first, in the beginning undeliberately applied adjuvant of DNA vaccination 
were CpG (cytidine–phosphate–guanosine) dinucleotide motives of the 
procaryontic genetic material. CpG motives can be allocated within the group of 
non-particulate, soluble, adjuvants, in contrast to particulate adjuvants [27]. 
These sequences are sur-represented in procaryontic cells and occur four to five 
times more frequently than in eucaryontic cells. Thus, eucaryontic immune 
systems have evolved to recognize these sequences as danger signals of bacterial 
infections. Hence, the simple injection of plasmid DNA generated in bacteria, 
resulted in the activation of the immune system, namely the innate, unspecific 
type, by CpG-binding to the toll-like receptor (TLR) 9 [21,22]. The toll-like 
receptor family represent components that recognize evolutionarily conserved 
pathogen patterns. There are currently 10 known TLRs.  
CpG motives further play an important role in the T helper cell pathway. They 
have been found to induce activation of the T helper cell 1 (TH1) pathway on the 
disfavor of a TH2 pathway, by up-regulating cytokines such as Il-12 [25,26]. TH1 
cells induce a CTL immune reaction, whereas TH2 cells activate a humoral 
immune response.  
Another adjuvant danger signal arising from bacterial genetic material is the rate 
of methylation of the nucleotides. Bacterial nucleotides are not methylated 
compared to a 75 % methylation to 5-methylcytosine in eucaryontic cells 
[23,24]. These differences in DNA composition result in relatively high immune 
responses of injected naked DNA.  
 
Other non-particulate adjuvants are mainly immuno-modulators, such as 
cytokines (Il-2 and Il-12 up-regulate the TH1 pathway [26,28]; Il-4 up-regulate 
the TH2 pathway) and isolated substances from LPS (lipopolysaccharide), 
especially lipid A and MPL (monophosphoryl lipid A) which induce strong TH1 
responses, for example in hyposensibilizing injections (Pollinex® Quattro, 
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Bencard) [29-31]. Saponins, natural glycosides, are used in micellar 
preparations, such as Quil A in veterinary vaccines. These boost the TH1, as well 
as the TH2 pathway [32].  
 
Particulate Adjuvants 
An early in the development in genetic vaccines used DNA coated on gold 
microprojectiles which were propelled into the skin of mice by the so-called 
‘gene gun’. This was the first method used to increase gene delivery into 
keratinocytes and especially into Langerhans cells, which are specific dermal 
dendritic cells [5,33]. This induced a shift of the immune response towards the 
TH2 pathway, inducing a humoral type of immune response.  
The only approved adjuvants for human use are i) alum, aluminum salts and 
calcium salts, ii) MF 59, a microemulsion, composed of the mixture of surface 
active components and iii) virosomes, phospholipid particles carrying 
hemaglutinin and neuraminidase moieties on their surface. Many other adjuvant 
systems have proven their efficacy in human trials, however these were 
predominantly associated with non-tolerable toxicities. 
 
Alum is the most commonly used adjuvant in humans. It is composed of 
aluminum hydroxide (AlO (OH)) or aluminum phosphate (Al
 
- PO4 in different 
ratios). This adjuvant system consists either of pre-formed particles or a gel 
(Alhydrogel). The antigen is adsorbed by electrostatic forces onto the surface of 
the Alum particles or particles form in-situ when the antigen is added to the gel 
[34,35]. Alum is used for a great variety of vaccines, such as the combined 
diphtheria-tetanus (Td) or the combination of five or six antigens in a 
preparation (Hexavac®, Aventis Pasteur MSD). The reproducible production of 
alum and its adsorption characteristics are a crucial part of the vaccine 
composition [36,37]. The mode of action is primarily the sustained desorption of 
the antigen or the toxoid from the Alum particles, resulting in an enduring 
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contact of the antigen with the immune system. Secondly, Alum enhances the 
immune response by activating the humoral immune response. Additionally, an 
increase in CTL reactions has been observed, compared to antigen preparation in 
solution [38]; however, strong IgE reactions and the toxicological concerns 
raised by use of aluminum represent the major drawbacks of these formulations 
[39,40]. 
Another mineral salt used for some vaccines is calcium phosphate, which has 
been shown to be better tolerated than alum, leading to fewer hypersensitivity 
reactions and an improved entrapment of antigens [41]. Other mineral, have also 
been investigated with minimal success, such as colloidal iron hydroxide, 
calcium chloride. 
 
MF 59 (micro-fluidized emulsion) has been recently approved in Europe for use 
in subunit flu vaccines [42]. It is composed of 0.5 % Tween 80, 0.5 % Span and 
4.3 % squalens forming an O/W-emulsion with a droplet size of 150 nm. This 
adjuvant is used in the influenza vaccines Fluad® (Chiron-Behring) und 
Addigripp® (Aventis Pasteur MSD). These vaccines are especially 
recommended for elderly, which frequently exhibited insufficient immune 
response using other conventional vaccines. 
 
Virosomes are reconstituted influenza virus envelopes with inserted purified 
influenza glycoproteins (hemaglutinin and neuramindase). They are further 
representatives for particulate adjuvants. They serve as delivery tool for 
inactivated viruses [43]. These adjuvants are used in Berna Pharm´s hepatitis A 
vaccines (Epaxal®, Niddapharm / Havpur®, Chiron-Behring) [44]. Antigen 
presenting cells recognize the influenza epitopes and phagocytose the 
inactivated virus associated with the hepatitis antigen.  
Other adjuvants retain only a scientific character. They are not used in humans 
because of frequent adverse reactions; some of these substances have been 
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approved for the use in animals. The effect of adjuvant mechanism and 
examples thereof are presented in Table 4. 
Action Adjuvant Type Example Benefit 
 
Presentation 
 
Amphiphilic molecules, 
complexes which interact 
with the immunogen  
 
ISCOM's, 
liposomes, 
Quil, Al(OH)3 
 
Increased antibody 
response and 
duration 
 
 
Targeting 
 
Particulate adjuvants 
which bind the 
immunogen  
 
Carbohydrate adjuvants 
which target lectin 
receptors on macrophages 
and DC  
 
 
 
Efficient use of the 
antigen: 
Antigen localization 
in the lymph nodes 
 
TH1 
 
Depot effect 
 
W/O emulsions  
         
 
 short term 
Particles  
         
 
 long term 
 
Microparticles 
Nanoparticles  
Oils, Al(OH)3, 
gels 
 
Prolonged antigen 
presentation 
Increased efficiency 
single dose vaccine ? 
 
 
Danger 
signals 
 
Oil emulsions, surface 
active agents, Al(OH)3, 
IFN's, hsp 
 
 
 
Tissue destruction, 
stress TCL binding 
on APC 
 
Immuno - 
modulation 
 
Small molecules or 
proteins which modify the 
cytokine network:  
co-stimulatory molecules, 
cytokines, chemokines  
 
Complement 
CpGs, LPS 
cytokines 
Up-regulation of the 
immune response.  
Selection of TH1 or 
TH2 balance 
Danger signal to 
innate immune cells. 
Inflammatory stimuli 
 
 
Table 4: Effects of different adjuvants on the immune system.  
 
Freund´s adjuvants are well-known and very potent immunostimulators. They 
can be divided into two groups, e.g. the complete (FCA) and the incomplete 
(FIA) adjuvants. Both consist of a mixture of a mineral oil with a surfactant 
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(Arlacel A). The complete adjuvant additionally contains mycobacteria 
components. The mechanism of action can be ascribed to a depot effect arising 
from the application of the antigen in a w/o emulsion. Further on, the activation 
of antigen presenting cells by the surfactant is achieved. The mycobacteria 
components in the FCA were found to be efficient adjuvant substances, due to 
the earlier mentioned CpG motives present in their genetic material. However, 
this complete Freund´s adjuvant was associated with severe inflammatory, 
painful and even harmful reactions [45]. 
Iscoms™ (Immune stimulating complexes) consist of saponins, phospholipides 
and cholesterol that form particles of approximately 40 nm into which the 
antigen can be incorporated. They induce TH2 as well as TH1 immune responses 
and are used for veterinary vaccines [46]. 
 
The adjuvants of interest in this work are particulate adjuvants, more specifically 
microparticles and nanoparticles prepared from biodegradable polymers. 
  
The great advantage arising from these systems is their structural variability, the 
low toxicity arising from most of the synthetic, as well as natural polymers used 
and the possibility of further modification of the delivery system to target 
specific cells and tissues. 
 
MICROPARTICLES  
 
Microparticles are characterized primarily by their size, ranging from 1 to 1000 
µm, although ideally > 100µm. In most cases, they are prepared of polymers. 
The mechanism of action of microparticles in vaccination is not entirely 
understood yet. However, similar to other particulate adjuvants they induce the 
activation of antigen presenting cells, due to the irritation of foreign particulate 
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matter in a size range similar to that of pathogens. It is further hypothesized that 
an inflammatory reaction results in danger signals. These signals attract antigen-
presenting cells, which, in consequence, phagocytose the particles. 
Microparticles exhibiting diameters of less than 10 µm are susceptible to 
phagocytosis [47]. Additionally, the uptake of particles containing high 
concentrations of antigen results in higher levels of antigen delivered to 
phagocytes, including dendritic cells, as compared to the pinocytotic uptake of 
antigens in solution. After phagocytosis, antigen presenting cells, in particular 
dendritic cells, mature and migrate to the local lymph nodes [48]. Here, direct 
contact can be made with the residing lymphocytes [49]. Antigens associated to 
microparticles have been shown to induce cytotoxic T lymphocyte reactions in 
small animal models, in contrast to aluminum hydroxide adsorbed antigens [50].  
 
The ideal microparticulate system should possess several characteristics: It 
should  
 
- provide a depot effect of the antigen and its release over a certain time 
period, thus prolonging the presence of antigen in the organism.  
- stabilize the antigen in the physiological environment against enzyme 
degradation. 
- be easily and reproducibly formulated.  
- be stable during storage. 
- be free from toxic degradation products. 
- be cost effective. 
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Preparation Techniques 
 
The development of microparticle formulations using biodegradable polymers 
was described by Bungenberg de Jong in 1930 and numerous other groups [51-
54]. The polymers used consisted of natural polymers, such as gelatin [55] and 
polysaccharides [56]. The disadvantages of natural products were their 
variability of the polymer quality, instabilities as well as safety concerns. 
Therefore, synthetic, biodegradable polymers have been preferentially studied 
for pharmaceutical use. The aim was to develop new drug delivery systems with 
defined and prolonged release profiles, especially for drugs susceptible to 
degradation in a physiological environment. The polymers for these 
formulations were strongly involved in the pharmacokinetics of the preparation. 
The type of polymer influences the rate of degradation, the type of degradation 
and the resulting degradation products and thereby the dug release. The most 
frequently used synthetic polymers were polyesters, poly(amides), poly(alyl-  -
cyano acrylates) and poly(orthoesters). Polyesters have found a widespread use, 
due to their excellent biocompatibility and biodegradability leading to their 
approval by regulatory authorities [57,58]. Depending on the process 
parameters, the payload, the physicochemical drug characteristics, polymers and 
solvents, a multitude of structures could be developed.  
The techniques most commonly used for the preparation of microparticles are 
spray drying, double emulsion methods and phase separation. 
 
Spray Drying 
The most popular method for microencapsulation is the spray drying technique. 
Particles of polyesters can be formulated by dissolving the polymer in a volatile 
organic solvent, such as methylene chloride or acetone. The polymer solution is 
nebulized inducing a fast evaporation of the solvent. The nozzle used for this 
purpose, the concentration and the viscosity of the solution, as well as the 
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boiling point of the solvent mainly determine the resulting size of the dried 
particles. Drugs can be incorporated by i) dissolving the drug in the organic 
solvent, ii) dispersing the solid, micronized drug in the polymer solution or iii) 
dispersing an aqueous solution of the drug in the polymer solution, either by an 
emulsion process or by high speed homogenization. As a result the drug 
becomes entrapped in the polymer matrix or it is covered by the polymer shell.  
Important advantages of the spray drying technique are the ease of formulation 
and particle isolation. This results in parameters especially important for the 
industrial preparation, such as cost effectiveness, reproducibility and a 
widespread knowledge of the technique. Moreover, the process can be operated 
under sterile conditions, which is extremely favorable for the formulation of 
parenteral delivery devices. The temperatures used for the process depend on the 
boiling point of the solvent. For example, the preparation of PLGA particles 
from a methylene chloride solution can be achieved at a maximal temperature of 
46°C. The polymer and the drug reach this temperature only for a very short 
period, as the evaporating solvent quickly cools the polymer solution and the 
droplets formed thereof. The exposure to organic solvents represents a noxious 
stress for many drugs, especially proteins. To stabilize the active components 
they can be lyophilized with cryoprotectants and dispersed a solid state in the 
polymer solution. DNA is less susceptible to degradation in organic solvents, 
therefore it is possible to use a dispersing process of the aqueous DNA solution 
in the organic solvent. A disadvantage of the spray drying technique is the 
relatively low yield, when small amounts of material are used. In large-scale 
productions this effect is reversed leading to very high yields.  
 
Solvent Evaporation / Double Emulsion Methods (W/O/W) 
These methods are based on the formation of small polymer solution droplets 
using a water immiscible organic solvent in an aqueous solution [59]. The 
double emulsion method has also been referred to as “in water drying method”. 
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The organic solvents mainly used for this process are methylene chloride and 
chloroform. When the solvent evaporation technique is used for the 
encapsulation of drugs, the drug substances have to be dissolved in the organic 
phase. For the encapsulation of drugs in aqueous medium a double emulsion 
method, e.g. a water - in oil - in water (W/O/W) technique has to be used. The 
primary emulsion is prepared by homogenizing a small volume of the aqueous 
drug solution into the organic solution containing the polymer by high-speed 
homogenization, sonication or vortexing. The primary dispersion is further 
rapidly injected into an aqueous stabilizer solution during simultaneous 
homogenization. Poly (vinyl alcohol) in concentrations ranging from 0.1 % to 
0.5% is a frequently used stabilizer of the external phase. Others, such as 
poloxamers and gelatin have previously been used as well. The organic solvents 
have to exhibit a low solubility in water to permit the diffusion into the large 
external phase and further their evaporation.  
During this process the polymer solidifies, resulting in microparticles containing 
small droplets of the aqueous drug solution. This implies that the solidification 
of the polymer occurs fast enough to inhibit the coalescence of the two, inner 
and external, aqueous phases. To achieve this, the volume of the external phase 
has to be large enough to rapidly extract the organic solvent from the polymer. 
The microparticles can be isolated and lyophilized for appropriate storage and 
stability. This technique provides the possibility to encapsulate hydrophilic 
drugs, including peptides and proteins, e.g. growth factors, LH-RH agonists [60-
63], vaccines [64,65], as well as small molecular compounds, such as 
pseudoephedrine [66,67]. However, the interaction of proteins with hydrophobic 
surfaces may lead to alterations of their quaternary structure. The release 
kinetics of small hydrophilic molecules as well was difficult to control. Thus, 
this technique remains a challenge as it highly depends on the drug used.  
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Phase-Separation 
The phase separation technique takes advantage of the decreasing solubility of a 
polymer in a solvent through the addition of a third non-solvent of this polymer. 
At a defined point of the process the polymer precipitates. This occurs 
particularly at surfaces and interphases. In this manner, the dispersed or 
dissolved drug is coated with the polymer. This method can be used for either 
hydrophilic compounds in aqueous solution, which are homogenized in the 
polymer solution, as well as for drugs that are dissolved or dispersed in a solid 
state in the polymer solution. The removal of the organic solvent, as well as the 
preservation of protein quaternary structures, however, have been shown to be a 
major difficulty related to that technique [68]. The preparation of organic, 
solvent-free systems using polymers such as chitosan for the preparation of 
microparticles may provide new possibilities [69]. 
 
Recently it has been demonstrated that microparticles have a great potential as 
DNA vaccine adjuvants [70-72]. Different strategies were pursued to exploit this 
property. Plasmid DNA was either encapsulated into the microparticles or was 
adsorbed onto the surface of cationic microparticles. Each system has shown 
both advantages and drawbacks.  
 
DNA Encapsulation into Microparticles 
Modern vaccines consist of proteins, peptides or polysaccharides, which have to 
be administered parenterally to circumvent degradation in the gastrointestinal 
tract. However, multiple injections have to be given to fully induce an effective 
immunization. Hence, the aim of many researchers was to develop a vaccine 
delivery system that would provide a modulation of antigen release, resulting in 
the `single shot  ´ vaccine [73,74]. These devices, in consequence, would exhibit 
prolonged immune responses [75-77]. Additionally, encapsulated antigens could 
be applied orally, thereby increasing the compliance and, more importantly, the 
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mucosal immunity. Particles < 10µm can be taken up by the gastrointestinal 
associated lymphatic tissue (GALT), which directly delivers the antigen to a 
mucosal tissue rich in dendritic cells [78]. Generally, the mucosa represents the 
main entry gate of pathogens into the organism. Thus, a strong mucosal immune 
response can directly neutralize the pathogen at the site of its entrance into the 
organism [70,79,80].  
In most of the studies, DNA has been encapsulated into microparticles using a 
double emulsion technique, due to the hydrophilicity of the molecules. 
However, to obtain particle sizes suitable for GALT, as well as APC uptake 
high-speed homogenization or sonication had to be used. Compared to peptides 
and proteins, DNA is a relatively stable molecule in organic solvents, however it 
is degraded and looses its bioactivity rapidly when sheared [81,82]. Moreover, 
DNA encapsulated in poly (D,L-lactide-co-glycolide) (PLGA) polymers is 
exposed to an acidic environment created by glycolic- and lactic acid PLGA 
degradation products in the core of the particle [83,84]. Under these conditions, 
DNA is damaged by acid-catalyzed depurination and chain breaks [81]. Several 
methods have been proposed to circumvent the detrimental effects of 
encapsulation, such as i) the complexation of DNA with cationic polymers prior 
to encapsulation [85-87], ii) the homogenization in a frozen state 
(cryopreparation) [82], iii) the addition of buffering excipients [88] and iv) the 
preparation by self-emulsification processes [89]. Walter et al. moreover used a 
spray drying approach to prepare DNA microparticles adding buffering agents 
[86,88]. While the formulation concerns could possibly be solved, the effect of 
DNA release kinetics on the immune response has not been fully elucidated yet. 
The synchronization of the danger signal, practically the injection of 
microparticles, and DNA release were shown to be crucial on the induction of a 
potent immune response [90]. 
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DNA Adsorption on the Surface of Cationic Microparticles  
DNA can be adsorbed onto cationic surfaces, due to the overall negative charge 
arising from anionic phosphate groups, situated every 0.17 nm throughout the 
molecule [91,92]. Therefore, DNA can be associated with pre-formed cationic 
microparticles via electrostatic forces.  
 
Fig.3: Scheme of DNA adsorption on microparticles containing PEI 
(polyethylenimine) as a model cationic agent.  
 
In such a system DNA is only added to the preparation after the particle 
formation. Thus, DNA is not damaged during the formulation by high-speed 
homogenization or sonication. 
Singh et al. successfully used these microparticles for in vivo immunization. The 
cationic surface properties of the microparticles were introduced by CTAB 
(Hexadecyltrimethylammonium-bromide), a cationic detergent, used as an 
external stabilizer [72]. CTAB thereby integrated into the surface of the particle. 
Immunizations against HIV gag and env proteins in small animals and rhesus 
macaques exhibited very promising results [93,94]. This system has different 
advantages over DNA encapsulation, i) DNA is not degraded during the 
formulation process, ii) a supplementary adjuvant effect arises from the CpG 
motives, presented on the surface of the system and iii) the interval between the 
injection of the particulate matter and release, or accessibility of DNA is much 
shorter than for encapsulated delivery systems.  
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NANOPARTICLES 
 
Nanoparticles are characterized by definition, ranging from 1 to 1000 nm, 
however typically most formulations range from 1 to 500 nm in size. It has been 
shown by several groups that the cellular uptake, especially into non-phagocytic 
cells, is facilitated by small particle sizes [95]. Therefore, the preparation of 
nanoparticulate antigen delivery devices was hypothesized to achieve better 
immune reactions. The uptake in both phagocytic, as well as non-phagocytic 
cells, could increase the overall efficiency, as there are two modes of action 
proposed for the induction of DNA immunization. The two pathways are either 
the direct transfection of antigen presenting cells or ‘cross-priming’ by the 
transfection of cells. Similar to the microparticles, antigens can be either 
encapsulated into nanoparticles or adsorbed on the surface of cationic 
nanoparticles.  
 
Preparation Techniques 
 
Nanoparticle formation can be achieved using the same methods used to prepare 
microparticles by adjusting process parameters to obtain smaller particles.  
 
Solvent Evaporation 
It has been described previously that this technique requires on the formation of 
a disperse system composed of an immiscible organic polymer solution within 
an external stabilizer solution. The formulation of nanoparticles, as compared to 
microparticles, requires higher homogenization speeds or sonication, which both 
produce smaller droplets. Other parameters, such as the polymer concentration, 
exhibiting lower viscosities or surface active stabilizers in the external phase, 
facilitate the formation of nanoparticles. Hydrophilic drugs can be encapsulated 
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in nanoparticles using this method [96]; however, the resulting encapsulation 
efficiency of the hydrophilic substances is low, due to an increased diffusion of 
the hydrophilic molecules into the outer stabilizer phase. This diffusion 
increases, due to a delayed precipitation of diluted polymer solutions, a larger 
surface area of the nanoparticles and decreased diffusion barriers. Moreover, the 
high-energy sources used for the homogenization are detrimental to most 
protein, peptide and DNA drugs. 
A modification of the solvent evaporation technique developed, is represented 
by the spontaneous emulsification / solvent diffusion method. In this case, a 
water soluble organic solvent is added to the water immiscible solvent 
containing the polymer [97]. Upon dispersion into the aqueous stabilizer 
solution, the water soluble organic compound diffuses into the aqueous phase. 
This leads to interphase turbulences resulting in smaller droplets and finally to 
the precipitation of the polymer. This method is effective for the encapsulation 
of lipophilic drugs. In contrast, hydrophilic drugs display low encapsulation 
efficiencies, due to their diffusion into the external phase. Several variations of 
this method exist, including the preparation in oil [98]. 
 
Solvent Displacement 
This technique has further evolved from the spontaneous emulsification / solvent 
diffusion method [98]. The polymer is dissolved in a water soluble organic 
solvent, for example acetone, and the solution is injected into a stirred, aqueous, 
stabilizer solution. Upon contact of both solutions, the acetone immediately 
diffuses into the water, creating interphase turbulences. These interphase 
turbulences lead to the rupture of the interphase and to the formation of droplets 
that can further disrupt, resulting in smaller droplets containing the polymer. 
This process continues until precipitation of the polymer occurs. The described 
interfaced turbulences and disruption are known as Marangoni effect [99-101]. 
The turbulences in the interphase occur from convection of acetone as mass 
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transport into the aqueous phase and back into the vicinity of the interphase. The 
rate of acetone diffusion, and thus droplet disruption tendencies are dependent 
on the gradient of the diffusing solvent. As this system is in direct contact with 
water, the encapsulation of hydrophilic drugs generally results in very poor 
encapsulation efficiencies [101]. An advantage however is the quasi absence of 
high-speed homogenization and the absence of chlorated organic solvents.  
 
 
 
Fig.4: Schematic process of nanoparticle formation by solvent displacement 
through the mass transport of the solvent acetone in the water phase. 
 
Salting out 
This technique is based on the competition of compounds for solvents. A highly 
concentrated salt solution, containing a stabilizer, is added to a stirred acetone 
solution containing the polymer. The high salt concentration leads to a phase 
separation. Further addition of the salt solution leads to the reversal of the 
emulsion. The obtained oil-in-water emulsion is added to a larger volume of 
water, which finally results in the precipitation and complete diffusion of the 
organic solvent into the water [102]. Again, this process can only be efficiently 
used for the encapsulation of lipophilic substances.  
 
polymer
acetone
polymer
acetone
        acetone
1 2 3 4
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DNA Encapsulation  
The encapsulation of hydrophilic molecules into small hydrophobic polymer 
nanoparticles has been shown to be a rather inefficient process. As a result, 
several groups have encapsulated DNA into hydrophilic molecules such as 
chitosan. This process can be managed using a complexation-coacervation 
technique, where both a chitosan solution at pH 5 and a DNA solution are 
heated to 55°C and mixed together resulting in coacervation [103]. This 
technique circumvents the use of organic solvents, however replaces them with 
other potentially degrading conditions. 
Several research groups have performed immunizations with these systems via 
oral administration. The immunizations resulted in elevated IgG antibodies 
against toxoplasma gonidii. However, a mucosal type of immunity indicated by 
IgA antibodies would be more beneficial [104]. Another group successfully 
modulated a peanut antigen-induced anaphylactic reaction in mice by converting 
high IgE levels to IgA and serum IgG antibodies using the oral allergen-gene 
immunization [105].  
 
DNA Adsorption onto Nanoparticles 
As discussed above, the encapsulation of hydrophilic molecules, such as DNA is 
difficult to achieve when using common nanoparticle preparation methods. 
Therefore, several research groups have adsorbed DNA onto the cationic surface 
of nanoparticles. The ideal ratio of DNA to nanoparticles depends on the 
nanoparticle size and charge. A prerequisite for the association of DNA with the 
particle surface through electrostatic interactions is the introduction of a cationic 
charge onto the nanoparticle surface. This has been achieved using CTAB, as 
was already mentioned for the preparation of cationic microparticles [72,106]. 
CTAB was internalized into the particles to generate a cationic surface of wax 
nanoparticles as well [107]. Other cationic polymers have recently been used for 
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the preparation of nanoparticles for DNA adsorption, e.g. poly (L-lysine) graft-
polysaccharides [108] and chitosan nanoparticles [109]. 
DNA can further be adsorbed onto inorganic, surface-modified nanoparticles. 
The preparation of surface - tethered DNA - gold-dendron nanoparticles [110], 
or amino modified silica nanoparticles [111] has been described. Aggregation 
and flocculation, resulting in impeded endocytosis is a frequently observed 
drawback of colloidal nanoparticle systems onto which DNA has been adsorbed 
[110,112]. Still, the immunizations with DNA nanoparticles of 300 nm have 
shown promising IgG levels, similar to those achieved with the CTAB modified 
microparticles studied by Singh et al. [72]. Cationic wax nanoparticles of 100 
nm containing the endosomolytic agent, DOPE (dioleoyl phosphatidyl-
ethanolamine), have demonstrated better immunization results as compared to 
naked DNA [113]. 
 
CONCLUSION  
Numerous methods have been proposed to increase and modulate immune 
responses of DNA vaccines. Particulate, as well as non-particulate adjuvants 
have been investigated. Protective vaccination in small animal models has been 
successful, however, neither the traditional adjuvants nor new developments 
have successfully led to protection in human trials [18]. Therefore, further 
developments in vaccine adjuvants and certainly the well-advised combination 
of adjuvants, such as particulate adjuvants with non-particulate, 
immunomodulators is necessary to succeed. Recently, it has been proposed that 
the combination of DNA vaccines and protein antigen boosts would result in 
more promising immune responses [94]. However, DNA vaccine adjuvants 
leading to better gene delivery, depot effects, targeting of antigen presenting 
cells and activation of the desired type of immune response have to be further 
improved. The exact mechanism of such systems is not yet fully understood and 
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further investigations will be necessary to continue the progress and 
developments for more effective vaccines  
  
REFERENCES 
 
[1] M.A. Liu, DNA vaccines: a review, J Intern Med 253 (2003) 402-410. 
[2] J.A. Wolff, R.W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani, 
P.L. Felgner, Direct gene transfer into mouse muscle in vivo, Science 247 
(1990) 1465-1468. 
[3] J.B. Ulmer, J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Felgner, V.J. 
Dwarki, S.H. Gromkowski, R.R. Deck, C.M. DeWitt, A. Friedman, et al., 
Heterologous protection against influenza by injection of DNA encoding a viral 
protein, Science 259 (1993) 1745-1749. 
[4] D.C. Tang, M. DeVit, S.A. Johnston, Genetic immunization is a simple 
method for eliciting an immune response, Nature 356 (1992) 152-154. 
[5] E.F. Fynan, R.G. Webster, D.H. Fuller, J.R. Haynes, J.C. Santoro, H.L. 
Robinson, DNA vaccines: protective immunizations by parenteral, mucosal, and 
gene-gun inoculations, Proc Natl Acad Sci U S A 90 (1993) 11478-11482. 
[6] J.B. Ulmer, R.R. Deck, C.M. DeWitt, A. Friedman, J.J. Donnelly, M.A. 
Liu, Protective immunity by intramuscular injection of low doses of influenza 
virus DNA vaccines, Vaccine 12 (1994) 1541-1544. 
[7] M. Corr, A. von Damm, D.J. Lee, H. Tighe, In vivo priming by DNA 
injection occurs predominantly by antigen transfer, J Immunol 163 (1999) 4721-
4727. 
[8] J.B. Ulmer, R.R. Deck, C.M. Dewitt, J.J. Donnelly, M.A. Liu, Generation 
of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral 
protein in muscle cells: antigen presentation by non-muscle cells, Immunology 
89 (1996) 59-67. 
[9] B. Doe, M. Selby, S. Barnett, J. Baenziger, C.M. Walker, Induction of 
cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is 
facilitated by bone marrow-derived cells, Proc Natl Acad Sci U S A 93 (1996) 
8578-8583. 
28                                                                                                             Chapter 1 
_________________________________________________________________________________________________________________ 
 
[10] E. Walter, D. Dreher, M. Kok, L. Thiele, S.G. Kiama, P. Gehr, H.P. 
Merkle, Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the 
delivery of DNA to human-derived macrophages and dendritic cells, J Control 
Release 76 (2001) 149-168. 
[11] E. Walter, L. Thiele, H.P. Merkle, Gene Delivery systems to phagocytic 
antigen-presenting cells, STP pharma sciences 11 (2001) 45-56. 
[12] K.S. Denis-Mize, M. Dupuis, M.L. MacKichan, M. Singh, B. Doe, D. 
O'Hagan, J.B. Ulmer, J.J. Donnelly, D.M. McDonald, G. Ott, Plasmid DNA 
adsorbed onto cationic microparticles mediates target gene expression and 
antigen presentation by dendritic cells, Gene Ther 7 (2000) 2105-2112. 
[13] K. Inaba, J.P. Metlay, M.T. Crowley, R.M. Steinman, Dendritic cells 
pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted 
T cells in situ, J Exp Med 172 (1990) 631-640. 
[14] M.L. Albert, B. Sauter, N. Bhardwaj, Dendritic cells acquire antigen from 
apoptotic cells and induce class I-restricted CTLs, Nature 392 (1998) 86-89. 
[15] R. Wang, D.L. Doolan, T.P. Le, R.C. Hedstrom, K.M. Coonan, Y. 
Charoenvit, T.R. Jones, P. Hobart, M. Margalith, J. Ng, W.R. Weiss, M. 
Sedegah, C. de Taisne, J.A. Norman, S.L. Hoffman, Induction of antigen-
specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine, Science 
282 (1998) 476-480. 
[16] S. Calarota, G. Bratt, S. Nordlund, J. Hinkula, A.C. Leandersson, E. 
Sandstrom, B. Wahren, Cellular cytotoxic response induced by DNA 
vaccination in HIV-1-infected patients, Lancet 351 (1998) 1320-1325. 
[17] Assessment of adenoviral vector safety and toxicity: report of the National 
Institutes of Health Recombinant DNA Advisory Committee, Hum Gene Ther 
13 (2002) 3-13. 
[18] J. Cohen, Disappointing data scuttle plans for large-scale AIDS vaccine 
trial, Science 295 (2002) 1616-1617. 
[19] A.T. Glenny, C.G. Pope, H. Waddington, C. Wallace, Immunological 
notes. XIII. The antigenic value of toxoid precipitated by potassium alum., J 
Pathol Bacteriol 29 (1926) 38-39. 
[20] G. Ramon, Procédé pour accroître la production des antitoxines, Ann. 
Inst. Pasteur 40 (1926) 1-10. 
[21] H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. 
Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira, A Toll-like receptor 
recognizes bacterial DNA, Nature 408 (2000) 740-745. 
Introduction                                                                                                         29 
_________________________________________________________________________________________________________________ 
 
[22] D.N. Cook, I.J. Hollingsworth, D.A. Schwartz, Toll-like receptors and the 
genetics of innate immunity, Curr Opin Allergy Clin Immunol 3 (2003) 523-
529. 
[23] E. Bullock, R.A. Elton, Dipeptide frequencies in proteins and the CpG 
deficiency in vertebrate DNA, J Mol Evol 1 (1972) 315-325. 
[24] A.M. Krieg, The role of CpG motifs in innate immunity, Curr Opin 
Immunol 12 (2000) 35-43. 
[25] M. Roman, E. Martin-Orozco, J.S. Goodman, M.D. Nguyen, Y. Sato, A. 
Ronaghy, R.S. Kornbluth, D.D. Richman, D.A. Carson, E. Raz, 
Immunostimulatory DNA sequences function as T helper-1-promoting 
adjuvants, Nat Med 3 (1997) 849-854. 
[26] R.S. Chu, O.S. Targoni, A.M. Krieg, P.V. Lehmann, C.V. Harding, CpG 
oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) 
immunity, J Exp Med 186 (1997) 1623-1631. 
[27] J.C. Cox, A.R. Coulter, Adjuvants-a classification and review of their 
modes of action, Vaccine 15 (1997) 248-256. 
[28] D. Frasca, L. Adorini, S. Landolfo, G. Doria, Enhancing effect of IFN-
gamma on helper T cell activity and IL 2 production, J Immunol 134 (1985) 
3907-3911. 
[29] D.L. Lodmell, N.B. Ray, J.T. Ulrich, L.C. Ewalt, DNA vaccination of 
mice against rabies virus: effects of the route of vaccination and the adjuvant 
monophosphoryl lipid A (MPL), Vaccine 18 (2000) 1059-1066. 
[30] G.L. Gustafson, M.J. Rhodes, Bacterial cell wall products as adjuvants: 
early interferon gamma as a marker for adjuvants that enhance protective 
immunity, Res Immunol 143 (1992) 483-488; discussion 573-484. 
[31] J.T. Ulrich, K.R. Myers, Monophosphoryl lipid A as an adjuvant. Past 
experiences and new directions, Pharm Biotechnol 6 (1995) 495-524. 
[32] S. Sasaki, K. Sumino, K. Hamajima, J. Fukushima, N. Ishii, S. 
Kawamoto, H. Mohri, C.R. Kensil, K. Okuda, Induction of systemic and 
mucosal immune responses to human immunodeficiency virus type 1 by a DNA 
vaccine formulated with QS-21 saponin adjuvant via intramuscular and 
intranasal routes, J Virol 72 (1998) 4931-4939. 
[33] A.T. Larregina, S.C. Watkins, G. Erdos, L.A. Spencer, W.J. Storkus, D. 
Beer Stolz, L.D. Falo, Jr., Direct transfection and activation of human cutaneous 
dendritic cells, Gene Ther 8 (2001) 608-617. 
30                                                                                                             Chapter 1 
_________________________________________________________________________________________________________________ 
 
[34] N. Exposito Raya, A. Garcia Diaz, Y. Carrazana Lopez, D. Quintana 
Vazquez, D. Pichardo Diaz, N. Martinez de la Puente, C. Duarte Cano, 
Preformulation study of the vaccine candidate TAB9 against HIV-1., Biotechnol 
Appl Biochem 36 (2002) 149-153. 
[35] W. Nicklas, Aluminum salts, Res Immunol 143 (1992) 489-494; 
discussion 574. 
[36] S. Shirodkar, R.L. Hutchinson, D.L. Perry, J.L. White, S.L. Hem, 
Aluminum compounds used as adjuvants in vaccines, Pharm Res 7 (1990) 1282-
1288. 
[37] Y. Shi, H. HogenEsch, S.L. Hem, Change in the degree of adsorption of 
proteins by aluminum-containing adjuvants following exposure to interstitial 
fluid: freshly prepared and aged model vaccines, Vaccine 20 (2001) 80-85. 
[38] N.R. Butler, B.D. Wilson, P.F. Benson, J.A. Dudgeon, J. Ungar, A.J. 
Beale, Effect of aluminium phosphate on antibody response to killed 
poliomyelitis vaccine, Lancet 2 (1962) 114-115. 
[39] D. Mancino, Z. Ovary, Adjuvant effects of amorphous silica and of 
aluminium 
hydroxide on IgE and IgG1 antibody production in different inbred mouse 
strains, Int Arch Allergy Appl Immunol 61 (1980) 253-258. 
[40] A. Mark, B. Bjorksten, M. Granstrom, Immunoglobulin E responses to 
diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid 
DT-vaccines, Vaccine 13 (1995) 669-673. 
[41] Q. He, A.R. Mitchell, S.L. Johnson, C. Wagner-Bartak, T. Morcol, S.J. 
Bell, Calcium phosphate nanoparticle adjuvant, Clin Diagn Lab Immunol 7 
(2000) 899-903. 
[42] M. Minutello, F. Senatore, G. Cecchinelli, M. Bianchi, T. Andreani, A. 
Podda, P. Crovari, Safety and immunogenicity of an inactivated subunit 
influenza virus vaccine combined with MF59 adjuvant emulsion in elderly 
subjects, immunized for three consecutive influenza seasons, Vaccine 17 (1999) 
99-104. 
[43] J.D. Almeida, D.C. Edwards, C.M. Brand, T.D. Heath, Formation of 
virosomes from influenza subunits and liposomes, Lancet 2 (1975) 899-901. 
[44] R. Gluck, E. Walti, Biophysical validation of Epaxal Berna, a hepatitis A 
vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes 
(IRIV), Dev Biol (Basel) 103 (2000) 189-197. 
[45] E. Claassen, W. de Leeuw, P. de Greeve, C. Hendriksen, W. Boersma, 
Freund's complete adjuvant: an effective but disagreeable formula, Res Immunol 
143 (1992) 478-483; discussion 572. 
Introduction                                                                                                         31 
_________________________________________________________________________________________________________________ 
 
[46] B. Morein, K.L. Bengtsson, Immunomodulation by iscoms, immune 
stimulating complexes, Methods 19 (1999) 94-102. 
[47] J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.R. Tice, R.M. Gilley, 
Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres 
as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level 
of toxin-neutralizing antibodies, Infect Immun 59 (1991) 2978-2986. 
[48] M. Kempf, B. Mandal, S. Jilek, L. Thiele, J. Voros, M. Textor, H.P. 
Merkle, E. Walter, Improved stimulation of human dendritic cells by receptor 
engagement with surface-modified microparticles, J Drug Target 11 (2003) 11-
18. 
[49] L. Thiele, B. Rothen-Rutishauser, S. Jilek, H. Wunderli-Allenspach, H.P. 
Merkle, E. Walter, Evaluation of particle uptake in human blood monocyte-
derived cells in vitro. Does phagocytosis activity of dendritic cells measure up 
with macrophages?, J Control Release 76 (2001) 59-71. 
[50] D.F. Nixon, C. Hioe, P.D. Chen, Z. Bian, P. Kuebler, M.L. Li, H. Qiu, 
X.M. Li, M. Singh, J. Richardson, P. McGee, T. Zamb, W. Koff, C.Y. Wang, D. 
O'Hagan, Synthetic peptides entrapped in microparticles can elicit cytotoxic T 
cell activity, Vaccine 14 (1996) 1523-1530. 
[51] H.G. Bungenberg de Jong, H.R. Kruyt, Koazervation (Entmischung in 
Kolloidalen Systemen), Koll. Zeitsch 50 (1930) 39-48. 
[52] D.L. Wise, G.J. McCormick, G.P. Willet, L.C. Anderson, Sustained 
release of an antimalarial drug using a copolymer of glycolic/lactic acid, Life 
Sci 19 (1976) 867-873. 
[53] B. Ekman, I. Sjoholm, Improved stability of proteins immobilized in 
microparticles prepared by a modified emulsion polymerization technique, J 
Pharm Sci 67 (1978) 693-696. 
[54] K.W. Leong, J. Kost, E. Mathiowitz, R. Langer, Polyanhydrides for 
controlled release of bioactive agents, Biomaterials 7 (1986) 364-371. 
[55] T. Yoshioka, K. Ikeuchi, M. Hashida, S. Muranishi, H. Sezaki, Prolonged 
release of bleomycin from parenteral gelatin sphere-in-oil-in-water multiple 
emulsion, Chem Pharm Bull (Tokyo) 30 (1982) 1408-1415. 
[56] I.M. van der Lubben, G. Kersten, M.M. Fretz, C. Beuvery, J. Coos 
Verhoef, H.E. Junginger, Chitosan microparticles for mucosal vaccination 
against diphtheria: oral and nasal efficacy studies in mice, Vaccine 21 (2003) 
1400-1408. 
[57] M. Chasin, R. Langer, Biodegradable polymers as drug delivery systems 
(Marcel Dekker, New York, 1990). 
32                                                                                                             Chapter 1 
_________________________________________________________________________________________________________________ 
 
[58] M. Vert, G. Schwach, R. Engel, J. Coudane, Something new in the field of 
PLA/GA bioresorbable polymers?, J Control Release 53 (1998) 85-92. 
[59] M. Yamamoto, H. Okada, Y. Ogawa, T. Miyagawa, Preparation of a 
biodegradable high molecular polymer and its use as a pharmaceutical 
excipient., in: (Eur. Pat. Appl, 1996) 23 pp. 
[60] H. Okada, T. Heya, Y. Ogawa, T. Shimamoto, One-month release 
injectable microcapsules of a luteinizing hormone-releasing hormone agonist 
(leuprolide acetate) for treating experimental endometriosis in rats, J Pharmacol 
Exp Ther 244 (1988) 744-750. 
[61] J.M. Pean, M.C. Venier-Julienne, F. Boury, P. Menei, B. Denizot, J.P. 
Benoit, NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect 
of some formulation parameters on encapsulated NGF stability, J Control 
Release 56 (1998) 175-187. 
[62] Y. Capan, G. Jiang, S. Giovagnoli, K.H. Na, P.P. DeLuca, Preparation and 
characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled 
release of human growth hormone, AAPS PharmSciTech 4 (2003) E28. 
[63] K.F. Pistel, B. Bittner, H. Koll, G. Winter, T. Kissel, Biodegradable 
recombinant human erythropoietin loaded microspheres prepared from linear 
and star-branched block copolymers: influence of encapsulation technique and 
polymer composition on particle characteristics, J Control Release 59 (1999) 
309-325. 
[64] S.J. Challacombe, D. Rahman, H. Jeffery, S.S. Davis, D.T. O'Hagan, 
Enhanced secretory IgA and systemic IgG antibody responses after oral 
immunization with biodegradable microparticles containing antigen, 
Immunology 76 (1992) 164-168. 
[65] A.K. Hilbert, U. Fritzsche, T. Kissel, Biodegradable microspheres 
containing influenza A vaccine: immune response in mice, Vaccine 17 (1999) 
1065-1073. 
[66] R. Alex, R. Bodmeier, Encapsulation of water-soluble drugs by a 
modified solvent evaporation method. I. Effect of process and formulation 
variables on drug entrapment, J Microencapsul 7 (1990) 347-355. 
[67] M.K. Yeh, S.M. Tung, D.W. Lu, J.L. Chen, C.H. Chiang, Formulation 
factors for preparing ocular biodegradable delivery system of 5-fluorouracil 
microparticles, J Microencapsul 18 (2001) 507-519. 
[68] K.S. Anseth, A.T. Metters, S.J. Bryant, P.J. Martens, J.H. Elisseeff, C.N. 
Bowman, In situ forming degradable networks and their application in tissue 
engineering and drug delivery, J Control Release 78 (2002) 199-209. 
Introduction                                                                                                         33 
_________________________________________________________________________________________________________________ 
 
[69] I.M. van der Lubben, J.C. Verhoef, A.C. van Aelst, G. Borchard, H.E. 
Junginger, Chitosan microparticles for oral vaccination: preparation, 
characterization and preliminary in vivo uptake studies in murine Peyer's 
patches, Biomaterials 22 (2001) 687-694. 
[70] D.H. Jones, S. Corris, S. McDonald, J.C. Clegg, G.H. Farrar, Poly(DL-
lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal 
antibody responses to encoded protein after oral administration, Vaccine 15 
(1997) 814-817. 
[71] M.L. Hedley, J. Curley, R. Urban, Microspheres containing plasmid-
encoded antigens elicit cytotoxic T- cell responses, Nat Med 4 (1998) 365-368. 
[72] M. Singh, M. Briones, G. Ott, D. O'Hagan, Cationic microparticles: A 
potent delivery system for DNA vaccines, Proc Natl Acad Sci U S A 97 (2000) 
811-816. 
[73] J.L. Cleland, L. Barron, P.W. Berman, A. Daugherty, T. Gregory, A. Lim, 
J. Vennari, T. Wrin, M.F. Powell, Development of a single-shot subunit vaccine 
for HIV-1. 2. Defining optimal autoboost characteristics to maximize the 
humoral immune response, J Pharm Sci 85 (1996) 1346-1349. 
[74] L. Shi, M.J. Caulfield, R.T. Chern, R.A. Wilson, G. Sanyal, D.B. Volkin, 
Pharmaceutical and immunological evaluation of a single-shot hepatitis B 
vaccine formulated with PLGA microspheres, J Pharm Sci 91 (2002) 1019-
1035. 
[75] D.E. Rafferty, M.G. Elfaki, P.C. Montgomery, Preparation and 
characterization of a biodegradable microparticle antigen/cytokine delivery 
system, Vaccine 14 (1996) 532-538. 
[76] R.K. Gupta, M. Singh, D.T. O'Hagan, Poly(lactide-co-glycolide) 
microparticles for the development of single-dose controlled-release vaccines, 
Adv Drug Deliv Rev 32 (1998) 225-246. 
[77] I.D. Spiers, J.E. Eyles, L.W. Baillie, E.D. Williamson, H.O. Alpar, 
Biodegradable microparticles with different release profiles: effect on the 
immune response after a single administration via intranasal and intramuscular 
routes, J Pharm Pharmacol 52 (2000) 1195-1201. 
[78] M. Kanke, I. Sniecinski, P.P. DeLuca, Interaction of microspheres with 
blood constituents: I. Uptake of polystyrene spheres by monocytes and 
granulocytes and effect on immune responsiveness of lymphocytes, J Parenter 
Sci Technol 37 (1983) 210-217. 
[79] D.H. Jones, C.D. Partidos, M.W. Steward, G.H. Farrar, Oral delivery of 
poly(lactide-co-glycolide) encapsulated vaccines, Behring Inst Mitt (1997) 220-
228. 
34                                                                                                             Chapter 1 
_________________________________________________________________________________________________________________ 
 
[80] D.J. Brayden, A.W. Baird, Microparticle vaccine approaches to stimulate 
mucosal immunisation, Microbes Infect 3 (2001) 867-876. 
[81] R.K. Evans, Z. Xu, K.E. Bohannon, B. Wang, M.W. Bruner, D.B. Volkin, 
Evaluation of degradation pathways for plasmid DNA in pharmaceutical 
formulations via accelerated stability studies, J Pharm Sci 89 (2000) 76-87. 
[82] S. Ando, D. Putnam, D.W. Pack, R. Langer, PLGA microspheres 
containing plasmid DNA: preservation of supercoiled DNA via cryopreparation 
and carbohydrate stabilization, J Pharm Sci 88 (1999) 126-130. 
[83] M. Vert, J. Mauduit, S. Li, Biodegradation of PLA/GA polymers: 
increasing complexity, Biomaterials 15 (1994) 1209-1213. 
[84] K. Mader, B. Bittner, Y. Li, W. Wohlauf, T. Kissel, Monitoring 
microviscosity and microacidity of the albumin microenvironment inside 
degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-
triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks 
and hydrophilic poly(ethyleneoxide) B blocks, Pharm Res 15 (1998) 787-793. 
[85] Y. Capan, B.H. Woo, S. Gebrekidan, S. Ahmed, P.P. DeLuca, Influence 
of formulation parameters on the characteristics of poly(D, L- lactide-co-
glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA, J 
Controlled Release 60 (1999) 279-286. 
[86] K.N. Atuah, E. Walter, H.P. Merkle, H.O. Alpar, Encapsulation of 
plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent 
evaporation and spray-drying methods, J Microencapsul 20 (2003) 387-399. 
[87] M. Dunne, D.C. Bibby, J.C. Jones, S. Cudmore, Encapsulation of 
protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide 
microparticles, J Control Release 92 (2003) 209-219. 
[88] E. Walter, K. Moelling, J. Pavlovic, H.P. Merkle, Microencapsulation of 
DNA using poly(DL-lactide-co-glycolide): stability issues and release 
characteristics, J Control Release 61 (1999) 361-374. 
[89] F.F. Zhuang, R. Liang, C.T. Zou, H. Ma, C.X. Zheng, M.X. Duan, High 
efficient encapsulation of plasmid DNA in PLGA microparticles by organic 
phase self-emulsification, J Biochem Biophys Methods 52 (2002) 169-178. 
[90] K. Regnstrom, E.G. Ragnarsson, M. Koping-Hoggard, E. Torstensson, H. 
Nyblom, P. Artursson, PEI - a potent, but not harmless, mucosal immuno-
stimulator of mixed T-helper cell response and FasL-mediated cell death in 
mice, Gene Ther 10 (2003) 1575-1583. 
[91] W.M. Gelbart, R.F. Bruinsma, P.A. Pincus, A.V. Parsegian, DNA-
Inspired Electrostatics, Physics Today (2000). 
Introduction                                                                                                         35 
_________________________________________________________________________________________________________________ 
 
[92] B.-Y. Ha, A.J. Liu, Physical questions posed by DNA condensation, in: T. 
Radeva (Ed.), Physical Chemistry of Polyelectrolytes (2001). 
[93] D. O'Hagan, M. Singh, M. Ugozzoli, C. Wild, S. Barnett, M. Chen, M. 
Schaefer, B. Doe, G.R. Otten, J.B. Ulmer, Induction of potent immune responses 
by cationic microparticles with adsorbed human immunodeficiency virus DNA 
vaccines, J Virol 75 (2001) 9037-9043. 
[94] G. Otten, M. Schaefer, C. Greer, M. Calderon-Cacia, D. Coit, J. Kazzaz, 
A. Medina-Selby, M. Selby, M. Singh, M. Ugozzoli, J. zur Megede, S.W. 
Barnett, D. O'Hagan, J. Donnelly, J. Ulmer, Induction of broad and potent anti-
human immunodeficiency virus immune responses in rhesus macaques by 
priming with a DNA vaccine and boosting with protein-adsorbed polylactide 
coglycolide microparticles, J Virol 77 (2003) 6087-6092. 
[95] M.P. Desai, V. Labhasetwar, E. Walter, R.J. Levy, G.L. Amidon, The 
mechanism of uptake of biodegradable microparticles in Caco-2 cells is size 
dependent, Pharm Res 14 (1997) 1568-1573. 
[96] M.F. Zambaux, F. Bonneaux, R. Gref, P. Maincent, E. Dellacherie, M.J. 
Alonso, P. Labrude, C. Vigneron, Influence of experimental parameters on the 
characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion 
method, J Control Release 50 (1998) 31-40. 
[97] T. Niwa, H. Takeuchi, T. Hino, N. Kunou, Y. Kawashima, In vitro drug 
release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with 
nafarelin acetate prepared by a novel spontaneous emulsification solvent 
diffusion method, J Pharm Sci 83 (1994) 727-732. 
[98] Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino, T. Niwa, Properties 
of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared 
by novel emulsion solvent diffusion methods, Eur J Pharm Biopharm 45 (1998) 
41-48. 
[99] C. Marangoni, Über die Ausbreitung der Tropfen einer Flüssigkeit auf der 
Oberfläche einer anderen, Ann. Phys. (Leipzig) 143 (1871) 337-354. 
[100] B. Dimitrova, I.B. Ivanov, E. Nakache, Mass transport effects on the 
stability of emulsion: Emulsion films with acetic acide and acetone diffusing 
across the interface, J. Dispersion Science and Technology 9 (1988) 321-341. 
[101] T. Niwa, H. Takeuchi, T. Hino, N. Kunou, Y. Kawashima, Preparations of 
biodegradable nanospheres of water-solubleand insoluble drugs with D,L-lactide 
/ glycolide copolymer by a novel spontaneous emulsification solvent diffusion 
method, and the drug release behavior, J Control Release 25 (1993) 89-98. 
[102] E. Allemann, J.C. Leroux, R. Gurny, E. Doelker, In vitro extended-release 
properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a 
salting-out procedure, Pharm Res 10 (1993) 1732-1737. 
36                                                                                                             Chapter 1 
_________________________________________________________________________________________________________________ 
 
[103] K.W. Leong, H.Q. Mao, V.L. Truong-Le, K. Roy, S.M. Walsh, J.T. 
August, DNA-polycation nanospheres as non-viral gene delivery vehicles, J 
Control Release 53 (1998) 183-193. 
[104] M. Bivas-Benita, M. Laloup, S. Versteyhe, J. Dewit, J. De Braekeleer, E. 
Jongert, G. Borchard, Generation of Toxoplasma gondii GRA1 protein and 
DNA vaccine loaded chitosan particles: preparation, characterization, and 
preliminary in vivo studies, Int J Pharm 266 (2003) 17-27. 
[105] K. Roy, H.Q. Mao, S.K. Huang, K.W. Leong, Oral gene delivery with 
chitosan--DNA nanoparticles generates immunologic protection in a murine 
model of peanut allergy, Nat Med 5 (1999) 387-391. 
[106] C. Chavany, T. Saison-Behmoaras, T. Le Doan, F. Puisieux, P. Couvreur, 
C. Helene, Adsorption of oligonucleotides onto polyisohexylcyanoacrylate 
nanoparticles protects them against nucleases and increases their cellular uptake, 
Pharm Res 11 (1994) 1370-1378. 
[107] Z. Cui, R.J. Mumper, Genetic immunization using nanoparticles 
engineered from microemulsion precursors, Pharm Res 19 (2002) 939-946. 
[108] A. Maruyama, T. Ishihara, J.S. Kim, S.W. Kim, T. Akaike, Nanoparticle 
DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and 
poly(D,L-lactic acid), Bioconjug Chem 8 (1997) 735-742. 
[109] X.W. Li, D.K. Lee, A.S. Chan, H.O. Alpar, Sustained expression in 
mammalian cells with DNA complexed with chitosan nanoparticles, Biochim 
Biophys Acta 1630 (2003) 7-18. 
[110] N. Hussain, B. Singh, T. Sakthivel, A.T. Florence, Formulation and 
stability of surface-tethered DNA-gold-dendron nanoparticles, Int J Pharm 254 
(2003) 27-31. 
[111] C. Kneuer, M. Sameti, E.G. Haltner, T. Schiestel, H. Schirra, H. Schmidt, 
C.M. Lehr, Silica nanoparticles modified with aminosilanes as carriers for 
plasmid DNA, Int J Pharm 196 (2000) 257-261. 
[112] H.W. Walker, S.B. Grant, Factors influencing the flocculation of colloidal 
particles by a model anionic polyelectrolyte, Colloids Surfaces 119 (1996) 229-
239. 
[113] Z. Cui, L. Baizer, R.J. Mumper, Intradermal immunization with novel 
plasmid DNA-coated nanoparticles via a needle-free injection device, J 
Biotechnol 102 (2003) 105-115. 
 
 
 
Aims and Scope  37 
_________________________________________________________________________________________________________________ 
 
 
CHAPTER 2 
_________________________________________________________________________________________________________________ 
 
 
AIMS AND SCOPE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38   Chapter 2 
_________________________________________________________________________________________________________________ 
 
AIMS AND SCOPE 
 
 
The great potential of DNA vaccines could not yet be used as efficiently, as 
hoped for in the beginning of DNA vaccine development in the 90’s. Adjuvant 
systems are needed to (1) increase the DNA delivery, (2) achieve targeting to 
antigen presenting cells and (3) induce the activation of the immune response to 
reach protective levels. Although encapsulation of DNA in particulate systems 
has demonstrated promising results, numerous drawbacks of such systems 
persist.  
Firstly, DNA is degraded by high-speed shear forces during the encapsulation 
into polymeric particles.  
Further, DNA is exposed to acidic degradation products, such as lactic and 
glycolic acids of the polymer, which, in consequence, reduce the DNA 
bioactivity.  
Finally, the gene delivery efficiency of most of the particulate systems is low.  
 
We hypothesized that protecting DNA during the encapsulation process would 
increase DNA stability and bioactivity. The stabilizing agents should further 
modulate the DNA release kinetics from the formulation, to reduce DNA 
degradation by acidic polyester degradation products.  
 
Adsorption onto pre-formed particles could circumvent DNA degradation during 
particle formation. As polyethylenimine (PEI) is a very efficient non-viral 
transfection agent we expected that the incorporation of PEI into particles could 
result in highly efficient DNA adsorption onto microparticles and gene delivery.  
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We hypothesized that the efficiency of DNA delivery systems could be greatly 
increased using polymers with specifically designed properties for that use.  
Hence, to inhibit the acidification of the particle core the polymer should be fast 
degrading, it should ideally protect the DNA during and after the formulation of 
particles and promote gene delivery.  
It was aimed to develop and characterize process parameters for DNA 
encapsulation using such a system. The formulation should then be optimized 
with respect to physico-chemical properties, such as small particle sizes and 
DNA stabilization, as well as efficient endocytosis and high gene delivery 
efficiencies by in vitro investigations.  
Promising formulations should prove their potency as adjuvants for DNA 
immunization in vivo.    
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SUMMARY 
 
Recently, several research groups have shown the potential of 
microencapsulated DNA as adjuvants for DNA immunization [1]. The 
techniques generally used for the encapsulation of hydrophilic molecules into 
hydrophobic polymers are the modified double emulsion method and spray 
drying of water in oil dispersions. We investigated the possibility to encapsulate 
DNA avoiding shear forces which readily degrade DNA during these processes. 
DNA microparticles were prepared with polyethylenimine (PEI) as a 
complexing agent for DNA. Polycations are capable of stabilizing DNA against 
enzymatic, as well as mechanical degradation. Further, complexation was 
hypothesized to facilitate the encapsulation by reducing the size of the 
macromolecule. In this study, we additionally evaluated the possibility of 
encapsulating lyophilized DNA and lyophilized DNA / PEI complexes. For this 
purpose, we used the spray drying and double emulsion techniques. The size of 
the microparticles was characterized by laser diffractometry and the particles 
were visualized by scanning electron microscopy (SEM). DNA encapsulation 
efficiencies were investigated photometrically after complete hydrolysis of the 
particles. Finally, the DNA release characteristics from the particles were 
studied.  
Particles with a size of < 10 µm which represents the threshold for phagocytic 
uptake, could be prepared with these techniques [2]. The encapsulation 
efficiency ranged from 100 % to 35 % for low theoretical DNA loadings. DNA 
complexation with PEI 25 kDa prior to the encapsulation process reduced the 
initial burst release of DNA for all techniques used. Spray-dried particles 
without PEI exhibited high burst releases, whereas double emulsion techniques 
showed continuous release rates. 
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INTRODUCTION  
 
Microencapsulation of hydrophilic bio-molecules has gained increasing interest 
in the past decades as more peptide, protein, oligonucleotide and DNA drugs 
have become available for pharmaceutical use. These bio-molecules are 
frequently characterized by instabilities in physiological environments resulting 
in very short half-lives, especially due to their susceptibility to acidic or 
enzymatic degradation. The encapsulation in biodegradable polymers was found 
to be a promising approach to protect these drugs from nocuous factors. Further, 
the possibility of a controllable and sustained release, resulting in prolonged 
application intervals presents a major advantage. As most of the molecules of 
interest are hydrophilic, the favored method of encapsulation is the modified 
double emulsion method, referred to as “in water drying” [3]. This method 
allows the encapsulation of aqueous drug solutions within a hydrophobic 
polymer. One significant disadvantage of this process is the possible degradation 
of bio-molecules during the homogenization step of particle formation. Several 
groups have investigated alternative methods for homogenization, such as 
cryopreparation, used by Ando et al [4]. In addition to the harsh environment 
created during microparticle preparation, subsequent polymer degradation can 
also induce a destructive environment. For example, a typical feature of 
polyester microparticles is the decrease of the pH in the particle core. This 
results in the deterioration of encapsulated compounds [5,6].  
Hence, we investigated the feasibility of several microencapsulation techniques, 
which, in our opinion, could be candidates for the protective encapsulation of 
bio-molecules, such as DNA. The encapsulation techniques used in this study 
were i) water in oil in water and ii) solid in oil in water techniques (Fig.1), as 
well as iii) spray drying water in oil and iv) solid in oil preparations (Fig.2). The 
effect of DNA complexation with PEI on the encapsulation efficiency and the 
DNA release were investigated in this study. 
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MATERIALS AND METHODS 
 
Microparticle Preparation  
Modified Double Emulsion Method  
Particle formation was performed by a modified double emulsion technique [7]. 
250 µl of an aqueous herring testes DNA (HT DNA) solution 2 mg/ml were 
homogenized in 5 ml methylene chloride solution containing 500 mg of a 
commercial PLGA (50:50), (Resomer® 503, Mw 41,000 g/ mol, specifications 
supplied by the manufacturer, Boehringer Ingelheim, Ingelheim, Germany). A 
scheme of the microparticle preparation is shown in Figure 1. The dispersion 
was formed by primary homogenization at 13,500 rpm for 30 s using an IKA 
10G homogenizer (IKA, Staufen, Germany). This product was immediately 
injected into 400 ml of a stirred 0.1% poly (vinyl alcohol) (PVA) (Mowiol® 3-
83, Mw 14,000; Clariant, Frankfurt) stabilizer solution in ultrapure water at pH 
7. This final dispersion was formed using an IKA 25F homogenizer (IKA, 
Staufen, Germany) at 20,500 rpm for 30 sec. The particle suspension was stirred 
with a propeller mixer at 200 rpm for three hours for methylene chloride 
extraction and evaporation. Microparticles were isolated by centrifugation at 
10,000 rpm for 10 min in a Sorvall high-speed centrifuge (LB-5, Haereus, 
Hanau, Germany). DNA/PEI 25 kDa (BASF, Ludwigshafen, Germany) 
complexes were encapsulated by the same method. The complexes were 
prepared in ultrapure water at a nitrogen to phosphate (N/P) ratios of 5 and 10. 
The PEI/DNA complexes in 250 µl water were dispersed in the organic polymer 
solution for the formation of microparticles. The centrifuged particles were re-
suspended and washed three times and finally redispersed in 2 - 5 ml of 
ultrapure water. The preparation was lyophilized in a Modulyo freeze dryer 
(Edwards, Sussex, UK). Microparticles were stored at 4 °C until further use.  
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Fig.1: Scheme of the modified double emulsion method (W/O/W) and the solid 
in oil in water method (S/O/W). 
 
Solid in Oil in Water  
Solid in oil in water microparticles were prepared by homogenizing dispersions 
of lyophilized HT DNA or PEI/DNA complexes combined with the 
lyoprotectants, glycin (Merck, Darmstadt, Germany) or lactose (Hoechst, 
Frankfurt, Germany)(Fig.1). 
For that purpose, a 0.1% DNA solution containing either 5 % lactose or 5 % 
glycin was lyophilized. In parallel, PEI 25 kDa / DNA complexes at a N/P ratio 
of 5 were lyophilized with a 0.1% DNA content in 5% lactose or glycin aqueous 
solutions. Both formulations were micronized in a mortar for 20 minutes. The 
powders were dispersed in 2 ml of the organic methylene chloride solution 
containing 200 mg RG 503. The amount of the powdered substance was 
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calculated to obtain a theoretical loading of 0.1 % DNA / polymer [m/m]. The 
dispersion was prepared by homogenizing the solids in the methylene chloride 
solution using an IKA 10G homogenizer (IKA, Staufen, Germany) at 13,500 
rpm for 30 seconds. The product was immediately injected into 200 ml of a 
stirred 0.1 % PVA stabilizer solution in ultrapure water at pH 7. The final 
dispersion was formed with an IKA 25F homogenizer (IKA, Staufen, Germany) 
at 20,500 rpm for 30 sec. The particle suspension was finally stirred at 200 rpm 
for three hours with a propeller mixer in order to extract and evaporate the 
methylene chloride. Microparticles were isolated by centrifugation at 10,000 
rpm in a Sorvall high-speed centrifuge LB-5 for 10 minutes. The particles were 
re-suspended and washed three times and redispersed in 2 – 5 ml volume of 
ultrapure water. Lyophilization was performed in a Modulyo freeze dryer. The 
microparticles were stored at 4 °C until further use. 
 
Spray Drying  
Microparticles were formed by spray drying either a water in oil dispersion or a 
solid in oil dispersion using a Büchi 190 laboratory Mini Spray dryer (Büchi, 
Flawil, Switzerland) (Fig.2). For the water in oil method, 1.47 ml aqueous phase 
was used either containing 1 mg/ml of an aqueous DNA solution or 1 mg/ml 
DNA complexed with PEI at a N/P ratio of 5. For the solid in oil method, 
powdered DNA or PEI/DNA complexes containing either lactose or glycin were 
used. Both of these internal phases were dispersed in 39.62 ml of a methylene 
chloride solution of 1.47 g RG 503. The dispersions were formed by high-speed 
homogenization with an IKA 25F homogenizer (IKA, Staufen, Germany) at 
13,500 rpm for 30 seconds. The resulting dispersion was stirred continuously 
and was spray dried immediately using a 0.5 mm outer mixing two-fluid nozzle 
and an inlet temperature of 45-46 °C. The outlet temperature was set to 32-35 °C 
by the pump rate, which was set to the lowest possible velocity.  
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Fig.2: Scheme of the spray drying techniques using a water in oil (W/O) and a 
solid in oil (S/O) technique for DNA encapsulation. 
 
The spray flow, representing the velocity of the air transport in the spray 
cylinder, was set to its maximum with the aspirator settings of 5 / 20, in order to 
reduce the escape of small particles through the cyclon. Particles were collected, 
lyophilized for remaining water elimination and stored at 4°C until use.  
 
Particle Size 
The microparticle size was analyzed by laser diffractometry in a Mastersizer X 
(Malvern Instruments, Germany) equipped with a magnetically stirred cell. 
Measurements were carried out with a 100 mm lens, covering a particle size 
range of 0.5 – 180 µm. The samples were diluted with 0.1% Tween 20 in 
ultrapure water. For data analysis the refractive index of ultrapure water (1.33) 
48   Chapter 3 
_________________________________________________________________________________________________________________  
   
was used. The calculation of particle sizes was carried out using the standard 
modus of the Malvern software according to the theory of Mie. The weighted 
average of the volume distribution [4.3] was used to describe the particle size. D 
[4.3] is defined by   nd4 /   nd3 ( n = number of particles in each area of particle 
sizes, d = medium particle diameter in the area of particle sizes). All 
measurements were carried out in triplicate. 
 
Scanning Electron Microscopy 
Scanning electron microscopy (SEM) was performed using a Hitachi S 510 
(Hitachi, Tokyo, Japan) in vacuum at a voltage of 25 kV after gold sputter 
coating using an Edwards/ Kniese Sputter Coater S150 (Edwards, Germany).  
 
DNA Encapsulation Efficiency 
DNA encapsulation efficiency was measured by complete hydrolysis of the 
weighted particles in 1 ml 0.4 N NaOH. The concentration of DNA was 
measured photometrically using a Shimadzu UV-160 (Shimadzu, Duisburg, 
Germany) at a wavelength of 260 nm. Concentrations were calculated from 
calibration curves of degraded DNA.  
 
DNA Release 
DNA release was studied by suspending triplicates of 5- 10 mg of microparticles 
exactly weighted in 1 ml of ultrapure water at pH 7. Water was chosen to 
circumvent solubility problems of DNA in buffers containing divalent ions. The 
samples were incubated at 37°C and agitated once a day. For DNA release 
analysis, the sample triplicates were centrifuged at 2000 rpm for 5 min in an 
Eppendorf 5415C centrifuge (Wesseling, Germany), according to Gebredikan et 
al. [8]. The supernatant was analyzed for DNA at 260 nm. 
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RESULTS AND DISCUSSION  
 
Microparticle size for gene delivery to antigen presenting cells or to the mucosal 
associated lymphocyte tissue is limited to 10 µm, which represents the threshold 
for phagocytic uptake [2]. Therefore, microparticles for this purpose have to be 
smaller that those usually formulated for controlled drug delivery [9]. In most 
cases, this implies the use of high-speed shear forces to better disrupt the 
aqueous phase, as well as the oil droplets. As a consequence, the effectiveness of 
encapsulation is reduced resulting from an increased diffusion of the hydrophilic 
compound into the external phase. Other possibilities to reduce the particle size, 
such as the use of a less viscous polymer solution, higher concentrations of 
stabilizers in the external phase cannot prevent this phenomenon [10,11]. 
Therefore, we investigated several methods of microparticle preparation with the 
aim of formulating microparticles <10 µm exhibiting efficient drug loadings and 
sustained drug release profiles.  
The size of the microparticles obtained by spray drying were similar, 
independently of the formulation variation in this study, ranging from 2.55 µm 
to 8,15 µm (Table 1). This is in accordance with the literature [12,13]. The 
particle size mainly depends on the viscosity of the organic phase, the boiling 
point of the organic solvent and the geometry of the nozzle [11]. 
W/O/W microparticles exhibited particle sizes smaller than 10 µm making them 
suitable for phagocytosis. In contrast, S/O/W microparticles exhibited diameters 
larger 10 µm. The microparticles prepared using solid in oil (S/O) techniques 
did not display increased diameters, although the micronized solid components 
were in part larger than the polyester particles (Fig.3). These larger solid 
fragments however did not appear to influence the size measurement. This could 
either be attributed to the dissolution of uncoated particles in the aqueous 
medium during laser diffractometry or, alternatively, this phenomenon could be 
attributed to the very low amount of the larger, polymer coated particles. 
50   Chapter 3 
_________________________________________________________________________________________________________________  
   
 
Microparticle  Method Size [µm] Content [%] 
DNA 0.1 % W/O 4.74 ± 0.15 0.104 ± 0.011 
DNA/PEI  0.1 % W/O 8.15 ± 1.09  0.111 ± 0.011  
DNA 1 % W/O 5.53 ± 0.42 0.665 ± 0.011 
DNA/PEI (5) 1 % W/O 2.87 ± 0.09 0.681 ± 0.016 
DNA/PEI (10) 1 % W/O 5.15 ± 1,54 0.673 ± 0.048 
DNA / glycin 0.1% S/O 3.32 ± 0.03 0.104 ± 0.011 
DNA / lactose 0.1% S/O 2.55 ± 0.18 0.049 ± 0.005 
DNA/PEI / glycin 0.1% S/O 3.97 ± 0.01 0.105 ± 0.014 
DNA/PEI / lactose 0.1% S/O 4.03 ± 0.17 0.035 ± 0.004 
DNA/PEI / glycin 1% S/O 6.68 ± 0.82 0.683 ± 0.027 
DNA 0.1% W/O/W 8.61 ± 2.87 0.086 ± 0.001 
DNA/PEI (5) 0.1% W/O/W 4.09 ± 1.01 0.112 ± 0.007 
DNA/PEI (10) 0.1% W/O/W 6.09 ± 0.66 0.085 ± 0.004 
DNA / glycin 0.1% S/O/W 15.84 ± 2.89 0.048 ± 0.008 
DNA / lactose 0.1% S/O/W 16.55 ± 1.88 0.107 ± 0.007 
DNA/PEI / glycin 0.1% S/O/W 7.44 ± 0.03 0.085 ± 0.003 
DNA/PEI / lactose 0.1% S/O/W 13.96 ± 8.73 0.064 ± 0.01 
 
Table 1: Characterization of microparticles formulated using the four 
preparation techniques described. Particle size was measured by laser 
diffractometry in triplicate and described by the weighted average of the volume 
distribution [4.3] as average and standard deviation. HT DNA content was 
assessed by photometric measurement at 260 nm after particle hydrolysis in 0.4 
N NaOH and presented as average and standard deviation. 
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Fig.3: SEM micrographs of 0.1% DNA loaded RG 503 (PLGA) particles. (a) 
PEI/DNA complexes lyophilized in a 5 % glycin solution. (b) S/O spray dried 
microparticles with DNA lyophilized in glycin, (c) S/O spray dried 
microparticles of PEI/DNA complexes lyophilized in glycin, (d) W/O 1% DNA 
spray dried particles with PEI/DNA complexes in solution. (e) W/O/W particles 
of DNA and (f) W/O/W particles of PEI/ DNA complexes. 
a b 
d c 
e f 
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The SEM micrographs showed large, non-spherical components mixed with the 
microparticles. This finding indicates an incomplete incorporation of the solid, 
due to insufficient size reduction. Other methods of particle size reduction, such 
as stirred ball mills would potentially be more appropriate. We considered that 
particles may have also been disrupted by the high-speed homogenization 
process. All other microparticle sizes measured by laser diffractometry were 
confirmed by SEM. Furthermore, SEM revealed microparticles with regular 
shapes and a smooth surfaces. 
The DNA content of all preparations was assessed by complete hydrolysis of the 
particles (Table 1). A low theoretical drug loading of 0.1%, resulted, as 
expected, in efficient encapsulation of most of the formulations, using the water 
in oil in water (W/O/W) technique [14]. The S/O/W preparations demonstrated 
encapsulation efficiencies ranging from 64 % of theoretical drug loading to 
complete encapsulation. However, the S/O/W-glycin-DNA particles had low 
encapsulation efficiencies. This was attributed to the incomplete encapsulation 
of the lyophilized components. The microparticles formulated by spray drying 
exhibited high drug loading efficiencies with the exception of the lactose solids. 
  
The DNA release was investigated for all preparations and presented as the 
fraction of DNA released into the medium. The release properties of W/O spray 
dried particles depended, to a great extent on the formulation parameters. For 
example, the microparticles prepared with 1% theoretical DNA loading released 
the complete dose within hours (Fig.4). In comparison, microparticles with a 
0.1% DNA theoretical loading exhibited an initial burst of approximately 40% 
and a slow release, reaching a maximal level of 70 %. High burst effects of 
small spray dried microparticles prepared from similar polyesters as used in this 
study have been previously reported [15,16]. Interestingly, the complexation 
with PEI 25 kDa resulted in an 80% retention of the DNA within the particle 
formulation.  
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Fig.4: HT DNA release from RG 503 microparticles using a water in oil spray 
drying technique. 
 
DNA 0.1%;    PEI/DNA 0.1% (N/P= 5);
 
 DNA 1%;   PEI 
/DNA 1% (N/P= 5)   PEI/DNA 1% (N/P = 10) 
 
This was surprising, as it was assumed that polymer degradation would be 
accelerated by PEI, due to a basic catalyzed polyester hydrolysis [17].  
One possible explanation may be the enhanced dispersion of the DNA/PEI 
complex in the polymeric matrix, due to the lower hydrophilicity of the complex 
or due to its reduced size. Another reason for the low release could be the 
aggregation of the DNA complexes in the particle core, which could arise from 
the swelling of PEI following its protonation in the acidic core of the particle. 
Due to strong electrostatic interactions of the complex, DNA will not get 
separated from PEI and retained in the particles.  
The S/O spray dried formulations with a theoretical DNA loading of 0.1% were 
compared to the 0.1% W/O particles (Fig.5). Both the lactose and glycin 
containing DNA microparticles released DNA instantly. This effect was 
explained by the high content of water soluble components, comparable to the 
1% DNA W/O formulation.  
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Fig.5: HT DNA release from RG 503 microparticles prepared by a solid in oil 
spray drying technique with a theoretical DNA loading of 0.1%. 

 DNA lactose; 
  PEI/DNA lactose;   DNA glycin; ∆  PEI/DNA glycin; 
 
DNA (W/O);    
PEI/DNA (W/O) 
 
The high content of small, water soluble molecules resulted in the formation of 
large pores in the particle followed by an immediate release of the DNA [18]. 
The formulations with DNA/PEI complexes, in contrast, again exhibited slower 
DNA release profiles. The lactose DNA/PEI formulation showed a faster release 
as compared to the glycin containing particles. This could be explained by a 
lower interaction of the sugar, lactose, with the DNA/PEI complex, as compared 
to that with the amino acid. 
The S/O/W and W/O/W microparticles were characterized by relatively constant 
release kinetics, exhibiting low burst releases of approximately 20% (Fig.6). The 
W/O/W formulations, either DNA alone or complexed with PEI, were 
characterized by very slow release profiles. This can be explained by the good 
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polymer shell formation over of the inner water droplets. Surprisingly, the 
glycin-S/O/W particles exhibited a faster release of the complexed DNA 
compared to DNA alone with the amino acid.  
Although, these release kinetics appear to be the most suitable, the particle sizes 
of these formulations were larger than the phagocytosis threshold.  
 
Fig.6: HT DNA release of RG 503 microparticles using a solid in oil in water 
encapsulation method and the water in oil in water method for 0.1% DNA 
encapsulation. 

 DNA lactose;   PEI/DNA lactose;   DNA glycin; ∆  PEI/DNA 
glycin; + PEI/DNA W/O/W; x DNA W/O/W 
 
CONCLUSIONS  
 
In this study we investigated potential techniques for DNA microencapsulation 
and possibilities to circumvent shear forces by lyophilizing the unstable 
component prior to its exposure. Still, the size of solid particles has to be further 
reduced before homogenous particles and efficient encapsulation could be 
0 2 4 6 8 10 12 14 16
0
20
40
60
80
100
120
D
N
A 
re
sl
ea
se
 
[%
]
time [d]
56   Chapter 3 
_________________________________________________________________________________________________________________  
   
achieved. The concentration of the lyoprotectants should be reduced to decrease 
the amount of water soluble components in the spray dried formulation in order 
to allow a higher drug loading. In this study, PEI 25 kDa obviously acted as 
retardation agent, in contrast to results reported by de Rosa et al. [17], who 
observed increased oligonucleotide release levels after PEI complexation. The 
extremely high N/P ratios (N/P 15 and 45) used in this study could be one 
explanation for this discrepancy. This could increase the DNA release, possibly 
by inducing pore formation or catalysis of polyester degradation. Further the 
decomplexation rate of oligonucleotides compared to DNA is considerably 
higher. Although the S/O/W and the W/O/W formulations exhibited the most 
regular release properties, the S/O formulations showed the greatest potential to 
modulate the release kinetics of DNA by allowing the addition of complexing 
agents and lyoprotectants.  
 
REFERENCES 
 
[1] D.H. Jones, S. Corris, S. McDonald, J.C. Clegg, G.H. Farrar, Poly(DL-
lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal 
antibody responses to encoded protein after oral administration, Vaccine 15 
(1997) 814-817. 
[2] J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.R. Tice, R.M. Gilley, 
Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres 
as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level 
of toxin-neutralizing antibodies, Infect Immun 59 (1991) 2978-2986. 
[3] M. Yamamoto, H. Okada, Y. Ogawa, T. Miyagawa, Preparation of a 
biodegradable high molecular polymer and its use as a pharmaceutical 
excipient., in: (Eur. Pat. Appl, 1996) 23 pp. 
[4] S. Ando, D. Putnam, D.W. Pack, R. Langer, PLGA microspheres 
containing plasmid DNA: preservation of supercoiled DNA via cryopreparation 
and carbohydrate stabilization, J Pharm Sci 88 (1999) 126-130. 
DNA Microparticles by Spray drying and Double Emulsion Techniques          57  
_________________________________________________________________________________________________________________ 
 
[5] K. Mader, B. Bittner, Y. Li, W. Wohlauf, T. Kissel, Monitoring 
microviscosity and microacidity of the albumin microenvironment inside 
degrading microparticles from poly(lactide-co-glycolide) (PLG) or ABA-
triblock polymers containing hydrophobic poly(lactide-co-glycolide) A blocks 
and hydrophilic poly(ethyleneoxide) B blocks, Pharm Res 15 (1998) 787-793. 
[6] M. Vert, J. Mauduit, S. Li, Biodegradation of PLA/GA polymers: 
increasing complexity, Biomaterials 15 (1994) 1209-1213. 
[7] H. Okada, T. Heya, Y. Ogawa, T. Shimamoto, One-month release 
injectable microcapsules of a luteinizing hormone-releasing hormone agonist 
(leuprolide acetate) for treating experimental endometriosis in rats, J Pharmacol 
Exp Ther 244 (1988) 744-750. 
[8] S. Gebrekidan, B. Woo, P.P. DeLuca, Formulation and In vitro 
transfection efficiency of poly (D,L-lactide-co-glycolide) microspheres 
containing plasmid DNA for gene delivery., AAPS Pharm SciTech 1 (2000) 
article 28. 
[9] A.K. Hilbert, Mikroverkapselung von viralen Impfstoffen als Adjuvants: 
In vitro und in vivo Charakterisierung von Influenza A- Spaltvakzienen in 
bioabbaubaren Polyestern, Department of Pharmaceutical Technology and 
Biopharmacy, Philipps University Marburg, 1997. 
[10] K. F. Pistel, B. Bittner, H. Knoll, G. Winter, T. Kissel, Biodegradable 
eecombinant humen erythropoetin loaded microspheres prepared from linear and 
star-branched block copolymers: Influence of encapsulation technique and 
polymer composition on particle characteristics, J. Coltrolled Release 59 (1999) 
309-325. 
[11] M. Jobmann, G. Rafler, Controlled release systems of biodegradable 
polymers. 6th Communication: control of particle size distribution of 
microparticles produced by the solvent evaporation technique., Drugs made in 
Germany 41 (1998) 28-32. 
[12] B. Baras, M.A. Benoit, J. Gillard, Influence of various technological 
parameters on the preparation of spray-dried poly(epsilon-caprolactone) 
microparticles containing a model antigen, J Microencapsul 17 (2000) 485-498. 
[13] P. Johansen, H.P. Merkle, B. Gander, Technological considerations 
related to the up-scaling of protein microencapsulation by spray-drying, Eur J 
Pharm Biopharm 50 (2000) 413-417. 
[14] T. Freytag, A. Dashevsky, L. Tillman, G.E. Hardee, R. Bodmeier, 
Improvement of the encapsulation efficiency of oligonucleotide- containing 
biodegradable microspheres, J Control Release 69 (2000) 197-207. 
58   Chapter 3 
_________________________________________________________________________________________________________________  
   
[15] E. Mathiowitz, H. Bernstein, S. Giannos, P. Dor, R. Langer, 
Polyanhydride microspheres. IV. Morphology and characterization of systems 
made by spray drying, J. Appl. Polym. Sci 45 (1992) 125-134. 
[16] B. Bittner, B. Ronneberger, R. Zange, C. Volland, J.M. Anderson, T. 
Kissel, Bovine serum albumin loaded poly(lactide-co-glycolide) microspheres: 
the influence of polymer purity on particle characteristics, J Microencapsul 15 
(1998) 495-514. 
[17] G. De Rosa, F. Quaglia, M. La Rotonda, M. Besnard, E. Fattal, 
Biodegradable microparticles for the controlled delivery of oligonucleotides, Int 
J Pharm 242 (2002) 225-228. 
[18] B. Bittner, M. Morlock, H. Knoll, G. Winter, T. Kissel, recombinant 
human erythropoietin (rhEPO)loaded poly(lactide-co-glycolide) microspheres: 
influence of the encapsulations technique and polymer purity on microsphere 
characteristics, Eur. J. Pharm. Biophar. 45 (1998) 295-305. 
 
Adsorption of DNA onto cationic Microparticles 59 
_________________________________________________________________________________________________________________ 
 
 
CHAPTER 4 
_________________________________________________________________________________________________________________ 
 
 
CATIONIC MICROPARTICLES CONSISTING OF 
POLY (LACTIDE-CO-GLYCOLIDE) AND 
POLYETHYLENIMINE AS PARENTERAL CARRIERS 
SYSTEMS FOR DNA VACCINATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adsorption of DNA onto cationic Microparticles 60 
_________________________________________________________________________________________________________________ 
 
SUMMARY 
Microparticles were formulated by blending the polymer, poly (lactide-co-
glycolide) (PLGA) (50:50), with different amounts of cationic agents, either PEI 
25 kDa (polyethylenimine) or CTAB (hexadecyltrimethylammonium-bromide). 
The aim was to create microparticles with cationic surface characteristics for 
DNA adsorption. Microparticles formulated with 10% PEI exhibited a highly 
positive ζ-potential, small particle sizes, in contrast to particles prepared with 
CTAB, which showed highly aggregated structures in the scanning electron 
micrographs. PEI 10% microparticles very efficiently adsorbed DNA and 
protected DNA from enzyme degradation.  
Microparticles with up to 10% PEI did not exhibit LDH levels considered as 
toxic, whereas CTAB particles showed higher membrane toxicities. Gene 
delivery efficiencies were assessed via quantification of the reporter gene, 
luciferase, and compared to PEI/DNA complexes. The PEI formulations with 
10% and 50% PEI exhibited elevated transfection efficiencies. The mechanism 
of gene delivery to non-phagocytic cells was studied via covalent fluorescence 
labeling of both the DNA and PEI by confocal microscopy. In vivo 
immunizations were performed with plasmids encoding Listeria monocytogenes 
antigens adsorbed onto PEI 10% microparticles. The efficiency was tested by 
the challenge with an i.v. injection of a lethal dose of the Listeria 
monocytogenes. Mice immunized with three booster injections of 10 µg DNA 
adsorbed onto the particle formulation exhibited a slightly better protection than 
naked DNA. 
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INTRODUCTION  
 
Vaccines can be considered to be one of the most effective developments in 
modern medicine. A considerable drawback of non-live vaccines, however, is 
their lack of effectiveness against intracellular and viral pathogens, such as 
tuberculosis or HIV. A strong immune response against these pathogens 
depends on the induction of a potent cellular immune response and cytotoxic T-
lymphocyte (CTL) reactions. During the past decade, DNA vaccination has been 
increasingly employed in an attempt to achieve simpler, safer, and more 
effective CTL reactions. DNA vaccination involves the inoculation with an 
expression vector that encodes an antigenic protein. The encoded antigen is then 
produced in situ and elicits an immune response [1]. Several studies have shown 
that the induction of more efficient immune responses from DNA vaccination 
could be generated by the use of adjuvant delivery systems [2]. More 
specifically, the adsorption of DNA on the surface of pre-formed cationic 
microparticles resulted in remarkable immune responses [3]. The cationic 
surface charge of these microparticles was obtained by the incorporation of a 
cationic detergent, CTAB, into the surface of the microparticles during their 
preparation. CTAB, was primarily used for DNA isolation from bacteria and 
plants by precipitation [4].  
A microparticulate DNA delivery system based on the adsorption of DNA onto 
its surface has the clear advantage of i) circumventing the degrading effects on 
DNA during particle preparation ii) facilitating a rapid delivery of DNA to 
targeted antigen presenting cells and iii) providing an additional adjuvant effect 
by the presence of bacterial CpG units of the plasmid on the surface of the 
delivery system.  
In the present study, we investigated the potential of PEI to form cationic 
microparticles by direct internalization of the polycation into the PLGA matrix. 
CTAB was also directly mixed with the PLGA (RG 502H) solution. PEI 25 kDa 
Adsorption of DNA onto cationic Microparticles 62 
_________________________________________________________________________________________________________________ 
 
is one of the most powerful non-viral transfection agents used in vitro and in 
vivo [5]. Thus, we hypothesized that the adsorption efficiency and the gene 
delivery would be increased with such a system. The microparticles were 
characterized with regard to their physicochemical properties, their stabilizing 
effects on DNA integrity, in vitro characterization of the membrane toxicity and 
gene delivery. Finally, the most effective in vitro delivery system was used for 
in vivo immunization against the intracellular bacterium, Listeria 
monocytogenes, to assess the induction of a protecting immune response. 
 
MATERIALS AND METHODS 
 
Materials and DNA 
The commercially available poly(lactide-co-glycolide) (PLGA) (50:50), Resomer® 502H, 
(Mw 15,200, uncapped end-groups specifications supplied by the manufacturer) and PLGA 
(50:50), Resomer® 505 (Mw 80,000, specifications supplied by the manufacturer) were 
purchased from Boehringer Ingelheim (Ingelheim, Germany). Partially hydrolyzed 
poly(vinyl-alcohol) (PVA) (Mowiol® 3-83, Mw 14,000) was purchased from Clariant 
(Frankfurt, Germany). Polyethylenimine (PEI) 25 kDa, was purchased from BASF 
(Ludwigshafen, Germany) and stored under exclusion of humidity. Hexadecyltrimethyl-
ammonium-bromide (CTAB) was purchased from Fluka (Buchs, Germany). Plasmid DNA, 
pLuc-CMV, a luciferase encoding plasmid, preceded by a nuclear location signal under the 
control of a CMV promoter, was kindly provided by Chiron (Emeryville, Ca) and amplified 
by PlasmidFactory, (Bielefeld, Germany). All pLuc-CMV probes used were from one 
endotoxin free batch in TE-Buffer pH 8 and stored at – 80°C until use. All other chemicals 
were of analytical grade.  
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Plasmid DNAs encoding p60 named pCiap, listeriolysin O (LLO) named pClisA, and non-
hemolytic, mutant LLO named pChly492 were constructed by Fensterle et al. and effectively 
used for DNA vaccination by gene gun immunization [6,7].  Briefly, wild-type LLO gene and 
p60 gene of Listeria monocytogenes without the bacterial signal sequence were amplified by 
polymerase chain reaction (PCR) and inserted into EcoRI/XbaI site and XhoI/XbaI site of pCI 
mammalian expression vector (Promega, Madison, WI, U.S.A.), respectively. L. 
monocytogenes strain BUG337 encoding an LLO version with a single amino acid (a. a.) 
exchange at the a. a position 492 (Trp-492-Ala) was kindly provided by Dr. P. Cossart [8]. 
The mutant LLO gene was amplified from genomic DNA of L. monocytogenes strain 
BUG337 by PCR, and integrated into XhoI/XbaI site of pCI vector. 
 
Particle Preparation  
Microparticles were prepared by a modified double emulsion procedure under aseptic 
conditions. Briefly, the cationic agent (PEI/CTAB) was dissolved in methylene chloride and 
dispersed in a PLGA solution in methylene chloride resulting in a final volume of 10 ml. The 
amount of cationic agent added to the polymer was specified as % of the PLGA mass. PBS 
buffer of the internal phase was added to the CTAB / methylene chloride solution for 
complete dissolution. Aside from the incorporation of cationic agents into the organic 
polymer solution, microparticles were also prepared in aqueous solutions containing CTAB as 
stabilizer. Microparticle preparation was performed by initial homogenization of 1 ml PBS 
within the polymer solution at 13,500 rpm for 30 s, using an IKA 10G homogenizer (IKA, 
Staufen, Germany). The preparation was immediately injected into 50 ml of a stirred 
stabilizer solution (PVA 0.5% or CTAB 0.5%) and homogenized at 20,500 rpm for further 30 
s, using the IKA 25F homogenizer. The particle suspension was stirred at 200 rpm for 
methylene chloride evaporation over 12 hours in a laminar air flow. Particles were isolated by 
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centrifugation at 4°C in a Sorvall high-speed centrifuge (LB-5, Haereus, Hanau, Germany) at 
6,000 rpm for 20 min. The pellet was re-suspended and washed three times. A sterile 5% 
sucrose solution in distilled water was used, to wash the particles and for the final 
lyophilization in a Beta II lyophilizer (Christ, Osterode, Germany). Particles were stored at 
4°C until use. 
 
Particle Size 
The particle sizes were analyzed by laser diffractometry using a Mastersizer X (Malvern 
Instruments, Herrenberg, Germany) in a stirred cell, with a volume of 15 ml. The 
measurements were carried out with a 100 mm lens, covering a particle size range of 0.5 – 
180 µm. The samples were diluted in ultrapure water for measurement within the required 
range of obscuration. For data analysis the refractive index of ultrapure water (1.33) was used. 
The calculation of particle size was carried out using the standard modus of the Malvern 
software according to the theory of Mie. The weighted average of the volume distribution 
[4.3] was used to describe the particle size. D [4.3] is defined by Σnd4 / Σnd3 ( n = number of 
particles in each area of particle sizes, d = medium particle diameter in the area of particle 
sizes). All measurements were carried out in triplicate. 
 
Scanning Electron Microscopy 
Scanning electron microscopy (SEM) was performed with a CamScan 4 (Cambridge, UK) 
after gold sputter coating using an AUTO 306 (Edwards, UK). High resolution transmission 
electron microscopy imaging (TEM) was performed after cryo-sectioning of the nanoparticles 
with a JEM 3010 (Jeol, Japan) on a collodium grid.  
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Zeta Potential Measurement 
ζ-potential measurements were carried out using the Zetasizer 4 (Malvern Instruments, 
Germany) by electrophoretic light scattering after re-suspending the lyophilized particles in 
low ionic strength buffers (I=0.01) with varying pH from 3 to 8. Samples were diluted to a 
defined count rate interval of 400 – 800 kcps. Electrophoretic light scattering was performed 
in a AZ 104 cell. Average ζ-potential values were calculated from the data of 3 runs. The 
instrument was calibrated with a Malvern –50 mV transfer standard. 
 
DNA Adsorption Efficiency 
DNA was adsorbed onto the microparticles using a 0.5 mg/ml DNA solution to obtain a 
theoretical DNA loading of 1%. The particle suspension containing the DNA resulted in a 
final volume of 400µl. The particles were centrifuged at 10,000 rpm in an Eppendorf 5415C 
centrifuge (Wesseling, Germany) for 10 min after one hour of incubation. The adsorption 
efficiencies were calculated from the remaining DNA in the supernatant by UV measurement 
in a Shimadzu UV-160 (Shimadzu, Duisburg, Germany) at 260nm.  
 
Lactate Dehydrogenase Release 
The release of lactate dehydrogenase (LDH) was performed to characterize the membrane 
toxicity of the microparticle formulations. L929 mouse fibroblasts (DSMZ, Braunschweig, 
Germany) were seeded at a density of 50,000 cells per 2 ml in 12 well culture dishes (Nunc, 
Wiesbaden, Germany) and grown for 24 h prior to the incubation with the particles, according 
to the supplier’s recommendations. The cells were washed twice with PBS buffer (0.1 M, pH 
7.4). Subsequently, the cells were incubated with 2 ml of a microparticle suspension 
containing 1 mg particles /ml PBS buffer. Blank PBS buffer and a 0.1 % Triton-X 100 
solution in PBS buffer were used as controls. 100 µl samples were withdrawn after 180 min 
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and processed according to the manufacturer’s instructions (Sigma Diagnostics). All sample 
values were normalized relative to Triton-X values and expressed as relative LDH release in 
[%]. Each sample was performed in triplicate. The differences of all population means were 
analyzed by a two-sample t-test and one-way ANOVA at the 0.05 level. 
 
DNase Stability 
DNA stability was studied using 100 µl aliquots of the microparticle suspensions containing 1 
µg pDNA. The probes were incubated with 12.25 µl DNase buffer 10x (1M Na-acetate, 50 
mM MgCl2) and 2.5 µl DNase I solution (DNase I Boehringer Mannheim, Germany) (50 I.U. 
/ ml in 50 mM Tris-HCl pH 8, 100 mM KCl). The reaction was terminated by adding 5.7 µl 
EDTA solution (0.5M, pH8). The probes were freeze-dried and stored at –20°C until use. At 
the time of DNA analysis, the dried probes were incubated for one hour in 10 µl TBE-buffer 
(89 mM Tris, 89 mM boric acid, 2 mM Na2EDTA) containing 50 I.U heparin (Serva, 
Heidelberg, Germany). Further, 10 µl Roti-phenol® (Roth, Karlsruhe, Germany) were added 
and incubated for additional 2 hours at room temperature. Before the application onto a 1% 
agarose gel 5 µl glycerol were added to the emulsion. Untreated DNA was applied to the gel 
as a reference. Electrophoresis (Blue Marine 200, Serva, Germany) was carried out at 100 V 
for two hours in TBE-buffer. Ethidium bromide was included in all gels to visualize the DNA 
localization by photography on a UV transilluminator. 
 
In Vitro Transfection Efficiency 
L929 mouse fibroblasts (DSMZ, Braunschweig, Germany) were plated 24 h before 
nanoparticle incubation at a concentration of 50,000 cells / 2 ml in DMEM medium 
supplemented with 10% fetal calf serum (FCS) in 12 well plates. Immediately prior to 
transfection, the medium was removed and replaced by fresh DMEM containing 10% FCS. 
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Aliquots of the microparticle suspension containing 4 µg pLuc-CMV were added to the 
medium. The cell culture medium was removed after 4 hours and replaced with fresh medium 
containing 10% FCS. Cells were harvested after 48 h and washed with PBS pH 7.4 twice, and 
lysed in cell culture lysis reagent (Promega, Mannheim, Germany). Luciferase content was 
assessed using a commercial luminescence kit (Promega) and a Berthold Sirius luminometer 
(Berthold, Pforzheim, Germany). RLUs were converted into luciferase content by calibration 
with recombinant luciferase (Promega). Protein concentrations were determined by a 
modified BCA assay [9]. Transfection experiments were performed in triplicate and presented 
as the mean of the luciferase / protein ratio [ng/mg]. 
 
Cellular Uptake of DNA Nanoparticles 
For confocal microscopy experiments, a Zeiss Axiovert 100M microscope coupled to a Zeiss 
LSM 510 scan module was used. Plasmid DNA was fluorescently labeled with a Cy-3 
rhodamin dye (Mirus, Madison, Wisconsin) according to the manufacturers 
instructions.  
The RG 502H+PEI 10% microparticles were fluorescently labeled by covalent 
coupling with Oregon green 488 (Molecular Probes, Leiden, The Netherlands). 
Briefly, the dry particles without lyoprotectant were re-suspended in 1 ml 
ultrapure water at pH 8. 10 µl of Oregon green in DMSO was added to the 
suspension and stirred for one hour with the particles at room temperature. The 
suspension was centrifuged 10 min at 3000 rpm in a 5415C Eppendorf 
centrifuge at 4°C and washed 4 times with ultrapure water. The resuspended 
particles were freeze-dried and stored at –20°C until further use.  
DNA was adsorbed according to the conditions used for the transfection assays. 
Briefly, Cy-3 labeled DNA was mixed with the original DNA (1:1) and was 
incubated for one hour with the Oregon green labeled particle suspension at a 
DNA / particle ratio of 1:100 [m/m].  
Adsorption of DNA onto cationic Microparticles 68 
_________________________________________________________________________________________________________________ 
 
L929 cells were seeded at a density of 20,000 cells per well in 8 well chamber 
slides (Lab Tek, Nunc, Wiesbaden, Germany). After 24 hours the medium was 
removed. Aliquots of the resulting nanoparticle suspension containing 0.8 µg 
DNA were added to new medium containing 10% FCS. The cells were 
incubated with the nanoparticles for 5, 15, 30, 60 and 180 minutes. The medium 
was removed and cells were washed 4 times with PBS buffer. Fixation of cells 
was performed by incubation with 400 µl paraformaldehyde solution 3% in PBS 
for 20 minutes. The cells were washed 4 times with PBS and incubated for 
additional 20 minutes with a 0.1 mg/ml DAPI (4',6-diamidino-2-phenylindole, 
dihydrochloride, Molecular Probes, Leiden, The Netherlands) solution in PBS 
for nucleus staining. For excitation of the blue DAPI fluorescence an Enterprise 
UV laser with an excitation wavelength 364 nm was used. Excitation of the 
green fluorescence of 5-DTAF labeled polymer was obtained using an argon 
laser with an excitation wavelength of 488 nm and for excitation of red 
fluorescence of the DNA a Helium-Neon laser with an excitation wavelength of 
543 nm was used. Images were recorded in multitracking mode using a longpass 
filter of 385 nm for DAPI, a longpass filter of 505 nm for Oregon Green and a 
longpass filter of 560 nm for rhodamine. 
 
In Vivo Immunization 
Female BALB/c mice (6-8 week-old) were purchased from the Federal Institute 
for Risk Assessment, Berlin, Germany and maintained under specific-pathogen-
free conditions in the animal facilities of the Federal Institute for Risk 
Assessment, Berlin, Germany, or in the animal facilities of the Max-Planck-
Institute for Infection Biology, Berlin, Germany. All animal experiments were 
performed in accordance with German and institutional animal care guidelines. 
Listeria monocytogenes EGD strain Sv 1/2a, a laboratory wild-type strain was 
originally obtained from G. B. Mackaness. The bacteria were grown in Luria-
Bertani (LB) broth (Difco, Heidelberg, Germany) without any antibiotics to an 
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OD600 of 0.6, harvested by centrifugation, and stored as stock in final 10% 
glycerol in LB at –80ºC. The next day, one stock was thawed, plated onto LB 
agar plates, and colony-forming units (CFU) were assessed. 
Sex- and age-matched BALB/c mice in groups of six mice were immunized with 
10 or 100 µg of naked DNA or with 10 µg of DNA adsorbed on 1 mg of the 
microparticle formulation. Immunizations were performed 3 times at 3 weeks 
intervals by intramuscularly (i.m.) injection of 100µl.  Microparticles were 
prepared under aseptic conditions. The freeze dried particles were re-dispersed 
with distilled water and incubated with the DNA constructs over 12 hours at 
4°C.The vaccination protocol was optimized by Fensterle et al.. As positive 
control, sublethal dose (0.1XLD50) of L. monocytogenes EGD strain was 
injected intravenously (i.v.) into mice at the same time as the prime vaccination.  
Mice vaccinated with DNA encoding L. monocytogenes genes were challenged 
i.v. with lethal dose (5XLD50 or 10XLD50) of L. monocytogenes strain EGD in 
100µl of sterile PBS, at day 0, 3 weeks after the last boost. Survival was 
checked daily until day 10 post infection. 
 
RESULTS AND DISCUSSION 
 
Multiple strategies of adjuvant systems have been investigated for the effective 
use of DNA vaccines. One of them represents particulate systems, which have 
been intensively studied by several groups [3,10,11]. The overall aim of 
vaccinologists using particulate systems has been to obtain antigen presentation 
via the (major histocompatibility) MHC I pathway, providing new possibilities 
to act against intracellular pathogens and tumors. With this objective, diversified 
processes for the formation of biodegradable microparticles were studied, such 
as the encapsulation of DNA by modified double emulsion methods [11], spray-
drying or the adsorption of the DNA on cationic microparticles [3,12]. It has 
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become clear that the encapsulation and further a controlled release of the large 
and hydrophilic DNA in a bioactive form was a delicate ambition [13]. 
Moreover, the influences of the release kinetics of DNA from the microparticles 
on the immune response have not yet been fully elucidated.  
However, recently it was shown that the reduction of the interval between the 
emergency of the danger signal, induced by the injection of the particulate 
matter, and DNA release is crucial for the induction of an immune response 
[14]. T achieve this, we developed a new type of cationic microparticles by 
incorporation of PEI 25 kDa into the biodegradable polymeric matrix. PEI 25 
kDa is a well known and highly efficient DNA transfection agent [5]. These 
microparticles were prepared by a modified double emulsion procedure. A 
summary of microparticle characteristics is shown in Table 1. ξ-potential 
measurements were performed to evaluate the capability of DNA adsorption via 
ionic interactions on the microparticle surfaces.  
This study demonstrated that only the incorporation of PEI into the polymer was 
able to produce positive surface charges.  
Particles prepared with the plain polyester RG 502H, using CTAB in the 
external phase had low positive ξ-potentials. RG 505 polymer particles exhibited 
a slight negative ξ-potential, when prepared in CTAB. The ξ-potentials of 
particles prepared with PVA as an external stabilizer were negative, irrespective 
of the PLGA used. The blending of the polyester matrix with increasing 
concentrations of PEI led to the reversal of charge from - 22.9 mV to + 47.3 
mV. For example, particles prepared with 1 % PEI still had a negative ξ-
potential which reversed to positive values when particles were prepared with a 
5 % PEI content. 
The incorporation of PEI into the polymer matrix was possible due to the solubility of PEI in 
methylene chloride, the solvent used for microparticle formulation. A partition coefficient of 
2.9 : 1 (water : methylene chloride) of PEI 25kDa was determined in the two solvents, water 
and methylene chloride. 
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Polymer Cation Stabilizer[a] Size [µm] ξ - Potential [mV] 
Efficiency 
[%][b] 
RG 505   CTAB  37.6 ±  39.9 - 4.40 ± 0.4 33.7 ± 9.5 
   PVA 3.29 ±  3.2 - 24.6 ± 0.7 1.53 ± 2.2 
RG 502H  CTAB 30.5 ±  14.2 5.23 ± 0.1 11.3 ± 2.5 
  PVA 3.82 ±  0.8 - 16.7 ± 0.5 12.0 ± 9.8 
 PEI 0.1% PVA 13.4 ±  1.0 - 22.9 ± 1.0 16.0 ± 1.6 
 PEI 0.5% PVA 0.93 ±  0.2 - 23.0 ± 0.3 18.1 ± 3.1 
 PEI 1% PVA 17.4 ±  9.0 - 17.2 ± 0.8 10.4 ± 1.8 
 PEI 5% PVA 6.94 ±  1.3 17.0 ± 2.8 10.9 ± 1.0 
 PEI 10% PVA 1.39 ±  0.2 47.3 ± 1.2 96.3 ± 4.7 
 PEI 10% CTAB 1.44 ± 0.6  17.7 ± 0.5 96.7 ± 4.0  
 PEI 50% PVA 15.2 ±  2.1 39.2 ± 0.7 31.3 ± 1.5 
 CTAB 0.1% PVA 17.1 ±  3.8 - 22.7 ± 0.3 18.7 ± 13.1 
 CTAB 1% PVA 22.0 ±  1.4 - 19.0 ± 1.5 18.2 ± 13.6 
 CTAB 10% PVA 56.0 ±  15.1 - 13.9 ± 0.8 13.0 ± 1.9 
 CTAB 50% PVA 63.1 ±  10.7 - 14.7 ± 0.3 24.1 ± 6.9 
 
 
Table 1: Characterization of microparticles prepared by blending PLGA with 
cationic components.  
[a] 0.5% PVA or CTAB in distilled water. 
[b] DNA loading efficiency using a 0.5 mg/ml DNA solution in distilled water for 
incubation with the microparticles suspended in distilled water with a resulting 
theoretical DNA loading of 1%.  
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Thus, a diffusion of the cationic agent from the methylene chloride solution into 
the aqueous stabilizer solution was expected. This, however, did not result in the 
complete redistribution of PEI into the external aqueous phase, as demonstrated 
by the highly positive ξ-potential of microparticles prepared with 10% PEI. 
Another cationic agent, CTAB, was used to prepare microparticles with the aim 
to create a cationic surface for DNA adsorption. In contrast to the PEI blend 
particles, these microparticles did not exhibit positive ξ-potentials. Blending 
PLGA with CTAB in concentrations from 0.1 % to 50 % only led to an increase 
in the ξ-potential of only –22.7 to –14.7 mV. This could possibly be explained 
by a different arrangement of the cationic molecule in the biodegradable 
polymer matrix. CTAB was soluble in methylene chloride to some extent. The 
partition coefficient of CTAB in methylene chloride and the aqueous solution 
was determined to be 1 : 2.32 (water : methylene chloride). We assumed, that 
CTAB induced the formation of reversed micelles when the aqueous medium 
(PBS buffer) was added to the organic solution [15]. In consequence CTAB 
would have accumulated in the water/methylene chloride interphase, orienting 
the polar head group into the core of the micelle. This is a reasonable 
assumption, since the CMC of CTAB (21.1 mg/ml) was exceeded in the 
formulation. Taking into account the highly negative ξ-potentials of the CTAB 
microparticles, a subsequent rearrangement of the detergent did not occur. This 
explanation of the ξ-potential values was further supported by the shift of ξ-
potential towards higher values for the particles containing increasing amounts 
of PEI, whereas the increase of the amount of CTAB in the formulation only had 
a minor effect on the ξ-potential. Still, the cationic charge density of the two 
agents has to be considered, as PEI has a very high amine density, compared to 
CTAB which contains only one permanent positive charge per molecule. 
Microparticle sizes ranged from 63.05 µm to 0.93 µm, depending on the 
external stabilizer and the cationic excipient used during particle preparation. 
CTAB exhibited an important influence on the microparticle size when used 
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both in the external stabilizer solution or when added to the internal phase. Both 
formulations with CTAB (RG 505, RG 502H) as cationic stabilizer showed 
approximately 10-times larger hydrodynamic diameters than the analogous 
preparations in PVA solution. The type of PLGA (RG 505, RG 502H) had no 
effect on the particle size. All subsequently prepared microparticles were 
formulated using the lower molecular weight and end-group un-capped PLGA 
(RG 502H), due to its faster degradation characteristics compared to the high 
molecular weight RG 505 polymer [16]. Increasing amounts of CTAB added to 
the polymer solution in methylene chloride and PBS buffer resulted in a 
substantial increase in particle size of the microparticles. Increasing amounts of 
PEI in the PLGA polymer, however, did not have any effect on the final particle 
size. The considerable increase in size of the CTAB containing microparticles 
(0.1% – 50%) can be ascribed to the surface active properties of the cationic 
agent, acting as plasticizer within the polymer matrix. This, in consequence, 
resulted in the aggregation of the microparticles during their preparation or 
during their isolation. This hypothesis was reinforced by the 10-fold larger 
particle diameter of microparticles prepared in CTAB solution compared to 
those formulated in PVA by the same procedure.  
The adsorption efficiency of DNA was investigated in water at pH 7 in presence 
of the sucrose used for lyophilization. The DNA adsorption onto microparticles 
exhibiting negative ξ-potentials was probably the result of non-ionic 
interactions. In contrast, the adsorption efficiencies of microparticles prepared 
with the 10% PEI blend with PLGA correlated with the extremely high ξ-
potential of these formulations, resulting in an approximately 100% DNA 
adsorption efficiency. However, the microparticles formulated with 50% PEI 
exhibited a reduced adsorption efficiency compared to the PEI 10% preparation. 
Under these conditions, PEI could possibly be detached from the PLGA matrix, 
causing the lower adsorption efficiency.  
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Interestingly, an increased DNA adsorption efficiency was measured for the RG 
505 / CTAB preparation compared to the analogue preparation in PVA. The 
50% CTAB blend preparation, as well showed higher DNA adsorption. The ξ-
potentials of these particles were demonstrated to be negative, therefore, an 
additional factor must have influenced the DNA / microparticle interaction, 
possibly the large size of the particles and their aggregated structure. An 
efficient DNA adsorption of the RG 505 / CTAB preparation has already been 
demonstrated by others [3]. With the preparation methods used in this study, we 
did not realize efficiencies as high as those reported, but we did detect 
adsorption of DNA onto the particles. No difference in adsorption efficiency 
was seen for the RG 502H set of particles either prepared with PVA or CTAB as 
a stabilizer.  
SEM micrographs of the microparticles, RG 502H +10% PEI, prepared in either 
PVA or CTAB and microparticles prepared with CTAB, either in the external 
phase or internalized, confirmed the PCS data (Fig.1).  
Interestingly, multiple pores in the particle surface could be observed for both 
+10% PEI preparations, suggesting that adsorption was improved by the larger 
surface area available. Particles prepared with the detergent CTAB were all 
highly aggregated. The RG 505 microparticles formulated with 0.5% CTAB in 
the external phase showed small, but highly aggregated particles. Those in 
which CTAB had been incorporated in an amount of 10% and 50% exhibited 
larger agglomerates. This finding was consistent with the size measurements. 
The CTAB micrographs showed that CTAB was responsible for aggregation as 
it is able to integrate in the polymer surface. The microparticles with 50% PEI 
did not show particles of regular shape. In this formulation, the amount of water 
soluble component disrupted particle formation. 
Adsorption of DNA onto cationic Microparticles 75 
_________________________________________________________________________________________________________________ 
 
 
Fig.1: SEM micrographs of the particles, RG 502H+PEI 10% in 0.5%PVA (a), 
RG 502H+PEI 10% in 0.5% CTAB (b), RG 505 in 0.5% CTAB (c), RG 
502H+CTAB 10% in 0.1% PVA (d), RG 502H+ CTAB 50% (e), RG 502H+PVA 
50% (f). 
e f 
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Specific microparticles were chosen for further analysis. The DNA adsorption, 
as well as the ξ-potential in low ionic strength buffers with different pH (Fig.2) 
were investigated. Low ionic strength buffers were chosen to reduce the 
influence of buffer components on the ξ-potential measurement [17]. We 
intended to evaluate the surface charges at different degrees of protonation and 
possibly correlate them with DNA adsorption characteristics. The formulations 
chosen were RG 505 / CTAB, RG 502H / PVA and the highly adsorbing RG 
502H + 10% PEI prepared in either CTAB or PVA. The RG 505 / CTAB, as 
well as RG 502H / PVA particles displayed negative ξ-potentials over the pH 
range from 8 to 5. In contrast, the microparticles formulated with RG 502H + 
PEI 10% blends exhibited positive ξ-potentials over the full pH range from 3 to 
8. For the latter particles, CTAB stabilization led to higher values than those 
stabilized with PVA. 
 
Fig.2: ξ – potential and adsorption efficiency of microparticles in low ionic 
buffer (I=0.01) at pH 3 – 8. RG 502H / PVA (■), RG 505 / CTAB (○), RG 
502H+PEI / PVA (▲), RG 502H + PEI / CTAB (∇ ). 
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The pronounced increase in ξ-potentials seen for PEI blend microparticles 
demonstrated the presence of protonable groups on the surface of the particles. 
This explanation was reinforced by negligible changes in the ξ-potential of 
particles formulated without PEI (RG 502H / PVA). 
There are two possible reasons for the increased ξ-potential of the CTAB 
stabilized RG 502H+PEI particles. Either CTAB was integrated within the 
polymer surface or the increase was due to the absence of PVA interaction with 
the polymer surface. PVA is known to be to some extent associated with the 
particle surface during particle preparation [18]. Therefore, PVA stabilized 
PLGA particles usually exhibited negative ξ-potentials, as demonstrated for the 
RG 502H / PVA formulation. Since the CTAB stabilized preparations did not 
exhibit greatly increased ξ-potentials, we concluded that the increased ξ-
potentials of the 10% PEI blend particles in CTAB arose from the absence of 
PVA stabilizer, rather than the presence of CTAB.  
The ξ-potentials correlated well with the DNA adsorption efficiencies, which 
were measured in the same low ionic strength buffers from pH 3 to pH 8. Both 
microparticle formulations containing PEI, either prepared in PVA or CTAB 
exhibited almost complete DNA adsorption efficiencies over the investigated pH 
range. The DNA adsorption onto RG 505 / CTAB and RG 502H / PVA particles 
increased in the acidic environment only, from pH 4 onwards.  
The membrane toxicity of the cationic microparticles and cationic agents were 
investigated by LDH release from L929 mouse fibroblasts in vitro (Fig.3). 
Cationic agents have often been demonstrated to induce membrane toxicity, due 
to electrostatic interactions with negatively charged glycocalyx of the cellular 
surface [19,20]. The levels of LDH release obtained for microparticles prepared 
with increasing amounts of PEI 25 kDa, were, with the exception of the 50% 
PEI formulation, less than 10%, the level at which preparations are considered to 
be toxic [19]. Despite the high ξ-potential of the PEI 10% formulation no 
membrane toxicity was observed. 
Adsorption of DNA onto cationic Microparticles 78 
_________________________________________________________________________________________________________________ 
 
 
Fig.3: Membrane toxicity analyzed by LDH release from L929 mouse 
fibroblasts after 3 hours of incubation with microparticles (a) [1 mg/ml] and (b) 
CTAB and PEI 25kDa in solution. 
 
This effect was explained by the incorporation of PEI into the PLGA matrix 
reducing the interactions with the cellular membrane and the accessibility of the 
charges. The PEI 50% blend formulation exhibited higher and toxic LDH 
release, possibly arising from the rapid disintegration of the particle resulting in 
PEI 25kDa release. Interestingly, microparticles prepared with 10% or more 
CTAB showed extensive toxicity levels, even though these preparations 
exhibited negative ξ-potentials. These findings can be explained by the 
dissociation of CTAB from the formulation and the detergent effect of CTAB. 
The effects of the microparticle formulations on membrane stability were 
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compared to the effects of the cationic agents in solution. Three concentrations 
of PEI and CTAB were incubated with fibroblasts, resulting all cases in high 
LDH release levels. As a consequence, both cationic agents, PEI 25 kDa and 
CTAB, were deemed toxic to cellular membranes.  
The stabilizing effect of cationic microparticles on DNA degradation by DNase 
was investigated by agarose gel electrophoresis (Fig.4). DNA integrity was 
analyzed by the application of an emulsion, using a phenol / glycerol mixture 
with TBE buffer containing the dissolved formulations after the incubation with 
the enzyme. As a result, no DNA extraction was necessary from the particle 
formulations after the incubation with the enzyme. Naked DNA was degraded 
within the first five minutes of incubation with DNase I (Fig.4a). The influence 
of the two cationic agents was investigated in Figure 4b/c.  
CTAB exhibited a stabilizing effect on DNA, however, DNA was completely 
degraded after 20 min of enzyme incubation. In contrast, PEI 25 kDa protected 
DNA against degradation over a 12 hour time period, although a conversion of 
the supercoiled to the open circular form was observed. This highlighted the 
excellent DNA condensation capabilities of PEI 25kDa. CTAB, as a single 
tailed cationic lipid, has been used for plasmid DNA isolation by precipitation, 
thus the CTAB / DNA interaction was expected to result in enzyme stabilization 
[4]. However, the protection against DNase I degradation was relatively low. 
This was attributed to the low electrostatic interactions of the single charged 
molecule, used at a 1:1 [m/m] ratio with DNA, compared to polycations.  
PEI containing microparticles, which displayed negative ξ-potentials and, as a 
result low adsorption efficiencies, for example RG 502H+PEI 1% did not 
protect DNA from enzyme degradation (Fig.4d). DNA was degraded within 5 
minutes of incubation. However, microparticles formulated using higher 
amounts of PEI, such as RG 502H+10% and +50%, (Fig.4e/f) protected the 
adsorbed DNA over almost 12 hours. Similar to DNA/PEI complexes, DNA 
exhibited a change to the open circular form in later time points of incubation. 
Adsorption of DNA onto cationic Microparticles 80 
_________________________________________________________________________________________________________________ 
 
Fig.4: DNA stabilization against DNase degradation, (a) DNA, (b) DNA/CTAB, 
(c) DNA/PEI, (d) DNA adsorbed on RG 502H+PEI 1%, (e) DNA adsorbed on 
RG 502H+PEI 10%, (f) DNA adsorbed on RG 502H+PEI 50%, (g) RG 
502H+CTAB 10%, (h) RG 502H+CTAB 50%.  
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We attributed the high protection efficiency of the RG 502H+PEI 50% 
formulation to the formation of DNA polyplexes, as PEI appeared to be only 
loosely associated with the PLGA polymer. The RG 502H+PEI 10% 
formulation showed considerable DNA stabilization in agreement with the high 
ξ-potential and the nearly complete adsorption of 1% [m/m] DNA. This finding 
was not attributed to a polyplex formation, since the low membrane toxicity 
suggests the absence of free PEI. The protection of DNA microparticles has so 
far only been demonstrated for DNA encapsulated in PLGA particles as well as 
for DNA adsorbed on aminosilanes modified silica nanoparticles and mineral 
surfaces [21-23]. In contrast, none of the microparticles prepared with CTAB 
displayed a stabilizing effect on DNA (Fig.4g/h). In both preparations 
formulated either using 10% or 50% CTAB the DNA was degraded after only 5 
minutes of incubation, demonstrating the inefficient adsorption.  
Transfection experiments were carried out with plasmid DNA microparticles 
incubated in a 1: 100 [m/m] ratio, corresponding to a DNA loading of 1% (Fig.5). 
The transfection efficiencies were relatively high for particles prepared by the 
incorporation of 10% and 50% PEI, when compared to DNA/PEI complexes at a 
N/P ratio of 5 (Fig.5a). The mechanism of PEI mediated gene delivery has been 
demonstrated to be based on the osmotic rupture of endosomes, resulting in the 
release of DNA into the cytosol [5,24,25]. However, the non-phagocytic cells 
used in this study could not take up the microparticles. Thus, another mechanism 
of gene delivery must have occurred. The blend particles with a lower content of 
PEI did not lead to effective gene delivery. Likewise, the formulations with 
CTAB and the DNA / CTAB 1/1 [m/m] mixture did not result in a significant 
transfection efficiency in vitro. These results are in line with observations made 
previously, showing that complexes of plasmid DNA with CTAB do not have a 
significant influence on DNA delivery and transfection [26]. Microparticles 
prepared with 10% PEI were further investigated, by varying the theoretical 
DNA loading.  
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Fig.5: Transfection efficiency of DNA microparticles. (a) Transfection of DNA 
adsorbed onto PEI blend RG 502H microparticles compared to the efficiency of 
DNA/PEI complexes at N/P 5. Microparticles with 10% and 50% PEI exhibited 
efficient gene delivery. (b) Transfection of DNA adsorbed onto CTAB blend 
particles compared to a DNA / CTAB 1/1 [m/m] preparation. (c) Transfection of 
luciferase DNA using different theoretical loadings on RG 502H+PEI 10%.  
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This was performed using constant amounts of DNA with increasing amounts of 
particles (Fig.5c). Higher amounts of particles mixed with constant amounts of 
DNA led to higher transfection efficiencies. The transfection of non-phagocytic 
cells, using cationic DNA microparticles exceeding the cutoff size of 0.5 µm for 
endocytotic uptake, has been discussed recently [26,27]. In these previous 
studies, the mechanism of gene transfer was ascribed to the detachment of the 
cationic agent from the microparticle, resulting in a polyplex transfection. 
However, the transfection mediated by covalently attached PEI 25 kDa on 
microspheres or polymer films has been described by Zheng et al. [28]. In this 
case, the transfection was attributed to a pH independent membrane disruptive 
effect [29]. 
This group also conceded the possibility of enzyme cleavage of the linker 
carrying PEI. From our data, we were not able to detect increased rates of 
membrane disruption. This was demonstrated by the low LDH release from cells 
incubated with the particles formulated with PEI blends up to 10%. Therefore, 
we hypothesized that the transfection was mediated by the physical approach of 
DNA loaded microparticles towards the cell surface, as suggested by Ogris et al. 
[30]. This facilitated the endocytosis of either naked DNA or detached DNA/PEI 
complexes. 
To study the transfection mechanism of DNA loaded microparticles, both PEI 
and DNA were fluorescently labeled. Non-phagocytic L929 cells were incubated 
with DNA microparticles for 3 hours and fixed. The confocal microscopy 
revealed high concentrations of the formulations on the surface of the cells. The 
colocalization of both covalently bound fluorescence markers demonstrated the 
conservation of the PEI/DNA complexation during incubation. The cells 
exhibited a diffuse green and red fluorescence throughout the cytosol in 
combination with some concentrated fluorescence. These observations could be 
explained by the membrane disruptive properties of high concentrations of 
PEI/DNA complexes on the surface of the cellular membrane [29]. Segura et at 
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al. achieved similar transfection levels weather using biotinylated PEI bound to 
neutravidin, which was covalently bound to the cell culture dish, or weather 
non-biotinylated PEI was nonspecifically adsorbed to that surface [31]. 
However, in this study 20% of PEI, specifically-bound or nonspecifically-
adsorbed, was released within 2 days. Therefore both transfection results could 
arise from un-bound DNA/PEI complexes. In our study the diffuse fluorescence 
of both the PEI label and DNA label showed that this complex is released into 
the cell, possibly through small local damages in the cellular membrane. This 
mechanism, however, has to be further investigated. 
 
 
Fig.6: Confocal microscopy of L929 mouse fibroblasts after 3 hours of 
incubation with Oregon green labeled RG 502H+PEI 10% (green) with Cy-3 
labeled DNA (red). The nucleus was stained using DAPI (blue). The DNA and 
PEI are co-localized. High concentrations of the microparticles were adsorbed 
on the cell. A diffuse fluorescence in the cell indicated that PEI and DNA were 
taken up into the cell. 
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The protection of mice immunized with DNA against antigens of Listeria 
monocytogenes adsorbed onto cationic microparticles was studied by measuring 
their survival after a lethal challenge. Listeria monocytogenes is an intracellular 
bacterium. Hence, a successful immunization must be T-cell mediated to 
eliminate infected cells. The survival rates of mice challenged with lethal doses 
of Listeria monocytogenes are represented in Figures 7 and 8. In the first setting 
(Fig.7) both groups of mice were either immunized with 10 µg naked DNA or 
10 µg DNA adsorbed onto RG 502H+PEI 10% microparticles. 
The antigen encoding vectors of Fensterle et al. were used [6]. After one prime 
and two booster immunizations the mice were challenged with 5xLD50 Listeria 
monocytogenes. Naïve mice of both groups and mice immunized with the p60 
encoding sequence died within 4 to 7 days from the Listeria infection. All mice 
actively immunized with the sublethal dose of Listeria monocytogenes survived 
the challenge in both groups. A significant difference was observed for the 
survival of mice immunized with a sublethal dose of L. monocytogenes and mice 
immunized with the vector control, referred to as ‘mock’ DNA adsorbed onto 
the microparticles (P=0.0178) (Fig.7a). 
This mock DNA, which did not encode a Listeria antigen was capable of 
protecting 33% of the mice encoding the typical listeriolysin, and the mutant 
LLO vector, led to higher survival rates compared to the naked DNA.  
Mice immunized with mutant LLO DNA adsorbed onto microparticles exhibited 
the highest survival rates. In this group 66% (4 out of 6) mice survived. The 
effect of DNA adsorption on survival, however, was not significant compared to 
that of mock (P=0.2029). 
Therefore, the experiment was repeated with higher dose of L. monocytogenes 
(Fig.8). In this experiment mice were either immunized with 100 µg naked DNA 
(Fig 8b) or the mice were immunized with 10 µg DNA adsorbed onto 
microparticles (Fig.8a) using 10xLD50 L. monocytogenes to challenge the mice.  
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Fig.7: Survival curves of balb-c mice. (a) Intramuscular immunization with 10 
µg DNA adsorbed onto 1 mg microparticles. The difference of survival of mice 
immunized with mutant LLO was not significant compared to the mock 
(P=0.2029). Difference of survival of mice immunized with a sublethal dose of 
L. monocytogenes was significant compared to that of mock (P=0.0178). (b) 
Intramuscular immunization with 10 µg naked DNA. The difference of survival 
with mutant LLO was not statistically significant compared to mock (P=0.5143). 
The difference of survival of mice immunized with sublethal dose of L. 
monocytogenes was significant compared to that of mock (P=0.0185). The 
difference of survival of mice immunized with mutant LLO adsorbed on 
microparticles was not significant compared to naked mutant LLO (P=0.4441). 
Statistics was assessed by logrank test using Prism software. 
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Fig.8: Survival curves of balb-c mice. (a) Intramuscular immunization with 10 
µg DNA adsorbed onto 1 mg RG 502H + PEI 10% microparticles. (b) 
Intramuscular immunization with 100 µg naked DNA. The difference of survival 
of mice immunized with mutant LLO was not statistically significant compared 
to that of mock (P=0.0701). The difference of survival of mice immunized with 
sublethal dose of L. monocytogenes was significant compared with that of mock 
or mutant LLO (P=0.0498). Statistics was assessed by logrank test using Prism 
software. 
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The purpose of this study was not only to improve the protection but also to 
reduce the amount of DNA required for efficient vaccination. All but the 
actively immunized mice died in the DNA microparticle group. The 
immunization with 100 µg naked DNA (mutant LLO), however, could protect 
50% of the mice. The difference of survival of mice immunized with naked 
mutant LLO was not statistically significant compared to that of naked mock 
(P=0.0701). Still, the difference of survival of mice immunized with sublethal 
dose of L. monocytogenes was significant compared with that of naked mock or 
mutant LLO (P=0.0498). Therefore, we could conclude that the adsorption of 
DNA onto RG 502H+PEI 10% microparticles could induced higher survival 
rates after a lethal challenge when equal doses of DNA were used for 
immunization, even if these effects were not equal to a 10-times higher dose of 
naked DNA. 
 
CONCLUSION 
 
In this study we developed a cationic microparticulate system by the 
incorporation of the cationic molecules, PEI or CTAB, into the polyester matrix. 
PEI 25kDa, added to the polymer at 10% exhibited the most promising 
characteristics of all microparticle formulations.  
The adsorption efficiency was complete for a theoretical loading of 1% over a 
pH range from 3 to 8. The ζ-potential was + 47.3 mV and, thus, correlated with 
the adsorption efficiency. Further, this formulation protected adsorbed DNA 
from enzyme degradation over 12 hours, without exhibiting membrane toxicity, 
as demonstrated by a LDH release assay.  
The transfection efficiency in non-phagocytic cells was elevated compared to 
naked DNA and all the other formulations. However, the mechanism of 
transfection studied by confocal microscopy has to be further investigated. The 
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RG 502H+PEI 10% microparticle formulation was used for in vivo 
immunization in mice. These experiments demonstrated that adsorption of DNA 
on the surface of cationic microparticles could reduce the amount needed for an 
immune response by DNA immunization. Still, the in vivo effect of DNA 
adsorption onto the surface of these cationic microparticles could not be set into 
relation with the in vitro transfection efficiencies observed earlier. 
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SUMMARY 
 
DNA loaded nanoparticles were prepared using a newly designed platform of 
polymers with the aim to create an effective particulate gene delivery system.  
The polymers were synthesized by carbonyldiimidazole (CDI) mediated 
coupling of diamines, diethylaminopropylamine (DEAPA), dimethlyamino-
propylamine (DMAPA) or diethylaminoethylamine (DEAEA) to poly (vinyl-
alcohol) (PVA) with subsequent grafting of D,L-lactide and glycolide (PLGA) 
(50:50) in the stoichiometric ratios of 1:10 and 1:20 (free hydroxyl groups / 
monomer units). The polymers were characterized by 1H-NMR, GPC-MALLS 
(gel permeation chromatography - multiple-angle-laser-light-scattering), and 
DSC (differential scanning calorimetry). DNA loaded nanoparticles, prepared by 
a specifically modified solvent displacement method, were characterized with 
regard to their zeta (ζ) -potential and size. The transfection efficiency was 
assessed with plasmid DNA, pCMV-luc, in L929 mouse fibroblasts. 
The polymers were composed of highly branched, biodegradable cationic 
polyesters exhibiting amphiphilic properties. The amine modification further 
enhanced the rapid polymer degradation and was held responsible for the 
interaction with DNA during particle preparation. The nanoparticles exhibited 
positive ζ-potentials up to + 42 mV and high transfection efficiencies, 
comparable to polyethlyenimine (PEI) 25kDa/DNA complexes at a nitrogen to 
phosphate ratio of 5. 
The polymers combined amine-functions and short PLGA side chains resulting 
in water insoluble polymers, capable of forming biodegradable DNA 
nanoparticles through coulombic interactions and polyester precipitation in 
aqueous medium. The high transfection efficiency was based on fast polymer 
degradation and the conservation of DNA bioactivity. 
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INTRODUCTION 
 
DNA vaccines have been subject to intensive research efforts recently and it has 
become increasingly clear that adjuvants are necessary to reduce the DNA dose, 
while reaching protective immune responses [1]. Adjuvants, such as micro – and 
nanoparticles have been studied intensively as DNA delivery systems providing 
i) a sustained and predictable DNA release; ii) targeting antigen of presenting 
cells using particles < 10 µm and iii) stabilization of DNA in physiological 
environment [2]. Several encapsulation techniques, mainly using biodegradable 
PLGA, have been reported, such as spray-drying [3] and modified double 
emulsion methods [4], all of which utilized high-speed homogenization or 
sonication. These shear forces were found to compromise plasmid integrity and 
bioactivity [5,6]. Additionally, DNA was damaged in the acidic environment 
created by PLGA degradation products [3].  
Here, we describe a gentle solvent displacement method for the encapsulation of 
DNA relying on a new class of biodegradable polymers with rapid degradation 
properties [7]. This method allows the encapsulation of DNA without high speed 
/ shear homogenization using amine-modified branched polyesters. These 
polymers interact with DNA by electrostatic interactions and facilitate 
nanoparticle formation due to their amphiphilic character. We systematically 
investigated these polymers to characterize the influence of polymer structure on 
functional properties such as nanoparticle size and charge, as well as the 
protection of plasmid DNA by the measurement transfection efficiency in vitro. 
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MATERIALS AND METHODS 
 
Polymer Synthesis and Characterization  
Biodegradable comb-branched polymers consisting of amine-modified poly 
(vinyl alcohol) (PVA) backbones, grafted with PLGA side chains in a ratio 
[n(OH)/n(monomer)] of 1:10 and 1:20 were synthesized and characterized as 
previously described [7]. The amine modifications consisted either of 3-
diethylamino-1-propylamine (DEAPA = P), 2-diethylamino-1-ethylamine 
(DEAEA = E) or 3-dimethylamino-1-propylamine (DMAPA = M). Briefly, after 
activation of the diamine component using carbonyl diimidazole (CDI) in 
tetrahydrofuran (Fig. 1) the activated components were added to PVA, (Fluka, 
degree of polymerization: P=300) in N-methylpyrrolidone and reacted for 4 days 
at 80°C. Then lactide and glycolide (50:50) were grafted in stoichiometric ratios 
of 1:10 and 1:20 (free hydroxyl groups / monomer units) by bulk polymerization 
onto the amine-modified PVA-backbones at 150°C using tin(II) 2-
ethylhexanoate as catalyst.  
The source-based IUPAC nomenclature for e.g. DEAPA modified polymers is 
the following: Poly (vinyl 3-(diethylamino)propylcarbamate-co-vinyl acetate-
co-vinyl alcohol)-graft-poly(DL-lactide-co-glycolide). As abbreviation we use 
A(x)-y. (A indicates the type of amine substitution (P=DEAPA, M=DMAPA, 
E=DEAEA), x is the number of monomers in the backbone carrying amine 
substitutions, y is the PLGA side chain length calculated from feed). 
Resomer®502H (RG 502H, Mw 15,200 g/mol, specifications supplied by the 
manufcturer) was purchased from Boehringer Ingelheim (Ingelheim, Germany). 
1H-NMR spectra were generated in d6-DMSO with a Jeol Eclipse+500 NMR 
Spectrometer (JEOL, USA) at 50°C using 64 scans (500 MHz). GPC-MALLS 
was carried out with a combination of DAWN EOS, Optilab DSP (Wyatt 
Europe GmbH, Germany) and PSS SDV linear M column (PSS, Mainz, 
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Germany, flow rate 0.5 ml/min, solvent: dimethylacetamide +2,5 g/L LiBr at 
60°C). DSC measurements were conducted with a Perkin-Elmer DSC 7 (USA). 
Polymer degradation was measured gravimetrically after incubation of polymer 
films in PBS-buffer at pH 7.4 (37°C) over 21days according to Wittmar et al. 
[8]. 
 
DNA Nanoparticle Preparation and Characterization  
Nanoparticles were prepared by a modified solvent displacement method [9]. 
Briefly, 500 µl of an aqueous solution containing 0.5 µg/µl plasmid DNA was 
added to 2.5 ml of an acetone solution containing 50 mg of the water insoluble 
polymer. The product was injected into 10 ml stirred 0.1% Pluronic™ F68 
(BASF, Germany) in distilled water. The resulting nanoparticle suspension was 
stirred 3 hours under constant laminar air flow to remove residual acetone. 
Particle size and ζ-potential measurements were carried out in a Malvern 
Zetasizer 4 (Malvern, Germany), according to Jung et al. [9] after calibration 
with a Malvern –50 mV transfer standard. Scanning electron microscopy (SEM) 
was performed with a CamScan 4 (Cambridge, UK) after gold sputter coating 
using a AUTO 306 (Edwards, UK). High resolution transmission electron 
microscopy imaging (TEM) was performed after cryo-sectioning of the 
nanoparticles with a JEM 3010 (Jeol, Japan) on a collodium grid. 
 
In Vitro Transfection Efficiency 
L929 mouse fibroblast (DSMZ, Germany) cells were plated at a cell density of 
50 000 cells/ 2 ml in 12 well dishes 24 h prior to transfection. Aliquots of the 
particle suspension containing 4 µg pCMV-luc theoretical load were added to 
0.5 ml glucose 5 % medium pH 7.4. The cells were pre-incubated with the 
nanoparticle suspension for 5 min, after which 1.5 ml cell culture medium 
containing 10% fetal calf serum (FCS) was added. The nanoparticle suspension 
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was dispersed in the glucose medium before the addition of the medium, since 
instabilities of nanoparticle suspension were observed in medium. The 
nanoparticle suspension was removed after 4 hours of incubation and replaced 
with fresh medium containing 10% FCS. Cells were harvested after 48 h and 
luciferase transfection efficiency was assessed according to Kunath et al. [10]. 
Results were presented as luciferase / protein ratio [ng/mg]. 
 
RESULTS AND DISCUSSION 
 
In this study we present a new class of water-insoluble, amphiphilic polyesters, 
developed specifically for DNA encapsulation. We hypothesized that the 
loading efficiency of DNA nanoparticles could be greatly increased by three 
characteristics of the comb-branched polymers. Firstly, electrostatic interactions 
are thought to stabilize and protect DNA during the encapsulation process. 
Secondly, fast polymer degradation rate should allow the release of bioactive 
DNA and thirdly, tertiary amino-functions should facilitate gene delivery. We 
therefore developed polymers containing an amine-modified backbone for ionic 
interactions and possible buffering capacities in the endosomes and relatively 
short but multiple, biodegradable PLGA side chains for fast polymer 
degradation. The unique properties of these polymers were confirmed during the 
nanoparticle formation process. DNA was solubilized by the polymer in the 
acetone solution due to the amphiphilic characteristics in the acetone/water 
mixtures used for the solvent displacement method, suggesting a strong 
DNA/polymer interaction. The subsequent injection in aqueous medium resulted 
in nanoparticle formation. The biodegradable DNA nanoparticles exhibited 
effective gene delivery, demonstrated by high transfection efficiencies in-vitro.  
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Fig.1: The synthesis of poly (vinyl 3-(diethylamino)propylcarbamate-co-vinyl 
acetate-co-vinyl alcohol)-graft-poly(D,L-lactide-co-glycolide) using a three step 
process with PVA, amine and CDI as precursors b) GPC elution profile of 
P(33)-20 (signal of the refractive index detector: straight line, light scattering 
signal: dashed line) indicating a monomodal distribution of the molar mass of 
the polyesters, but also a small, low molecular weight part c) plot of the radius 
of gyration against MW
. 
The reduced slope of the amine-modified polyester 
(P33)-20) demonstrated the highly branched structure in comparison to random 
coiled pullulan. 
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We synthesized 24 cationic, as well as two neutral derivatives of amine-
modified comb-branched polyesters, and characterized their functional 
properties in relationship to their structure (Fig.1). We grafted relatively short 
PLGA side chains consisting of approximately 10 or 20 repeating units on the 
amine-modified PVA-backbone. Consequently, already a small number of 
hydrolytic cleavage events would result in water soluble polymer fragments, 
thereby releasing the encapsulated DNA. The total number of biodegradable 
PLGA side chains grafted on an amine-modified PVA backbone ranged from 
150 - 240, resulting in a cationic and water insoluble polyester. The general 
characteristics of the polymers properties with different amine substitutions 
(DEAPA / DMAPA / DEAEA) were similar. The DEAPA substituted polyesters 
were all soluble in acetone and thus, suitable for the nanoparticle preparation 
process. Therefore, we selected this type of polymers for further study. 
The brush-like structure of the graft-polymers was verified using 1H-NMR 
spectroscopy, as well as GPC-MALLS depicted in (Fig.1b/c) for P(33)-20. The 
degree of PLGA side chain substitution was calculated from the 1H-NMR 
spectrum showing that only 5 to 35 % hydroxyl-groups of the PVA still 
remained free after reaction. The PLGA side chain lengths (SCL) were 
calculated from these data, demonstrating good correspondence with the 
theoretical values (Table 1). However, increasing amine substitution led to a 
decrease of SCL. A possible explanation could be an inhibitory effect of the 
amino-function on the tin catalyst which competed with lactide/glycolide 
monomers. The molecular weights of the polymers were calculated from a 
combination of this data, based on the known amine substitution of the PVA 
backbones. The values for molecular weight (MW) were confirmed by GPC-
MALLS (Fig.1b). GPC measurements demonstrated the monomodal MW 
distribution of the polyesters. The molecular weights did not show an expected 
trend towards lower MW with increasing amine-substitution because of i) the 
fast degradation of the polyesters, ii) the resolution of GPC and iii) decreasing 
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acetate content with increasing amine substitution. The nanostructure of the 
polymers in solution was characterized by the evaluation of the radius of 
gyration in a double logarithmic scale plotted against the molar mass of the 
polyesters (Fig.1b). The resulting slope of the linear fit was compared to the 
slope of random coiled pullulan (0.55). The flatter slope exhibited by the amine-
modified polyesters (P(33)-20: 0.40) indicated a compact, highly branched 
nanostructure of these polymers.  
Polymer degradation at 37°C in PBS buffer at pH 7.4 was greatly accelerated as 
compared to common linear PLGA. NMR studies demonstrated the reduction of 
the SCL of P(12)-10 from originally 10.8 units to 8.6 units in seven days and to 
5.4 units after another week. These measurements cannot be exclusively 
explained by physical erosion. Such an erosion would either not show deceased 
SCL or only a small SCL reduction. This behavior may substantially reduce the 
exposure time of the encapsulated substance to the detrimental effects of acidic 
degradation products generated by PLGA bulk erosion. The degradation 
behavior thus was remarkable, since the molecular weights of the graft-
polyesters were approximately ten-fold higher than the linear PLGA (RG 502H) 
(Table 1). This property corresponded to our hypothesis of a substantial 
reduction in time for the drug release. An increase in the PLGA side chain 
length from approximately 10 to 20 repeating units increased the degradation 
time as expected. P(33)-20, for example, showed a degradation half-life of 13 
days, compared to one day for the P(33)-10 analogue (Table 1). The degradation 
rates increased more than proportionally with increasing amine substitutions of 
the polymer. For example, the degree of amine substitution in P(33)-10 was 
three times greater than in P(12)-10, however, P(33)-10 exhibited a nine-fold 
increase in the rate of degradation. This effect could be explained by the rapid, 
initial PLGA mass loss of the P(x)-10 polymer in comparison to the slower mass 
loss of P(x)-20 polymers, attributed to a catalytic effect of the amino-functions, 
promoting the acidic ester degradation, caused by their protonation. 
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Polyester 
 
Tg 
 
 
[°C]a 
 
MW 
 
 
[kg mol-1] 
 
SCLd 
 
Degradation 
half-lifee,f 
 
[d] 
 
Nanoparticle 
sizef 
 
[nm] 
 
Zeta 
Potentialf 
 
[mV] 
  Mnb 
Mnc 
Mwc 
    
P(6)-10 30.6 (107) 211 281 11.2 >21 n.d. n.d. 
P(12)-10 30.8 179 196 263 10.8 9 163 ± 1 22 ± 1 
P(33)-10 27.7 179 195 367 9.4 1 152 ± 3 35 ± 3 
P(68)-10 11.5 172 282 799 7.4 n.d. 309 ± 16 42 ± 2 
P(12)-20 33.0 422 227 304 19.3 >21 n.d. n.d. 
P(33)-20 32.8 385 375 712 17.2 13 351 ± 7 31 ± 5 
RG 502Hf 36.5 6.1 6.6
f
 
15f 84.6 19 602 ± 3 -55 ± 3 
 
Table I: Characterization of the amine-modified polyesters, demonstrating the 
low glass transition temperatures, extremely high molecular weights (MW) 
combined with fast polymer degradation at 37 °C in PBS buffer. DNA 
nanoparticles exhibited smaller sizes and high ζ (zeta)-potentials, compared to 
PLGA nanoparticles. 
a
 Glass transition temperature (heat rate: 10 °C/min, -10 to 200 °C, second run) 
b
 MW calculated from the 1H-NMR data  
c
 MW from GPC-MALLS (DAWN EOS, Optilab DSP, column PSS SDV 
linearM, solvent DMAc+2.5 LiBr g/L, 60°C, 0.5 mL/min) 
d
 PLGA side chain length calculated from 1H NMR 
e
 Days for 50% mass loss of a polymer film (extrapolated from plot, n=3) 
f
 mean of three independent measurements ± standard deviation 
g
 Commercial PLGA (1:1) lactic acid : glycolic acid subunits. MW: 
specifications supplied by the manufacturer (Boehringer Ingelheim) 
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This would lead to new carboxyl-functions restarting the catalytic cycle.  
Further, the protonated amino-functions will promote water uptake into the 
polymer effecting an increased rate of hydrolysis. All polymers displayed glass 
transition temperatures near 30 °C, implying that they exist in the glassy state in 
physiological environment (Table 1). In general, polymers with longer PLGA 
side chains and reduced amine substituents had higher transition temperatures. 
Thus, the amine-groups were thought to have acted as a plasticizer in the 
polymer. The influence of the polymer chain motility has to be further 
investigated for possible interactions with cellular membranes and the influence 
on the gene delivery process. 
An important feature of the polymer characteristics were the tertiary amine-
modifications of the polymers, hypothesized to stabilize DNA within the 
polymer matrix and to facilitate the gene transfer. Ionic interactions with the 
polymer were presumably the reason for the solubilization of DNA in the 
acetone/water mixture. For example, DNA could be completely dissolved in an 
acetone/water 5:1 [v/v] solution of the polymer, whereas DNA alone precipitated. 
Therefore, no further homogenization process was necessary to disperse DNA 
before the subsequent coacervation of the water insoluble polymer in the 0.1% 
poloxamer solution. Nanoparticles were only obtained with polymers exhibiting 
amine substitutions of 4% (P(12)-10) and higher, underlining the importance of 
the amphiphilicity, induced by the amine substituents. The structure of the 
polymers was described to be brush-like, due to the short and numerous PLGA 
chains. Therefore, we did not expect a micellar assembly of the polymers neither 
in acetone, nor in the non-solvent water. In contrast, water soluble, poly(l-
lysine)-g-PLGA polymers had a more distinct amphiphilic structure, containing 
a shorter hydrophilic backbone with few and long PLGA chains of 
approximately 210 monomers [11]. 
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The nanoparticles exhibited hydrodynamic diameters ranging from 152.4 nm 
(P(12)-10) to 351.3 nm (P(33)-20), whereas PLGA (RG 502H) nanoparticles 
prepared by the same procedure were approximately 200 nm larger (Table 1).  
 
Fig.2: TEM (left) and SEM (right, 1µm scale of the inlay) micrographs of DNA 
P(12)-10 nanoparticles confirmed the particulate structure of the nanoparticle 
and the size measured by photon correlation spectroscopy. 
 
Hence, despite a 33-fold higher molecular weight, the amphiphilic qualities of 
the polymers, influencing the interface tension, resulted in nanoparticles of 
reduced size.  
ζ-potentials of all preparations were clearly positive, with the exception of the 
linear PLGA, arising from the DNA phosphate groups, which were inverted by 
the cationic polymers. Particle sizes measured by photon correlation 
spectroscopy were confirmed by scanning electron microscopy (SEM) and 
transmission electron microscopy of nanoparticle cryo-sections (TEM). The 
particle morphology was examined by these methods as well for the polymer 
P(12)-10 in Figure 2. Particles were uniform in size and had smooth surfaces. 
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All DNA nanocarriers were used in vitro for transfection assays, as efficient 
gene delivery remains a prerequisite for subsequent in vivo immunization. By 
directly using the nanoparticles in vitro, we could detect the gene transfer 
properties of the amine-modified polymers, as well as the DNA bioactivity after 
nanoparticle preparation. Free plasmid and DNA complexes with PEI 25kDa, a 
potent polymeric transfection agent, were used as references to compare the 
luciferase expression levels with other polymer types [12]. On account of this, 
we could consider the nanoparticles as a potent transfection agent. All DNA 
nanocarrier formulations resulted in increased transfection efficiencies 
compared to naked DNA (Fig.3). The efficiency increased exponentially with 
the amount of amine substitution of the polymer.  
 
 
 
Fig.3: Transfection efficiency of pCMV-luc DNA, encapsulated in amine-
modified nanoparticles was greatly enhanced compared to free DNA, DNA/PEI 
25kDa complexes (N/P 5) and a DNA RG 502H particle preparation. 
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The 500,000-fold increase in transfection efficiency of the P(68)-10 plasmid 
nanoparticles, compared to free DNA, was remarkable, especially when 
considering the fact that the amount of polymer in relation to DNA was reduced 
by the factor 0.4 to avoid nocuous effects of an excess of cationic charges. 
Nanoparticles of P(x)-10 polymers clearly displayed higher efficiencies than 
their P(x)-20 analogous.  
The careful elucidation of the transfection mechanism of the polymers is yet to 
be investigated, however, we assume that these findings do not depend on 
increased ζ-potentials or particle size effects. They but must be dependent on the 
particle structure and DNA polymer interactions as well. The polymers 
consisted of dimethlyaminopropylamine substituents, representing tertiary 
amines. These have been shown to be essential for the endosomal escape of 
polyplexes by the osmotic rupture, the `proton sponge  ´ effect [13]. This effect 
could be intensified by the fast polymer degradation resulting in an increase of 
the osmotic pressure in the endosome, as proposed by Koping-Hoggard [14]. 
However, other mechanisms of endosomal release have eventually to be 
considered, for example, fusogenic activities, taking into account the low glass 
transition temperatures and hydrophobic moieties of the polymer [15], or the 
`hydrogel effect  ´ of swelling polymer in the endosome [16]. Therefore, we 
concluded that the combination of different properties within one biodegradable 
polymer, resulting in a fast degradation, ionic interactions with DNA and the 
formation of water insoluble nanoparticles, provided considerable advantages 
with regard to the transfection efficiency in vitro. Further experiments 
investigating the transfection efficiency under in vivo conditions and the 
encapsulation with other compounds, such as peptides, susceptible to acid 
degradation are in progress. 
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SUMMARY 
 
To circumvent DNA degradation during particle formation, the DNA was 
adsorbed onto pre-formed particles [1,2]. However, the adsorption via 
electrostatic interactions of DNA or other macromolecules onto colloidal 
structures can cause instabilities, such as flocculation, by either charge 
neutralization or bridging [3]. In this study, we intended to characterize a new 
approach for DNA nanoparticle formation. This new process allowed the 
encapsulation of DNA without using high-speed shear forces. Thereby, we 
aimed to reduce both particle flocculation and DNA degradation by DNA 
encapsulation.  
One representative polymer, P(26)-10, of a new class of amine-modified 
polyesters was used for the study of nanoparticle formation. The formulation 
method used in this study had previously only been described for the efficient 
encapsulation of hydrophobic compounds. We investigated the influence of 
several process parameters on the nanoparticle size. The DNA nanoparticle size 
was dependent on the volume of the organic solvent, as well as on the volume of 
the aqueous solutions. The viscosity of the organic solvent further influenced the 
particle size and the encapsulation efficiency. This system exhibited some 
variations, when compared to the standard solvent displacement techniques. 
These were explained by polyelectrolyte interactions of the polymer with DNA 
in the acetone/water medium. The ratio of the water/acetone medium apparently 
influenced the polyelectrolyte interactions of the DNA with the cationic 
polymer. The subsequent particle formation was dependent on the polymer 
coalescence, which we hypothesized to be influenced by the polymer / DNA 
interactions and solvent composition. The new class of amine-modified 
polyesters used in this study, was shown to be a promising tool for a one step 
DNA encapsulation into nanoparticles without using shear forces. 
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INTRODUCTION  
 
Recently, DNA has been successfully adsorbed on cationic microparticles and 
nanoparticles for the use as adjuvant systems for DNA immunization and gene 
delivery [1,4,5]. Thereby, DNA interacts via electrostatic forces with particle 
surfaces. The DNA / particle ratio was determined by the particle’s size and the 
particle’s surface charge. However, we and others have found that these 
colloidal systems exhibited instabilities, namely flocculation, when used for the 
adsorption of macromolecules, such as DNA [6]. The two mechanisms mainly 
involved in this phenomenon were charge neutralization and polymer bridging 
[3]. To avoid thee drawbacks we investigated methods to encapsulate DNA into 
nanoparticles.  
The solvent displacement method has typically not been an efficient technique 
for the direct encapsulation of water soluble drugs [7]. The method is based on 
polymer deposition on interfaces, due to the aggregation of polymers by organic 
solvent displacement. The driving force of the particle formation is the mass 
transport of an organic solvent into a second solvent, mostly water. This 
phenomenon was first described by Marangoni in 1871 [8]. The mass transport 
into the larger second phase induced interphase turbulences that resulted in 
interphase disruption and small solvent droplet formation. Commonly used 
organic solvents are water soluble and non-chlorated which exhibit low boiling 
points for efficient extraction and evaporation of the organic solvent form the 
preparation.  
In this study, we used P(26)-10, as a representative polymer for the new class of 
amine-modified polyesters [9]. These polymers were characterized by 
amphiphilic and cationic structures, which enabled us to modify the solvent 
displacement method for the encapsulation of DNA [10]. All nanoparticles were 
formulated according to a standard method, changing one parameter at a time.  
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MATERIALS AND METHODS 
 
Polymer and DNA 
The biodegradable polyester P(26)-10, was composed of an amine-modified 
poly(vinyl alcohol) (PVA) backbone with grafted poly(lactic-co-glycolic acid 
(PLGA) side chains, synthesized according to Wittmar et al. [9]. The cationic 
polymer backbone was composed of 26 units 3-diethylamino-1-propylamine 
(DEAPA = P) substituted on poly (vinyl alcohol) (PVA, Fluka, degree of 
polymerization: P=300). The grafted side chains consisted of D,L-lactide and 
glycolide (50:50) in a ratio of 1:10 (free hydroxyl groups / monomer units), 
resulting in approximately 200 PLGA side chains per hydrophilic backbone.  
Herring testes (HT) DNA (Sigma-Aldrich, Taufkirchen, Germany) was used for 
the mechanistic and feasibility studies. It was dissolved in low ionic strength (I = 
0.01) TE-buffer pH 7.4 (3.3 mM Tris(hydroxymethyl) aminomethane (Tris-
HCl), 0.3 mM disodium edetate (Na2EDTA) pH 8). 
 
Nanoparticle Preparation 
DNA nanoparticles were prepared using a modified solvent displacement 
technique. Therefore, 50 mg of the polymer were dissolved in 1.25 ml acetone. 
The HT DNA was diluted to a final concentration of 2 µg/µl in 250 µl of low 
ionic strength buffer at pH 7.4 and dispersed into the acetone solution containing 
the amine-modified polymer. The dispersion was prepared by fast injection of 
the aqueous solution into the polymer solution while mixing several times with 
the pipette. The resulting dispersion was then slowly injected into 20 ml of a 
magnetically stirred 0.1 % aqueous Pluronic™ F68 (BASF, Germany) solution, 
using a 14-gauge needle. Under these conditions spontaneous nanoparticle 
formation could be observed. The nanoparticle suspension was stirred for 3 
hours under constant air flow for complete removal of residual acetone. Particles 
were characterized directly after the preparation. 
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Particle Size Measurement 
The effective hydrodynamic diameter was measured by photon correlation 
spectroscopy (PCS), using a Malvern Zetasizer 4 (Malvern Instruments, 
Germany) at 25°C, equipped with a 5 mW helium neon laser and the Malvern 
software. Samples were measured in an AZ 110 cell at 633 nm and a scattering 
angle of 90°. The samples were diluted in ultrapure water if needed, to measure 
within a defined count rate interval of 100 – 400 kilo counts / second and to 
avoid multiscattering. The viscosity (0.88 mPa s) and the refractive index of 
ultrapure water (1.33) were used for data analysis. The PCS V. 1.26 - software 
was used to calculate the particle mean diameter and width of the fitted gaussian 
distribution. All measurements were carried out in triplicate.  
Scanning electron microscopy (SEM) was performed with a CamScan 4 
(Cambridge, UK) after gold sputter coating using a AUTO 306 (Edwards, UK) 
for particle size confirmation. 
 
DNA Encapsulation Efficiency 
The DNA distribution in either the nanoparticles or in the supernatant was 
evaluated using 1% agarose gel electrophoresis with ethidium bromide staining. 
The nanoparticle samples were centrifuged at 14,000 rpm (16,025 g) for 20 min 
in an Eppendorf 5415C centrifuge (Wesseling, Germany), to separate the 
particle pellet from the supernatant. The supernatants were directly applied into 
the gel adding 5 µl glycerol and 10 µl of dextran sulfate (Mw 5,000, Sigma-
Aldrich, Taufkirchen, Germany) 0.25 mg/ml to 20 µl of the probe. DNA 
encapsulated and associated with the polymer nanoparticles was extracted from 
the polymer using Roti-phenol® (Roth, Karlsruhe, Germany). The pellet was 
firstly incubated for one hour with 80 µl of a 0.25 mg/ml dextran sulfate solution 
in isotonic TE buffer (1mM Na2EDTA; 10mM Tris; 143mM sodium chloride). 
Roti-phenol®, 100 µl, was added thereafter and incubated for one additional 
hour under constant stirring of 10 rpm in a Rotatherm® (Liebisch, Bielefeld, 
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Germany) at room temperature. The two phases were separated by 
centrifugation at 14,000 rpm for 20 min in an Eppendorf 5415C centrifuge. 
Glycerol, 5 µl, was added to 20 µl of the aqueous phase and applied into the 1% 
agarose gel. Electrophoresis (Blue Marine 200, Serva, Germany) was carried out 
at 100 V for one hour in 0.1M TE-buffer. 8 µl of a 1 % (w/v) ethidium bromide 
solution were included into all gels to visualize the DNA localization by 
photography with UV transillumination. 
 
RESULTS AND DISCUSSION  
 
The solvent displacement method represents a very promising tool for the 
encapsulation of drugs, susceptible to shear and heat degradation. For the 
hydrophilic compound, such as DNA, this process has been shown to be non-
effective [7]. We hypothesized, that the complexation of DNA with polycations 
would reduce its hydrophilicity. Alternatively, a polycation / DNA complex 
could represent a surface for polymer deposition and aggregation. Thus, we 
were primarily interested in the encapsulation of complexed DNA within the 
newly synthesized fast degrading polyesters. Interestingly, we observed that 
neither the aqueous DNA solution nor the polymer precipitated when the two 
solutions were mixed. This was noteworthy, as DNA is insoluble in acetone and 
the polymer is insoluble in water (Fig.1). This phenomenon was explained by 
polyelectrolyte interactions in the acetone/water medium. Polyelectrolyte 
complexes in low-polar solvents, such as chloroform have been studied by 
Sergeyev et al. [11]. The interaction and solubilization of polyelectrolyte / 
surfactant complexes was ascribed to the high stability of salt bonds in the low 
polar environment. Further, the complexation capacity was hypothesized to arise 
from the DNA inherent property to reside in a condensed state [11]. As in this in 
the present study, DNA was insoluble in the organic solvent. Still, the solvent 
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acetone is much more polar (dielectrical constant: 20.7) compared to chloroform 
(dielectrical constant: 4.81) which was used by Sergeyev.  
 
Fig.1: Scheme of the nanoparticle formation process by solvent displacement. 
The mixture of the DNA and the polymer in a water / acetone medium is injected 
into a stirred stabilizer solution in which nanoparticles form spontaneously. 
 
Desbrieres et al. have studied pre-formed and lyophilized polyelectrolyte 
complexes in more polar solvent, such as dimethylformamide (dielectrical 
constant: 37). In this solvent both components were soluble and thus behaved 
similar to polyelectrolyte complexes in water [12]. Our system was considered 
to be similar to dimethylformamide, as we combined acetone and water. The 
particularity of the present method, compared to others, arises from the 
insolubility of DNA in the acetone/water mixture. This was demonstrated by 
DNA precipitation in the absence of the polymer in the acetone/water mixture. 
In both studies previously discussed, either both components were soluble in 
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water, or both were soluble in the organic solvent. P(26)-10 was insoluble in 
water. This enabled us to further use the solvent displacement method for 
nanoparticle formation by polymer coalescence in aqueous medium.  
Investigators have studied the influence of formulation parameters of the solvent 
displacement technique on nanoparticle formation. In this study we varied 
several parameters to characterizes our system, especially the nanoparticle size 
[13-17].  
All nanoparticles were formulated according to the standard method described, 
changing one parameter at a time. Nanoparticles prepared with the standard 
method had hydrodynamic diameters of approximately 160 nm (Fig.2). The 
standard volume of 250 µl of low ionic strength TE buffer corresponded to 20% 
of the 1.25 ml volume of acetone. When the acetone volume was doubled to 2.5 
ml, the size of the particles was decreased to 135 nm. A further increase of the 
acetone volume led to larger particles again. It is known from the literature that 
lower solvent viscosities, as well as higher volumes of organic solvents result in 
a better disruption of polymer droplets and inconsequence, in smaller 
nanoparticles [13,14]. 
 
Fig.2: Nanoparticle sizes using increasing amounts of acetone. An increase first 
led to a minimum particle size, further increase produced lager particles again. 
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For the P(26)-10 system, this could not be observed for all of the samples. This 
effect was attributed to the influence of the polymer/DNA interaction. We 
assume that the coalescence rate of the polymer is also dependent on the size of 
the polyelectrolyte complex in the acetone/water medium. As ionic interactions 
increase with the hydrophilicity of the solvent, the complex size decreased [12]. 
Higher amounts of acetone could have resulted in larger complexes, arising from 
less intensive interactions of the polymers resulting in higher viscosities and 
reduced droplet disruption. 
This hypothesis is in line with the nanoparticle sizes obtained by the 
encapsulation of polyethylenimine (PEI) 25 kDa (BASF, Ludwigshafen, 
Germany) complexes with DNA (Fig.3).  
 
Fig.3: (a) Size of nanoparticles prepared with equal amounts of PEI/DNA 
complexes dispersed in increasing volumes of low ionic-strength TE-buffer. The 
particle size increased with the volume of the aqueous phase mixed to the 
acetone solution. (b) DNA recovered from the nanoparticles prepared with 200 
µl, 300 µl, 400µl and 500 µl of DNA complex solution, respectively bands 1 to 
4. A volume of 500 µl aqueous solution led to the highest DNA encapsulation 
into the nanoparticles, as compared to formulations with lower buffer contents. 
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All complexes were prepared at a nitrogen to phosphate ratio of 5 in ultrapure 
water. The complexes were diluted with TE buffer to the final volume of the 
aqueous phase. PEI 25 kDa is a well-known and very effective complexing 
agent for DNA. Therefore, the DNA / polymer interaction will have a less 
relevant impact on the nanoparticle formation process. Nanoparticle sizes 
increased with higher volumes of the aqueous complex solution. The diffusion 
rate of the solvent is dependent on the concentration gradient of the solvent. 
Thus, a dilution of acetone caused a slower diffusion, less droplet disruption and 
faster coalescence.  
HT DNA of these nanoparticles was extracted and analysed by agarose gel 
electrophoresis (Fig.3b). The DNA encapsulation efficiency was the highest for 
500 µl TE buffer preparation and decreased with lower aqueous volumes. This 
suggested that the coalescence rate of the polymer is higher, when increasing 
amounts of aqueous solutions are mixed to the acetone polymer solution. This 
restricted the distribution of the PEI/DNA complex into the aqueous phase 
during encapsulation.  
A further well-known parameter influencing the nanoparticles size is the volume 
of the aqueous stabilizer solution. The concentration gradient of the acetone is 
greater when large aqueous phases are used. Hence, the mass transport is faster, 
resulting in more extensive droplet disruptions [13]. In our study this effect was 
observed for the preparations in 5 ml to 10 ml volumes of poloxamer solution. 
However, a volume of 20 ml resulted in larger nanoparticles again. Sterling et al. 
selectively described the two factors influencing the interfacial turbulences, i) 
the magnitude of surface viscosity and ii) the steepness of the concentration 
profile near the interface [13]. Therefore, we could only explain this finding by a 
hindrance of acetone diffusion into the aqueous phase, due to reduced mixing in 
the higher volume of aqueous solvent level during the preparation. 
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Fig.4: Size of nanoparticles prepared in 5, 10, 20 ml poloxamer solution using 
either 1.25 ml acetone or 3.75 ml acetone. 
 
 
Fig.5: Size of nanoparticles prepared using different DMSO / acetone ratios as 
organic polymer solvent. (a) The nanoparticle size increased with rising 
amounts of DMSO. (b) The amount of encapsulated DNA recovered from 
nanoparticles decreased with raising amounts of DMSO solvent. 
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Increasing the amount of a model solvent DMSO in the acetone phase, led to 
larger hydrodynamic diameters of the nanoparticles (Fig.5a). This effect was 
attributed to the slower diffusion of the solvent mixture into the stabilizer 
solution because of a higher viscosity of DMSO (2.4 mPa*s) compared to 
acetone (0.34 mPa*s). 
Particles in a size range of 350 nm could be prepared exclusively using DMSO 
as organic solvent. DMSO however, does not represent a realistic candidate for 
nanoparticle preparation, as it cannot be evaporated easily form the formulation. 
DNA of the nanoparticles was extracted and analyzed by agarose gel 
electrophoresis. The encapsulation efficiency of DNA decreased significantly 
when the amount of DMSO was raised (Fig.5b). This was ascribed to the 
prolonged coalescence rate of the polymer, due to slower mass transport of the 
solvent from the organic phase. This resulted in a greater diffusion of DNA into 
the supernatant.  
In a further study an organic solvent, ethanol, was used as external phase instead 
of the 0.1% Pluronic solution (Fig.6). All other parameters for the nanoparticle 
preparation were held constant. We hypothesized that complete association of 
DNA with the nanoparticles was possible, as both, DNA and the polymer were 
not soluble in ethanol. The sizes of DNA loaded nanoparticles prepared without 
additives exhibited hydrodynamic diameters of approximately 600 nm. 
Interestingly, pre-complexed DNA with either PEI 25 kDa or the hydrophilic 
amine-modified PVA backbone resulted in smaller particles. We hypothesized 
that ethanol is a suitable external phase as it can be readily evaporated. Thus, 
concentrating the samples in smaller volumes or the transfer of the formulation 
into another medium would be easier to achieve. Still, aqueous systems have 
great advantages, especially with regard to the application on cells or in 
physiological environment. 
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Fig.6: Nanoparticle suspensions prepared with ethanol used as external 
solution. (a) PEI/DNA complexes encapsulated in P(26)-10 dissolved in 
acetone.(b) DNA encapsulated in P(26)-10 dissolved in DMSO/acetone 
(1:1)[v/v], (c) DNA encapsulated in P(26)-10 dissolved in acetone. 
 
The morphology of nanoparticles formulated by the standard setting was 
analyzed by SEM (Fig.7).  
 
Fig.7: SEM micrographs of nanoparticles prepared with the solvent 
displacement method using P(26)-10 as representative polymer for the amine-
modified polyesters.  
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These micrographs exhibited some well-defined structures, however, a majority 
of the particles appeared as a collapsed structures. This effect can be attributed 
to the very low glass transition temperature of the polymers [9]. This could 
result in the collapsed structure of the nanoparticles, upon exposure of the 
polymers to higher temperatures and energy during the gold sputter coating. 
Nanoparticle sizes however could be confirmed. 
 
CONCLUSION 
 
In this study we investigated the particle formation process for direct 
encapsulation of DNA into a representative polymer of a new class of amine-
modified polyesters. We successfully encapsulated DNA using the solvent 
displacement technique which has been previously only described for the 
efficient encapsulation of hydrophobic compounds. We investigated the 
influence of several parameters on the particle size. Our findings were mostly in 
line with the literature. Still, this system exhibited specific properties, which 
could be explained by the polyelectrolyte interactions of the polymer with DNA. 
The characterization of DNA extracted from the nanoparticles represented some 
difficulties, as the P(26)-10 polymer precipitated in the aqueous solution. 
However, this study demonstrated that the polymer used is a very promising 
candidate for DNA encapsulation without the application of major shear forces. 
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BRANCHED POLYESTERS FORMED BY A 
MODIFIED SOLVENT DISPLACEMENT METHOD 
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SUMMARY 
  
The encapsulation of plasmid DNA into biodegradable micro- and nanoparticles 
has recently been a challenge for many groups, aiming to use the system for 
DNA vaccination and gene delivery. In this study we present a technique for 
DNA encapsulation into nanoparticles avoiding shear or ultrasonic forces by the 
use of biodegradable amine-modified polyesters. These biodegradable polymers 
combined specific characteristics, as ionic interactions with DNA and 
protonable amino-functions, providing an efficient nanoparticular system for 
gene transfer. The resulting DNA nanoparticles had hydrodynamic diameters 
ranging from 175 nm to 285 nm and highly positive ξ-potentials, depending on 
the nitrogen to phosphate (N/P) ratio used for the particle formation. Atomic 
force microscopy (AFM) confirmed particle sizes and showed well-defined 
shapes to more collapsed particle morphologies. DNA stability was investigated 
upon DNA release in PBS buffer and enzymatic degradation was assayed by 
agarose gel electrophoresis. This demonstrated that DNA was released in its 
supercoiled form and that it was protected from enzyme degradation. DNA 
nanoparticle cellular uptake was measured by flow cytometry using different 
N/P ratios. The efficient particle endocytosis was further followed over time by 
confocal microscopy.  
 The efficiency of the DNA nanoparticles was demonstrated by in vitro 
transfection assays in four cell lines. The gene delivery efficiencies of the 
amine-modified polymers were increased compared to free DNA. To 
demonstrate the power of the nanocarrier system, we compare the luciferase 
expression of the pCMV-Luc plasmid with PEI 25 kDa / DNA complexes used 
at equal N/P ratios. Thereby, we could show that one of the polyesters, P(68)-10, 
had higher efficiencies than the PEI 25 kDa complex.  
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INTRODUCTION  
 
DNA vaccines have been under intensive investigation for over a decade [1,2]. 
During this time, it has become clear that a sufficient immune response with 
DNA vaccines can only be achieved with adjuvant systems. While, the injection 
of naked plasmid DNA in mice has been shown to induce an immune response, 
including the generation of antibodies and cytotoxic T lymphocytes [3,4], 
relatively high doses of DNA were needed to reach protective levels [5,6]. By 
the use of adjuvants, however, one could reduce the required DNA dose to 
practical levels. Several groups have successfully developed DNA adjuvant 
delivery systems based on micro – and nanoparticles [7]. Ideally, such systems 
should i) protect DNA from enzymatic degradation; ii) allow a sustained and 
predictable DNA release from the carrier and iii) target the delivery system to 
antigen presenting cells by appropriate particle sizes. The most commonly used 
biodegradable polymer for DNA encapsulation has been poly(lactic-co-glycolic 
acid) (PLGA). Many techniques have been used to encapsulate DNA within 
PLGA including spray-drying [8] and modified double emulsion methods [9], 
all of which rely on high-speed homogenization or sonication for the formation 
of particles suitable for phagocytic uptake. The effect of high shear forces on 
DNA, however, has been found to be very detrimental for plasmid integrity 
[10,11]. To circumvent DNA damage during this procedure, several methods 
have been proposed, such as complexation of DNA with cationic polymers prior 
to encapsulation [12], cryopreparation and the addition of ionic excipients [8]. 
All methods were able to diminish the effects of mechanical stress on DNA 
during encapsulation. However, upon release from these particles, DNA had 
been exposed to the PLGA acidic degradation products, namely lactic and 
glycolic acid, resulting in acid-catalyzed depurination and chain breaks [10]. 
Even the encapsulation of DNA using the least hydrophobic, uncapped PLGA 
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with a relatively small molecular weight exhibited DNA nicking shortly after its 
burst release [8].  
To overcome these draw-backs, we developed a modified solvent displacement 
method for DNA encapsulation using a new class of biodegradable polymers 
which exhibit rapid degradation [13]. This method enabled us to encapsulate 
DNA without the use of high-speed homogenization. In the present study, we 
systematically investigated series of polymers belonging to branched polyesters 
with regard to their abilities to encapsulate, protect and deliver plasmid DNA. 
 
MATERIALS AND METHODS 
 
Polymers and DNA 
Biodegradable comb polymers consisting of amine-modified poly(vinyl alcohol) 
(PVA) backbones grafted with PLGA at a backbone to PLGA side chain ratio 
[m/m] of 1:10 and 1:20 were used in this study [13]. The amine modification of 
the polymer backbone using either 3-diethylamino-1-propylamine (DEAPA = 
P), 2-diethylamino-1-ethylamine (DEAEA = E) or 3-dimethylamino-1-
propylamine (DMAPA = M) was accomplished by N,N'-Carbonyldiimidazole 
coupling chemistry. PLGA grafting was performed using a ring opening 
polymerization procedure. The degree of amine-substitution was indicated by 
the number following the type of amine modification, representing the number 
of monomers of the PVA backbone carrying an amine-substitution. The PLGA 
chain length was described by the number after the degree of amine substitution, 
calculated from feeding. The commercially available PLGA (50:50), Resomer® 
502H, (Mw 15,200, specifications supplied by the manufacturer) was purchased 
from Boehringer Ingelheim (Ingelheim, Germany). 
Plasmid DNA, pLuc-CMV, a luciferase encoding plasmid, preceded by a 
nuclear location signal under the control of a CMV promoter, was kindly 
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provided by Chiron (Emeryville, Ca) and amplified by PlasmidFactory, 
(Bielefeld, Germany). The pLuc-CMV used in this study originated from a 
single endotoxin-free batch in TE-buffer pH 8 and was stored at -80°C until use. 
Pluronic™ F68 was purchased from BASF (Parsippany, NJ). All other 
chemicals were purchased by Sigma and were of analytical quality. 
 
Nanoparticle Preparation 
Nanoparticles of amine-modified PVA-graft-polyesters and PLGA were 
prepared by a modified solvent displacement method [14]. Briefly, herring testes 
(HT) DNA or plasmid DNA, was diluted to a final concentration of 0.5 µg/µl in 
500 µl distilled water and dispersed into 2.5 ml acetone solution containing the 
amine-modified polymer. The dispersion was prepared by simple injection of 
the aqueous solution into the polymer solution. The amount of polymer in the 
acetone solution was determined by the requested N/P ratio. The resulting 
mixture further was slowly injected into 10 ml of a magnetically stirred 0.1 % 
aqueous Pluronic™ solution, using a 14-gauge needle. Under these conditions 
spontaneous nanoparticle formation could be observed. The nanoparticle 
preparation was stirred for 3 hours under constant laminar air-flow for complete 
removal of residual acetone. Particles were characterized and used directly after 
the preparation. 
 
Particle Size Measurement 
The effective hydrodynamic diameter was measured by photon correlation 
spectroscopy (PCS) using a Malvern Zetasizer 4 (Malvern Instruments, 
Germany) at 25°C equipped with a 5 mW helium neon laser and the Malvern 
software. Samples were measured in a AZ 110 cell at 633 nm and a scattering 
angle of 90°. The samples were diluted in ultrapure water if needed, to measure 
within a defined count rate interval of 100 – 400 kilo counts / second to avoid 
multiscattering. The viscosity (0.88 mPa s) and the refractive index of ultrapure 
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water (1.33) were used for data analysis. The PCS V. 1.26 - software was used 
to calculate particle mean diameter and width of fitted gaussian distribution. All 
measurements were carried out in triplicate. 
  
Zeta Potential Measurements 
ξ-potential measurements were carried out using the Zetasizer 4 (Malvern 
Instruments, Germany). Samples were diluted in ultrapure water to a defined 
count rate interval of 400 – 800 kcps. Electrophoretic light scattering was 
performed in a AZ 104 cell. Average ξ-potential values were calculated from the 
data of 3 runs. The instrument was calibrated with a Malvern –50 mV transfer 
standard. All measurements were carried out directly after particle preparation. 
 
Polymer Mass Balance 
The polymer mass balance was determined gravimetrically after centrifugation 
of the nanoparticle preparation directly after preparation at 10,000 rpm (8,176 g) 
in an Eppendorf 5415C centrifuge for 20 min. The nanoparticle pellet and the 
supernatant were lyophilized separately in a Christ beta-II freeze-dryer 
(Osterode, Germany). The polymer mass balance was measured gravimetrically 
to rule out the possibility of free polymer in solution, taking into account the 0.1 
% poloxamer stabilizer. The difference of all population means was analyzed by 
a two-sample t-test and one-way ANOVA at the 0.05 level. 
 
Atomic Force Microscopy 
The DNA nanoparticles were directly transferred onto a silicon chip after 
preparation, by dipping into the nanoparticle solution. Atomic force microscopy 
was performed on a Digital Nanoscope IV Bioscope (Veeco Instruments, Santa 
Barbara, CA) as described elsewhere [15]. The microscope was vibration-
damped. Commercial pyramidal Si3N4 tips (NCH-W, Veeco Instruments, Santa 
Barbara, CA) on a cantilever with a length of 125 µm, a resonance frequency of 
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about 220 kHz and a nominal force constant of 36N/m were used. All 
measurements were performed in Tapping mode to avoid damage of the 
sample surface. The scan speed was proportional to the scan size and the scan 
frequency was between 0.5 and 1.5 Hz. Images were obtained by displaying the 
amplitude signal of the cantilever in the trace direction, and the height signal in 
the retrace direction, both signals being simultaneously recorded. The results 
were visualized either in height or in amplitude modus. 
 
Lactate Dehydrogenase Release 
The release of lactate dehydrogenase (LDH) was measured to characterize the 
membrane toxicity of nanoparticle formulations. L929 mouse fibroblasts 
(DSMZ, Braunschweig, Germany) were seeded at a density of 50,000 cells per 2 
ml in 12 well culture dishes (Nunc, Wiesbaden, Germany) and grown for 24 h 
prior to the incubation with the particles, according to the supplier’s 
recommendations. The cells were washed twice with PBS buffer (0.1 M, pH 7.4) 
and incubated with 100 µl nanoparticle suspension resulting in 0.5 mg polymer 
per ml PBS buffer. Blank PBS buffer and a 0.1 % Triton-X 100 solution in PBS 
buffer were used as controls. 100 µl samples were withdrawn after 120 and 180 
min and processed according to the manufacturer’s instructions (Sigma 
Diagnostics, Deisenhofen, Germany). All sample values were normalized 
relative to Triton-X values and expressed as relative LDH release in [%]. All 
DEAPA polymers were used as nanoparticle preparations at N/P ratio of 5. Each 
sample was performed in triplicate. The difference of all population means were 
analyzed by a two-sample t-test and one-way ANOVA at the 0.05 level. 
 
DNA Release and DNase Stability 
DNA release from the nanoparticles was evaluated in the supernatant of the 
particle preparations in isotonic TE-buffer at pH 7.4 (1 mM Na2EDTA; 10 mM 
Tris; 143 mM NaCl). Aliquots containing 300 µl of the nanoparticle suspension 
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corresponding to 7.5 µg pDNA were prepared for each time point. Polymer 
mass was dependent on the N/P ratio. After predetermined time points, the 
samples were centrifuged at 14000 rpm (16,025 g) for 30 min in an Eppendorf 
5415C centrifuge. The supernatant and the pellet were lyophilized in a Christ 
beta-II freeze-dryer (Osterode, Germany). The soluble components from the 
supernatant were re-dissolved in 20 µl TBE-buffer (89 mM Tris, 89 mM boric 
acid, 2 mM Na2EDTA), containing 25 IU heparin (Serva, Heidelberg, Germany) 
to separate possible DNA / backbone complexes. Glycerol (5 µl) was added to 
the preparation prior to the separation using a 1% agarose gel. 
DNA stability was studied using 100 µl aliquots of the nanoparticle suspensions, 
corresponding to 2.5 µg DNA. The samples were incubated with 12.25 µl 
DNase buffer 10x (1M Na-acetate, 50 mM MgCl2) and 2.5 µl DNase I solution 
(DNase I, Boehringer Mannheim, Germany) (50 I.U. / ml in 50 mM Tris-HCl 
pH 8, 100 mM KCl). The reaction was terminated with 5.7 µl EDTA solution 
(0.5 M, pH 8). The probes were freeze-dried and stored at –20 °C until further 
use. At the time of analysis, the dried probes were incubated for one hour in 10 
µl TBE-buffer containing 50 I.U heparin. Further, 10 µl Roti-phenol® (Roth, 
Karlsruhe, Germany) were added and incubated for additional 2 hours at room 
temperature. Glycerol (5 µl) was added to the emulsion before application onto a 
1 % agarose gel. Untreated DNA was applied to the gel for comparison of the 
DNA forms. Electrophoresis (Blue Marine 200, Serva, Germany) was carried 
out at 100 V for two hours in TBE-buffer. 8 µl 1 % (w/v) ethidium bromide 
solution were included into all gels to visualize the DNA localization by 
photography with UV transillumination. 
 
Nanoparticle Cell Association 
Flow cytometry was performed using plasmid DNA labeled with 25 µl/mg DNA 
of the intercalating fluorescence dye YOYO-1 (Molecular Probes, Leiden, The 
Netherlands), as described by Ogris et al. [16]. L929 mouse fibroblasts were 
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plated at a density of 400, 000 cells / well in 6-well cell culture dishes (Nunc, 
Wiesbaden, Germany) and grown for 24 hours in DMEM with 10 % FCS. 
Nanoparticles were prepared with the polymer P(68)-10 and the fluorescence 
labeled DNA, using the standard protocol at different N/P ratios. The volume of 
the nanoparticle dispersion was reduced by ¼ to 2.5 ml. Aliquots of 160 µl 
particle suspension, containing 4 µg DNA were incubated with the cells for 4 
hours according to the transfection protocol. 
The cells were washed twice with glucose 5 %, pH 7.4 and once with 1M NaCl 
as described by Ruponen et al. to remove adsorbed nanoparticles [17]. The cells 
were suspended in PBS buffer after detachment by trypsin incubation for 1 min. 
Cell suspensions were kept on ice until analysis. Flow cytometry was performed 
with 10,000 cells, using a Becton Dickinson FACS Scan equipped with an argon 
laser with an excitation wavelength of 488 nm. 
 
Cellular uptake of DNA Nanoparticles 
For confocal microscopy experiments a Zeiss Axiovert 100M microscope 
coupled to a Zeiss LSM 510 scan module was used. 
Plasmid DNA was covalently fluorescence labeled with a rhodamin dye, Cy-3 
(Mirus, Madison, Wisconsin) according to the manufacturers instructions. The 
P(68)-10 amine-modified polyester was covalently labeled with a fluorescein 
chromophore using the amine reactive 5-DTAF (5-(4,6-
dichlorotriazinyl)aminofluorescein, Molecular Probes, Leiden, The 
Netherlands). For polymer labeling, 96 mg of the polymer and 2.5 mg 5-DTAF 
were dissolved in a total volume of 7.5 ml DMSO and stirred for 1.5 hours at 
65°C for amine coupling. The polymer was ice-cooled and precipitated with a 
mixture of propanol-2 and water. The pellet was washed several times to 
eliminate unbound components.  
Nanoparticles were prepared according to the standard protocol by mixing the 
fluorescence labeled polymer with non-labeled polymer in a mass ratio of 1/6. 
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Rhodamin labeled DNA was mixed with the original plasmid in a ratio of 
1/61.5. L929 cells were seeded at a density of 20,000 cells per well in 8 well 
chamber slides (Lab Tek, Nunc, Wiesbaden, Germany). After 24 hours medium 
was removed. Aliquots of the nanoparticle suspension containing 0.8 µg DNA 
were added to new medium containing 10 % FCS. The cells were incubated for 
5, 30, 60 and 180 minutes with the nanoparticles. The medium was removed and 
cells were washed 4 times with PBS buffer. Fixation of cells was performed by 
incubation with 400 µl paraformaldehyde solution 3 % in PBS for 20 minutes. 
The cells were washed again for 4 times with PBS and incubated for additional 
20 minutes with a 0.1 mg/ml DAPI (4',6-diamidino-2-phenylindole 
dihydrochloride, Molecular Probes, Leiden, The Netherlands) in PBS for 
nucleus identification. An Enterprise UV laser with a wavelength 364 nm was 
used for excitation of the blue DAPI fluorescence. Excitation of green 
fluorescence of 5-DTAF labeled polymer was performed using an argon laser 
with an excitation wavelength of 488 nm. A Helium-Neon laser with an 
excitation wavelength of 543 nm was used and for the excitation of red 
fluorescence of the DNA. Images were recorded in multitracking mode using a 
longpass filter of 385 nm for DAPI, a longpass filter of 505 nm for Oregon 
Green and a longpass filter of 560 nm for rhodamine. 
 
Transfection Efficiency  
L929 mouse fibroblasts (DSMZ, Braunschweig, Germany) and NIH-3T3 
fibroblasts (DSMZ, Braunschweig, Germany) were cultured in Dulbeco's 
modified Eagle’s medium (DMEM, Gibco, Eggenstein, Germany) and 
supplemented with 10 % fetal calf serum (FCS, Gibco) according to the 
supplier’s recommendations. The cells were plated 24 h before nanoparticle 
incubation at a density of 50,000 cells / 2 ml in 12 well plates (Nunc, 
Wiesbaden, Germany). U937, human pre-monocytic cells (DSMZ, 
Braunschweig, Germany), cultured according to the supplier’s instructions, were 
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plated at a density of 50,000 cells / 2 ml in RPMI medium containing 10 % FCS 
and incubated for 72 h with 81 nmol / ml phorbol 12-myristate 13-acetate 
(PMA, Sigma, Deisenhofen, Germany) for cell activation and adhesion to the 
cell culture dish. Rabbit vascular smooth muscle cells (RbVSMC), a primary 
cell line was supplied by the department of experimental radiology (University 
of Marburg) after their isolation according to Axel et al. [18]. The cells were 
cultured in DMEM medium supplemented with 10 % FCS. The RbVSM cells 
were plated at a density of 20,000 cells / 2 ml because of their larger cell size. 
Immediately prior to transfection, the medium was removed and replaced by 500 
µl glucose 5 % at pH 7.4. Aliquots of 160 µl particle suspension, containing 4 
µg pLuc-CMV, were added to the glucose 5 % medium at pH 7.4. 
The cells were pre-incubated with the nanoparticle suspension for 5 min, after 
which 1.5 ml cell culture medium containing 10 % FCS was added. The 
nanoparticle suspension was dispersed in the glucose medium before the 
addition of the medium, since instabilities of nanoparticle suspension were 
observed in the medium. The nanoparticle suspension was removed after 4 hours 
of incubation and replaced with fresh medium containing 10 % serum. Cells 
were harvested after 48 h, washed with PBS pH 7.4 twice, and lysed in cell 
culture lysis reagent (Promega). Luciferase content was assessed using a 
commercial luminescence kit (Promega) measured in a Berthold Sirius 
luminometer (Berthold, Pforzheim, Germany). RLUs were converted into 
luciferase content by calibration with recombinant luciferase (Promega). Protein 
concentrations were determined by a modified BCA assay [19]. Transfection 
experiments were performed in triplicate and presented as the mean of the 
luciferase / protein ratio [ng/mg]. 
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RESULTS 
 
Particle Preparation and Characterization 
DEAPA (P), DEAEA (E) and DMAPA (M) -modified PVA-graft-polyesters, 
represented in Figure 1, were used in this study for DNA nanoparticle formation.  
 
Fig.1: Representative structure of the biodegradable amine-modified (polyvinyl 
alcohol)-graft-poly(lactide-co-glycolide) polymers. The PVA degree of 
polymerization was 300 containing from 12 to 68 amine-substituents and 150 to 
240 grafted PLGA side chains. The PLGA (50:50) grafts were built up of 
approximately 10 or 20 monomer units. 
 
The nanoparticles were formulated using variable nitrogen to phosphate (N/P) 
ratios, based on the fact that one amine side chain represented one protonable 
amine. The amount of DNA used in our study was held constant at 250 µg DNA 
for each preparation. The properties of the branched polyesters allowed us to 
modify the solvent displacement method for optimized DNA encapsulation.  
 
This was highlighted by the fact that, although DNA (0.5 mg/ml) was not 
soluble in acetone, no precipitation occurred after the addition of 500 µl of the 
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DNA solution into the acetone polymer solution (2.5 ml). In contrast, the 
addition of DNA solution into an acetone solution resulted in a visible 
precipitation. Nanoparticles formed spontaneously after the injection of the 
acetone/water solution containing DNA and the polymer into the aqueous 
stabilizer medium.  
 
Polymer Size a 
 
[nm] 
Poly-
dispersity a 
ξ - potential a 
 
[mV] 
Molecular
Weight b 
[g/mol] 
P(12)-10 238.0 0.25 24.2 ± 1.7 262,600 
P(26)-10 199.4 0.28 46.7 ± 0.7 n.d. 
P(33)-10 175,4 0.53 45.4 ± 0.4 366,900 
P(68)-10 280.5 0.4 45.6 ± 0.4 798,500 
P(33)-20 285.1 0.25 45.0 ± 1.0 711,900 
E(33)-10 211.7 0.32 44.7 ± 1.5 1199,000 
E(12)-20 188.7 0.68 41.3 ± 0.6 350,300 
E(33)-20 > 1000 1.0 n.d.  767,000 
M(13)-10 186.7 0.31 38.9 ± 1.2 631,700 
RG 502H 563.4 0.74 -54.6 ± 2.6 15,200 
a Average value of three independent measurements and standard deviation 
b MW from GPC-MALLS (gel permeation chromatography - multiple-angle-
laser-light-scattering) according to Wittmar et al. [13] 
 
Table 1: Characterization of DNA nanoparticles prepared with amine-modified 
PVA - graft polyesters at a N/P ratio of 5 and one PLGA (RG 502H) polymer, 
using a modified solvent displacement method. The nanoparticles were 
characterized directly after their preparation with regard to their hydrodynamic 
diameters by PCS and their ξ - potentials by electrophoretic light scattering. 
The molecular weights of the of the polymers were specified in the table.  
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Particles sizes and ξ-potentials were measured directly after preparation and 
results are presented in Table 1. DEAPA polymer nanoparticles at the N/P ratio 
of 5 had hydrodynamic diameters ranging from 175 – 285 nm, while DEAEA 
nanoparticle sizes were in the range of 200 nm. The E(33)-20 polymer did not 
form nanoparticles at the N/P ratio investigated in this study. The DMAPA 
polyester studied, M(13)-10, had an average hydrodynamic diameter of 187 nm. 
Particle sizes were independent of the polyester side chain length and amine-
modification. However, the commercial PLGA (RG 502H) polymer particles 
showed roughly a two-fold increase in hydrodynamic diameter as compared to 
the amine-modified polyester formulations when the same method of particle 
formation was used. 
The ξ-potential of the DNA / PLGA nanoparticle preparation was highly 
negative, arising from the presence of DNA and the uncapped carboxylic groups 
of the polymer. The DNA nanoparticles formulated with the amine-modified 
polyesters had very similar positive ξ-potentials, independent of the polymer 
used, when they were prepared at the N/P ratio of 5.  
In Figure 2 nanoparticles prepared with P(68)-10, as a representative polymer, at 
different N/P ratios were studied for their size and ξ-potential. Nanoparticles 
with HT DNA at a N/P ratio of 0.5 were relatively large, measuring 
approximately 890 nm. At the calculated point of neutrality, the nanoparticle 
formulation exhibited a mean hydrodynamic diameter of approximately 200 nm. 
Further increase in the N/P ratio did not have any influence on the nanoparticle 
size measured. The polymer P(68)-10 was further used to study the effect of the 
N/P ratio on the nanoparticle ξ-potentials (Fig.2). 
At the N/P ratio of 0.5, the particles exhibited a negative ξ-potential (- 48.6 
mV). From the point of calculated charge neutrality on, the ξ-potentials 
increased to reach a constant level at N/P 3 to N/P 9 (+ 51 mV) (Fig.2). 
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Fig.2: Nanoparticle size (□) and ξ-potential (●) of DNA nanoparticles 
prepared with the amine-modified polymer P(68)-10 at different N/P ratios. The 
nanoparticle size remains approximately constant and small from N/P 1 to N/P 
9, whereas the ξ-potential increases from N/P 1 to N/P 3 by the value of 100 
mV. 
 
Polymer Mass Balance 
The amphiphilic properties of the polymers observed during particle preparation 
were attributed to the hydrophilic amine modifications and the remaining 
hydroxyl groups of the PVA backbone combined with the short hydrophobic 
PLGA grafted side chains. 
As a result, it was necessary to investigate if the polymer molecules could 
solubilize in the aqueous stabilizer solution. The mass balance of the 
nanoparticle suspension compared to the polymer mass in the supernatant was 
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characterized. Gravimetric analysis of the lyophilized supernatants and of the 
pellets added up to the total yield.  
The total yield was > 81% for the nanoparticle suspensions characterized in this 
study (Table 2). Small polymer amounts (1.61 – 5.6%) were recovered in the 
supernatant, suggesting that the amphiphilic properties of the polymer did not 
result in the solubilization of the polymer in the aqueous medium after particle 
preparation. A high amine substitution, and thus theoretically a more hydrophilic 
polymer resulted in an almost complete recovery of the polymer mass in the 
pellet.  
 
Polymer Pellet  
 
[%]±sd 
Supernatant  
 
[%]±sd 
Recovered Mass  
 
[%]±sd 
P(12)-10 97.11 ± 1.79 2.89 ± 1.79 81.33 ± 3.06 
P(26)-10 97.11 ± 2.51 2.89 ± 2.51 88.00 ± 3.27 
P(33)-10 96.26 ± 5.77 3.74 ± 5.77 94.00 ± 1.06 
M(13)-10 96.15 ± 2.81 3.85 ± 2.81 91.73 ± 1.15 
E(33)-10 98.39 ± 2.45 1.61 ± 2.45 101.87 ± 2.05 
P(33)-20 97.66 ± 2.72 2.34 ± 2.72 90.00 ± 11.00 
RG 502H 94.40 ± 4.85 5.60 ± 4.85 100.00 ± 14.90 
 
Table 2: Polymer mass balance of the recovered mass of the DNA nanoparticle 
preparations at N/P ratio of 9. The recovered mass [%] was in the range of 80 – 
100% for the amine-modified polyesters as well as PLGA. The mass fraction 
recovered in the pellet was approximately 95% of the recovered mass for all 
preparation. At the 0,05 level, the difference of all population means were not 
significantly different from the PLGA (RG 502H) nanoparticles analyzed be 
two-sample t-test and one-way ANOVA. 
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Atomic Force Microscopy 
Atomic force microscopy (AFM) was used to characterize the morphology of 
the nanoparticles (Fig.3). The particle sizes measured by dynamic light 
scattering could be confirmed by the micrographs.  
The DNA / P(26)-10 polymer particles were distinct and spherical.  
 
 
 
Fig.3: AFM imaging of DNA nanoparticles preparations: P(26)-10 N/P 9 (a), 
P(33)-10 N/P 11 (b), P(68)-10 N/P 5 (c), M(13)-10 N/P 5 (d), E(33)-10 N/P 5 
(e), RG 502H (f). Nanoparticles have well defined structures and could confirm 
the particle size measurements. E(33)-10 nanoparticles led to a more collapsed 
structure on the silicium support. 
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Nanoparticles prepared using E(33)-10 led to larger particles which had a less 
discrete morphology up to a collapsed structures. DMAPA particles, used in a 
N/P ratio of 5, as well as the PLGA nanoparticles were again round and well 
defined. 
 
LDH - Release 
The amounts of LDH released from cells incubated with the nanoparticles of the 
homologous series of the DEAPA polymers at the N/P ratio of 5 did not show 
significant differences analyzed by a two-side t-test and one-way ANOVA (P ≤ 
0.5) (Fig.4a).  
 
Fig. 4: LDH-release assay after 3 hour incubation of 1 mg nanoparticles in PBS 
buffer, (a) homologous series of DEAPA substituted polyesters all at N/P ratio 
of 5; (b) DNA P(68)-10 nanoparticles at different N/P ratios. At the 0.05 level, 
the difference of all population means were not significantly different from the 
blank PBS medium analyzed by two-sample t-test and one-way ANOVA. 
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Further, the effect of the N/P ratio (1 to 13) on the membrane stability was 
studied, using P(68)-10 polymer nanoparticles (Fig.4b). No membrane toxicity 
over the 10 % level was detected taking into account that no significant 
differences compared to the PBS blank were observed using the statistical 
analysis two-side t-test and one way ANOVA test (P ≤ 0.05). 
 
DNA Release and Enzyme Stability 
DNA release from the nanoparticles, prepared at the N/P ratio of 5, was studied 
over 9 days in isotonic TE buffer, pH 7.4 using separate aliquots for each time 
point which contained 7.5 µg DNA (Fig.5). 
Agarose gel electrophoresis of the supernatants of the P(12)-10 and the PLGA 
particles showed high levels of DNA in the supernatant from day 0 on, implying 
that the encapsulation efficiency of these preparations was incomplete compared 
to the other amine-modified polymer particles. 
In both the DNA / P(33)-10 and the DNA / P(68)-10 nanoparticle supernatants 
no DNA was apparent in the gel directly after the nanoparticle preparation, 
demonstrating complete DNA retention in the formulation. In the supernatant of 
P(33)-10 no DNA release was observed within the 9 days of incubation, whereas 
P(68)-10 polymer nanoparticles released small amounts of DNA beginning from 
day 2 on. 
The stabilizing effect of the nanoparticles against DNA degradation by DNase 
was studied with P(68)-10 particles (Fig.6). Nicking of naked DNA took place 
by the conversion of the supercoiled form into the open circular form and ended 
in the complete destruction of the DNA. Formulations at N/P ratio of 0.5, did 
not offer much protection, as the DNA was completely degraded after 5 minutes 
of enzyme incubation. 
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Fig.5: Agarose gel of DNA release from nanoparticles at N/P 5 from 0 to 9 days 
at pH 7.4 from the supernatant, a) P(12)-10; b) P(33)-10; c) P(68)-10; d) 
PLGA. Complete DNA encapsulation could be demonstrated for the P(33)-10 
and P(68)-10 nanoparticles. 
 
 
Fig.6: DNA protection from enzyme degradation by encapsulation in P(68)-10 
nanoparticles, followed from 0 minutes to 60 minutes and 12 hours of 
incubation with DNase I a) N/P 0.5; b) N/P 1; c) N/P 3; d) N/P 5. C represents 
non-degraded DNA samples.  
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In contrast, protection of DNA could be observed in formulations at the N/P 
ratio of 1 for 35 min, while for N/P 3 and N/P 5 the DNA was only degraded 
after 12 hours. Nicking of the supercoiled DNA-form could be observed in the 
N/P 3 preparation after 60 min of incubation. The DNA of the N/P ratio of 5 
particles was at the same time point still present in the supercoiled form.  
 
Nanoparticle Cell Association  
Nanoparticles prepared with raising N/P ratios were found to associate better 
with the L929 fibroblast cells as shown in Figure 7 and by the geometric means 
of the fluorescence counts.  
 
Fig.7: YoYo - 1 fluorescence labeled DNA association with cells after 
incubation of DNA / P(68)-10 nanoparticles at different N/P ratios. DNA 
association with the cells increases with the N/P ratio. Nanoparticles formulated 
at N/P 0.5 exhibited a minor association. Geometric means (gm) of the 
fluorescence, blank (6), N/P 0.5 (18), N/P 5 (430), N/P 9 (569), N/P 11(619). 
 
blank N/P 0.5 
N/P 9 N/P 5 N/P 11 
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Intensive washing with glucose 5% and high ionic salt solution reduced the 
adsorption of the nanoparticles on the cell surfaces. Therefore, the fluorescence 
measurement can be in majority ascribed to nanoparticle uptake via non-specific 
nanoparticle endocytosis. For nanoparticle formulations of a N/P ratio of 5 the 
DNA uptake was extensively increased (gm: 430) compared to blank cells (gm: 
6) and to cells incubated with nanoparticles formulated at a N/P ratio of < 1 
(gm:18). A doubling of the calculated positive charge excess, represented by 
particles prepared at a N/P ratio of 9 (gm: 569) and 11 (gm: 619), exhibited only 
a slight increase in fluorescence counts per cell.  
 
Cellular uptake of DNA Nanoparticles 
The double labeling enabled us to simultaneously follow the transport of DNA 
and the polymer P(68)-10 into mouse fibroblasts in vitro (Fig.7). After a 5 
minute incubation only little fluorescence of the particles was associated to the 
cells or the cell membranes. Compared to that, the 30 minutes time-point 
exhibited cells that already had taken up nanoparticles. The fluorescence was 
localized in several defined areas of the cells. The red, rhodamine fluorescence 
of the DNA and the green P(68)-10 fluorescence were co-localized. At the 1 
hour time-point the fluorescence was localized in large vesicles and remained 
superimposed. The three hour time-point exhibited cells that had endocytosed 
very large amounts of DNA nanoparticles. These were not arranged in groups 
anymore but dispersed over the entire cell and specifically around the nucleus. 
Fluorescence of the DNA and polymer remained superimposed, whereas diffuse 
polymer fluorescence was detectable throughout the cytoplasm. The red DNA 
fluorescence remained concentrated in specific areas. 
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Fig.8: Confocal laser scanning microscopy micrographs of DNA nanoparticle 
uptake at different time-points. (a) 5 min, (b) 30 min, (c) 60 min, (d) 180 min. 
The nanoparticles are extensively taken up into the endosomal compartment of 
the cells from 30 min post incubation on. DNA (red) and the P(68)-10 polyester 
(green) were associated during incubation and uptake, represented by the 
yellow/ white fluorescence. 
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Transfection Efficiency 
The transfection efficiency of DNA nanoparticles prepared with the homologous 
series of DEAPA and DEAEA polymers were investigated in L929 mouse 
fibroblasts (Fig.9-10). All DNA nanoparticles were prepared at a N/P ratio of 9 
by adjusting the polymer mass during formulation using invariant amounts of 
plasmid DNA. Hence, equal volumes of particle suspension were added to the 
cells, each containing 4 µg of plasmid DNA per well.  
The transfection efficiency of the nanoparticle suspension was evaluated and 
compared to that of an equal amount of free DNA in solution, to DNA/PEI 25 
kDa complexes and a DNA / PLGA (RG 502H) nanoparticle suspension. The 
luciferase expression of cells incubated with most of the amine-modified 
polymer DNA nanoparticles was greater than that of naked DNA. The efficacy 
of the DEAPA polymers to transfect increased with the degree of amine 
modification of the polymer, resulting a maximum value of luciferase 
expression for the P(68)-10 polymer (Fig.9a). P(68)-10 nanoparticles exhibited a 
40,950-fold higher transfection efficiency than DNA in solution and an 8.57-
fold higher luciferase expression than DNA/PEI complexes, both prepared at 
N/P 9. PLGA nanoparticles achieved only slight luciferase expression. 
Polyesters with reduced amine modification as well as those with 20 units of 
PLGA grafting were less effective than P(68)-10. The polyester, P(68)-10, in 
consequence, was investigated more intensively. P(68)-10 / DNA nanoparticles 
were formulated at N/P 0.5 to N/P 11 and their transfection efficiencies are 
represented in Figure 9b. The values were compared to DNA in solution and 
DNA/PEI complexes at N/P 5. The amount of luciferase increased exponentially 
from N/P 0.5 to N/P 7. A plateau was reached at N/P 7 through to N/P 11. 
Nanoparticles at N/P 0.5, which exhibited a negative charge, nonetheless, 
achived higher transfection efficiencies than DNA in solution. At an equal N/P 
ratio (N/P 5), the nanoparticles were 273-times more effective than the 
PEI/DNA complexes (Fig.9b). 
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Fig.9: Transfection efficiencies of DNA DEAPA nanoparticles, a) homologous 
series of DEAPA substituted polyesters and PEI 25kDa / DNA complexes all at 
N/P 9 compared to DNA in solution and DNA PLGA nanoparticles, b) DNA 
P(68)-10 nanoparticles at different N/P ratios and PEI 25kDa at N/P 5. 
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Fig.10: Transfection efficiencies of DNA DEAEA nanoparticles, homologous 
series of DEAEA substituted polyesters and PEI 25kDa / DNA complexes all at 
N/P 9 compared to DNA in solution and DNA PLGA nanoparticles. The higher 
amine-modifications result in higher transfection. The values however are 
inferior to PEI25 kDa / DNA complexes. 
 
The DEAEA polyester nanoparticles were also able to transfect L929 cells, 
however, DEAEA polymers were not as efficient as the DEAPA series (Fig.10). 
DNA/PEI complexes exhibited a nearly 700-fold better transfection efficiency 
than the most potent nanoparticles (E(33)-10), at N/P 9. The E(33)-10 DNA 
nanoparticles showed only a 2.3-fold higher efficiency than plasmid DNA in 
solution. The only DMAPA polymer used in this study exhibited a minimal 
increased transfection efficiency compared to DNA in solution (Fig.10).  
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The transfection efficiency of the nanoparticles at a N/P ratio of 9 was also 
investigated with three complementary cell lines: i) PMA activated U937 human 
pre-monocytic cell line, ii) rabbit smooth muscle cells (RbVSM) and iii) NIH-
3T3 mouse fibroblasts. The results of the P(33)-10, P(68)-10 and PEI 25 kDa 
were compared to those of DNA in solution (Table 3). It was demonstrated that 
the transfection efficiency was greatly enhanced for the P(33)-10 and P(68)-10 
polyesters compared to free DNA in non-monocytic cells.  
 
Cell line PEI/DNA P(33)-10 P(68)-10  DNA sol. 
U937 1.6 1.5 1.8 1 
L929 4,545.5 818.2 39,090.9 1 
RbSMC 1,470.6 132.3 1,147.1 1 
NIH – 3T3 10,989.0 604.4 17,582.4 1 
 
 
Table 3: Effect of the cell line on the transfection efficiency of DNA : DEAPA 
nanoparticles and DNA/PEI 25 kDa complexes at N/P 9 compared to free 
DNA. The DNA / P(68)-10 nanoparticles exhibit similar efficiency than the PEI 
25kDa / DNA complex 
 
Monocytic cells, however, did not exhibit luciferase expression. The P(68)-10 
formulation was more efficient than the DNA/PEI complex in fibroblasts. The 
measured values were reduced for all the preparations in RbVSM, where the PEI 
/ DNA complex was 1.3-fold more efficient than the P(68)-10 nanoparticles. 
P(33)-10 particles consistently exhibited lower luciferase levels than P(68)-10 
and PEI 25 kDa but still the values were greatly enhanced compared to DNA in 
solution. 
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DISCUSSION  
 
A tremendous effort has been put into the development of new delivery devices 
for gene delivery and more particularly into the development of new 
formulations for the effective use of DNA as a vaccine. In this study we 
investigated a new polymer class to evaluate its efficacy of DNA encapsulation, 
gene transfer and conservation of DNA bioactivity after nanoencapsulation. The 
polymers were designed specifically for DNA delivery by combining different 
functional modules which, from our hypothesis, were favorable for DNA 
encapsulation, in a polymer (e.g. biodegradation, hydrophobic PLGA grafts and 
cationic, hydrophilic amine substitutions) [13]. These possible structural 
varieties resulted in a spectrum of characteristics that were differently 
pronounced depending on the proportions in the polymer composition.  
The encapsulation of hydrophilic molecules in hydrophobic biodegradable 
polymers has been a challenge for some time. It was previously accomplished 
using ternary systems, such as emulsification / solvent evaporation techniques 
and double emulsion encapsulation techniques [9]. All of these methods, 
however, used high energy sources to stabilize the molecule in the polymer 
matrix [8,11,20]. The solvent displacement method is typically not an efficient 
technique for the direct encapsulation of water soluble drugs [21]. The synthesis 
of the new amine-modified polymers, possessing amphiphilic structures, 
however, has enabled us to encapsulate the hydrophilic molecule DNA without 
the degrading effects of shear or ultrasonic forces. The modified solvent 
displacement method was based on the solubilization of DNA by the polymer, 
interacting intensively via polyelectrolyte forces in the acetone/water mixture. 
Final nanoparticle formation in the aqueous medium was a result of the 
Marangoni effect, which describes the process of droplet formation arising from 
the rapid diffusion of acetone into the aqueous phase [22]. This results in 
interface turbulences and small droplet formation. The solvent diffusion process 
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for nanoparticle formation was described by Quintanar-Guerro et al. [23,24]. In 
these studies, particle sizes were described to be dependent upon the polymer 
concentration in the organic phase. This was attributed to the substantial 
increase of viscosity of the organic phase. Thus, it was found that homologous 
polymers with increasing molecular weights formed larger nanoparticles, due to 
higher viscosities [25]. The amine-modified polymers used in our study had very 
high molecular weights, ranging from Mw 261,600 g/mol to Mw 1199,000 g/mol 
for P(12)-10 to P(33)-10. PLGA, which was used for comparison had a 
molecular weight of only Mw 15,200 g/mol, leading to the assumption that the 
amine-modified polyester particles would exhibit larger hydrodynamic 
diameters. Remarkably, our new polymers formed smaller particles than PLGA 
even when nanoparticles were prepared with equal amounts of polymer and 
DNA (Table 1) [26]. Hence, the amine substitution increased the hydrophilicity 
of the polymer, which decreased the coalescence rate of the polymer droplets.  
The influence of the N/P ratio on the particle size of P(68)-10 nanoparticles 
revealed that an excess of negative charges of the DNA resulted in large 
aggregates (Fig.2). This could be explained by the incomplete nanoparticle 
formation and DNA aggregation. At charge neutrality, sufficient polymer was 
available to form small nanoparticles. The excess of polymer beyond this 
resulted in nanoparticles that were mainly regulated in their size by the polymer 
properties. The ξ-potential values of the P(68)-10 preparations with increasing 
N/P ratios were expected to increase from the calculations of the nanoparticle 
stoichiometry. Indeed, nanoparticles with N/P ratios ranging from N/P 1 to N/P 
2 exhibited a ξ-potential increase from –49 mV to +51 mV. This complete 
reversal of the surface charge characteristics demonstrated the ability of the 
polymer to efficiently encapsulate and compact DNA. Nanoparticles with N/P 
ratios ranging from 3 to 9 exhibited little change in the ξ-potential. The ξ-
potentials of nanoparticles prepared from DEAPA and DEAEA polymers at N/P 
5 in Table 1 were, all very similar, demonstrating that a five-fold excess in 
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amine groups over the phosphate groups resulted in similar surface charges of 
the nanoparticles independently of the polymer used. P(12)-10 and M(13)-10 
nanoparticles had reduced ξ-potentials, possibly resulting from a steric 
hindrance of amine arrangement in the particle due to higher PLGA grafting per 
amine group in the polymer.  
The polymer mass distribution showed that nearly the total polymer mass could 
be recovered in the pellet after particle preparation (Table 2). Therefore, the 
polymers used for the nanoparticles formation were not dissolved in the aqueous 
medium.  
Atomic force micrographs confirmed the PCS data and revealed the nanoparticle 
structure (Fig.3). The PLGA component seemed to be responsible for the 
formation of smooth particles. Polymers with a higher proportion of PLGA 
components compared to the amount of amine groups, for example, M(13)-10 
and P(26)-10, had a more defined structure than the E(33)-10 DNA polymer 
particles. This can be attributed to a reduced interaction of the polymer with 
DNA or an increased water uptake leading to a collapsed structure interacting 
more intensively with the silicium support.  
The lactate dehydrogenase release assay was performed to investigate the 
membrane toxicity of the nanoparticles preparations (Fig.4). High cationic 
surface charges have often been shown to be the cause of cell toxicities [27,28]. 
No membrane toxicity, defined by a LDH release inferior to 10%, was observed 
after 3 hours of incubation at 37°C. This preliminary data demonstrated that the 
nanoparticles preparations in the concentration used are suitable gene delivery 
agents, exhibiting no membrane toxicity. Further toxicity studies are under 
investigation.  
The release of DNA from nanoparticles at N/P 5 was studied using polymers 
with increasing degrees of amine substitution (Fig.5). Large amounts of DNA 
were discovered in the supernatant of the PLGA particles, which implied that 
the DNA / polymer interaction was low during PLGA particle preparation. 
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P(12)-10 nanoparticles, despite their cationic charge excess at N/P 5, also 
allowed free DNA to remain in the supernatant. This can be attributed to a 
shielding of amine-substituents charges by the PLGA side chains. In this case, 
the polymer could probably not interact as fully with DNA, compared to higher 
amine-modified polymers. The DNA encapsulation efficiency for P(33)-10 and 
P(68)-10 was complete, as no DNA was detected in the supernatant of the 
preparations. The low DNA release of the P(68)-10 and the absence of release 
from P(33)-10 was attributed to the strong association of DNA to the polymer 
and polymer backbone. The protection from DNase increased with the N/P ratio 
of the P(68)-10 nanoparticles, demonstrating an increase in DNA compactation 
firstly within the particles and during polymer degradation with the polymer 
backbone (Fig.6). The DNA in the nanoparticles at a N/P ratio of 9 was 
protected over 60 minutes.  
The association of P(68)-10 nanoparticles with fluorescence labeled DNA was 
studied to quantify the nanoparticle uptake into fibroblasts (Fig.7). Therefore, 
the similar incubation conditions as for the transfection experiments were used. 
The adsorption of the nanoparticles on the cell membranes was reduced by 
throughoutly washing with low ionic strength buffer, as well as highly 
concentrated salt solutions. The fluorescence intensity emitted by 10,000 cells 
was assessed by flow cytometry. Thereby, the intensity increased with the N/P 
ratio of the nanoparticles. The increase of fluorescence cell association could not 
be defined as linear compared to the raise of the N/P ratio. This phenomenon 
was in line with the ξ-potential (Fig.2) and the transfection data (Fig.9b) of 
P(68)-10 polyester DNA nanoparticles at different N/P ratios. As for the ξ-
potentials, this phenomenon could be explained by the formation of 
nanoparticles that did not have DNA encapsulated within the polymer. 
Consequently, the uptake of particles carrying DNA and particles without DNA 
compete for endocytosis. Still, the uptake of the particles with a N/P ratio of 11 
is higher that the N/P 9 and N/P ratio of 5. 
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The nanoparticle uptake into non-phagocytic cells, such as fibroblasts was 
studied by confocal laser scanning microscopy with fluorescence labeled DNA 
nanoparticles (Fig.8). Adsorptive endocytic uptake was observed from the 30 
min time-point on to the three hour time-point. The DNA and polymer 
fluorescences thereby mainly remained superimposed. The primary nanoparticle 
cell membrane interaction took place due to ionic interactions of the cationic 
nanoparticles with the negatively charged cell glycocalyx. This induced the non-
specific endocytosis of the nanoparticles into the non-phagocytic cells. 
Fluorescence was restricted to distinct areas of the cell for the 30 minutes time-
point, leading to the assumption that several particles were internalized in one 
endosome. After 3 hours of incubation, the particles were dispersed over the 
cell, arranging themselves in the proximity of the nucleus, which is common for 
lysosomes. The diffuse green polymer fluorescence in the cytosol of the cell 
revealed that endosomal escape of the polymer occurred. We hypothesized that 
the 5-DTAF fluorescein label was mainly bound to PLGA end groups of the 
polymer. These PLGA end groups of the P(68)-10 polymer are rapidly 
hydrolyzed, especially in the acidic endosomal environment. Therefore, we 
explained the diffuse green fluorescence by free fluorescently labeled lactic or 
glycolic acid in the cytoplasm of the cell. This allows the assumption, that the 
DNA nanoparticle formulation escaped the endosome. Other groups have 
explained the PLGA nanoparticle escape from the endosomal pathway by a 
combination of osmolytic activity localized-destabilization of the membrane that 
was followed by the extrusion of the nanoparticles into the cytosol [29]. 
However, we consider that further studies are needed to fully explain the fate of 
the nanoparticles within the cell. Still, this study demonstrated that DNA 
particles are intensively taken up by the cells, thus facilitating the gene transfer. 
The high transfection efficiencies of the DNA nanoparticles prepared by the 
modified solvent displacement method demonstrated the potency of this new 
polymeric system and the bioactivity of the DNA after encapsulation in vitro. 
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Generally, cationic surface characteristics, and thus, positive ξ-potentials, are 
required for high transfection efficiencies [30]. This could be observed for 
P(68)-10 nanoparticles prepared with increasing N/P ratios. The transfection 
efficiency increased exponentially from N/P 0.5 to N/P 7 (Fig.9b). At the same 
time, the ξ-potentials of P(68)-10 nanoparticles prepared with increasing N/P 
ratios exhibited a substantial shift from N/P 0.5 to N/P 5 (Fig.2). Further 
increase in the cationic polymer excess, however, did not result in considerable 
changes in ξ-potential or transfection efficiency. This was an indicator that 
increased DNA / polymer interaction took place in the range of N/P 5 to N/P 7. 
Higher N/P ratios only resulted in the formation of particles without DNA, 
which in contrast to water soluble polymers did not show membrane toxicity 
effects, which could influence the transfection efficiency (Fig.4) [19].  
The transfection efficiency of the homologous series of polymer particles was 
mainly dependent on the degree of amine substitution of the polymer (Fig.9a). 
Moreover, the polymers with shorter PLGA side chains exhibited higher 
luciferase expression than polyesters with a 1:20 backbone to PLGA ratio. This 
correlated with the PLGA degradation of the amine-modified polymers 
demonstrated by Wittmar et al. [13]. Still, primary experiments in our 
laboratories revealed that polymer backbone/DNA complexes did not exhibit 
comparable transfection efficiencies. Therefore, additional factors arising from 
the polymer PLGA grafting must interfere with the DNA delivery. 
While all particles were shown to exhibit similar ξ-potentials (Table 1), their 
transfection efficiencies greatly increased with the degree of amine substitution. 
Therefore, the transfection efficiency was not only dependent on the N/P ratio, 
but it was significantly dependent on the rate of amine modification of the 
polymeric backbone (Fig.5). It has been demonstrated by others that the charge 
density and not only the total amount of surface charge mainly influences the 
transfection efficiency [31]. This effect was further demonstrated comparing the 
two amine modifications (DEAPA, DEAEA) at N/P 9. DEAPA amine-modified 
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polyesters were considerably more effective than their DEAEA analogous. It 
was assumed that the interaction of DNA with the polymer was enhanced by the 
propyl-spacer (DEAPA) as opposed to the shorter ethyl-spacer (DEAEA), 
possibly due to reduced accessibility of the positive charge by PLGA shielding. 
While PEI 25 kDa exhibits a much higher amine density than the P(68)-10 
polyester, the enhanced transfection efficiency of P(68)-10 may, in contrast, be 
attributed to the combination of different effects contributing to an enhanced 
DNA release from the endosomal compartment. The careful elucidation of the 
transfection mechanism has yet to be investigated, but different effects could 
simultaneously interfere during the process [30,32,33]. The efficient amine-
modified polymers consisted of dimethlyaminopropylamine substituents, 
representing tertiary amines, that have been demonstrated to be essential for the 
endosomal escape of polyplexes by a `proton sponge´ effect [34]. This effect, 
leading to the osmotic rupture of the endosome and DNA release into the 
cytosol, could be intensified by the fast polymer degradation, resulting in an 
increase of the osmotic pressure by acidic degradation products within the 
endosome, as proposed by Koping-Hoggard [35]. The fast polymer degradation 
of the amine-modified polymers containing PLGA side chain lengths of 10 
monomers, could explained the observed effect, that polymers with shorter 
PLGA side chains were more efficient in transfecting cells [13,36]. This 
mechanism would additionally explain the diffuse green fluorescence in the 
cytoplasm, as well as the reduced transfection efficiency of polymer backbones. 
However, other mechanisms of endosomal release have eventually to be 
considered, for example, membrane destabilizing activities, taking into account 
the low glass transition temperatures and hydrophobic moieties of the polymer, 
demonstrated by Wittmar et al. [13]. Further, the `hydrogel effect´ proposed by 
Ishii, describing the swelling of the polymers in the endosome could increase the 
disruption of endosomes, due to polymer protonation [37]. Therefore, we 
concluded that the combination of different modules within one biodegradable 
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polymer, resulting in a fast degrading polymer, ionic interactions with DNA and 
the formation of water insoluble nanoparticles, provided considerable 
advantages with regard to the transfection efficiency in vitro.  
 
CONCLUSION 
 
Efficient gene delivery is a prerequisite to reduce the amount of DNA needed 
for successful DNA vaccination. The novel biodegradable branched polyesters 
described in this study, composed of an amine-modified PVA backbone with 
multiple and short hydrophobic PLGA side chains, allowed us to modify the 
solvent displacement method for DNA nanoparticle preparation. Thereby we 
were able to encapsulate DNA within biodegradable nanoparticles without the 
use of high energy sources, as a result of the interaction of DNA by the polymer 
within the acetone/water solution. The investigation of the polymer series 
demonstrated that efficient gene delivery, comparable and better than PEI 25 
kDa could be achieved in vitro using this nanocarrier system.  
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SUMMARY 
 
In this dissertation different microparticular and nanoparticular DNA carrier 
systems were developed, with the aim to create an efficient adjuvant system for 
DNA vaccination.  
Their suitability was investigated by physico-chemical parameters, such as 
particle size, ζ-potential and encapsulation efficiency. Further, the systems were 
studied in-vitro for DNA stabilization and DNA bioactivity after encapsulation 
and release, as well as for gene delivery. A promising formulation was finally 
used as DNA delivery system for in-vivo immunization. 
In Chapter 1 we described the basic fundamentals of DNA vaccines, the 
chances arising from their use, the current research and results indicating the 
difficulties to reach protective levels of immune responses. Further, vaccine 
adjuvants were described concentrating on microparticular and nanoparticular 
systems. These were presented in detail with regard to the preparation 
techniques and their applications. 
In Chapter 3 we investigated modified double emulsion methods and spray 
drying techniques for DNA microencapsulation. To prevent possible DNA 
degradation during the encapsulation process, DNA was formulated using 
several additives. Firstly, DNA was complexed with polyethylenimine (PEI) 25 
kDa. We further studied the possibility to encapsulate lyophilized DNA and 
lyophilized DNA / PEI complexes in the presence of lyoprotectants. The 
microparticles were formulated using i) a modified double emulsion technique 
(W/O/W), ii) a solid in oil in water method (S/O/W), iii) a water in oil spray 
drying technique (W/O) and iv) a solid in oil spray drying technique (S/O). The 
microparticles were smaller 10 µm for the spray-dried and the W/O/W 
formulations, thus suitable for phagocytic uptake. DNA release from particles 
prepared with double-emulsion methods, in contrast to spray drying techniques, 
resulted in constant DNA release and relatively low initial burst effects. The 
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complexation with PEI substantially retarded the DNA release for all 
preparation techniques. 
DNA encapsulated in polyester particles is exposed to the acid degradation 
products of polymer hydrolysis. 
In Chapter 4, DNA we adsorbed DNA onto the surface of microparticles. We 
developed a cationic microparticular system by the incorporation of different 
amounts of the cationic molecules, PEI or CTAB (Hexadecyltrimethyl-
ammonium-bromide), into the polyester matrix. PEI 10% microparticles 
exhibited the most promising characteristics, such as a small particle size, a high 
ζ-potential of + 47 mV, a high DNA adsorption efficiency for a theoretical 
loading of 1% over the physiological pH range. In contrast to the PEI 
formulations, microparticles containing the detergent CTAB exhibited 
aggregated particles demonstrated by SEM micrographs, as well as high 
membrane toxicities and low adsorption efficiencies.  
The mechanism of gene delivery was studied by confocal microscopy and 
revealed diffuse fluorescence of DNA and PEI in the cytoplasm of non-
phagocytic L929 fibroblasts. This was attributed to polyplex formation after PEI 
release from the particle. The efficient gene transfer of RG 502H+PEI 10% 
microparticles was confirmed by luciferase transfection. Hence, this formulation 
was chosen for in-vivo DNA immunization against Listeria monocytogenes in 
mice. The challenge experiments with a lethal dose of the pathogen 
demonstrated that the formulation had an adjuvant effect. 
However, adsorption of DNA onto microparticles by electrostatic interactions 
can cause instabilities, such as flocculation. In consequence, we encapsulated 
DNA into nanoparticles to reduce both particle flocculation and DNA 
degradation. 
In Chapter 5 a new polymeric system was designed, consisting of poly (vinyl-
alcohol) coupled with diamines, such as diethylaminopropylamine (DEAPA), 
dimethlyaminopropylamine (DMAPA) or diethylaminoethylamine (DEAEA). 
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The hydrophilic backbone was further grafted with D,L-lactide and glycolide 
(50:50) side chains consisting of 10 or 20 monomers. These polymers were 
characterized by 1H-NMR, gel permeation chromatography-multiple-angle-
laser-light-scattering, and differential scanning calorimetry. The amphiphilic 
properties allowed the formulation of DNA nanoparticles by a modified solvent 
displacement technique without the use of shear forces. DNA nanoparticles 
exhibited positive ζ-potentials up to +42 mV. The gene delivery of the 
nanoparticles was assessed in L929 mouse fibroblasts, which demonstrated high 
transfection efficiencies, comparable to PEI 25kDa/DNA complexes at a 
nitrogen to phosphate ratio of  5. 
In Chapter 6 we chose one representative polymer, P(26)-10, of the new class 
of amine-modified polyesters to investigate the influence of several process 
parameters on the nanoparticle formation. The nanoparticle size was dependent 
on the volume of the organic solvent as well as on the volume of the aqueous 
solution. The organic solvent composition further influenced the particle size 
and the encapsulation efficiency. The variations form parameters of the solvent 
displacement technique could be explained by polyelectrolyte interactions of the 
cationic polymer with DNA in the acetone / water mixture. These in 
consequence influenced the coalescence rate of the polymer.  
In Chapter 7 DNA nanoparticles with amine-modified polyesters were further 
characterized using two classes of polymers (DEAPA /DEAEA) with different 
amounts of amine modifications. The nanoparticles were prepared at specific 
nitrogen to phosphate ratios. The nanoparticle ξ-potentials and sizes were 
dependent on the N/P ratio and highly positive for a N/P ratio higher 3. Atomic 
force microscopy confirmed the small particle sizes. DNA stability during the 
encapsulation process and release over nine day was demonstrated by 
electrophoresis, as well as DNA protection from enzyme degradation in 
dependence of the N/P ratio.  
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The amount of cellular uptake of an efficient candidate P(68)-10, DNA 
nanoparticles was shown to be dependent on the N/P ratio of the formulation by 
flow cytometry. The mechanism of cellular uptake was followed by confocal 
microscopy and exhibited endocytotic uptake of the particles. The endosomal 
escape of the formulation was observed by the covalently bound polymer label 
in the cytosol and detected by reporter gene expression. The endosomal escape 
was ascribed to a combination of osmotic effect of the readily degraded PLGA 
side chains and the polycationic properties of the backbone. The very efficient 
gene delivery of the P(68)-10 polymer was demonstrated by in-vitro transfection 
assays in four cell lines compared to PEI / DNA complexes  at equal N/P ratios. 
 
OUTLOOK 
 
DNA nanoparticles formulated with amine-modified polymers were 
demonstrated to be efficient gene delivery systems. In-vivo immunizations with 
this system are ongoing. DNA nanoparticles of the most promising polymer 
P(68)-10 are either injected intra-muscularly or applied intra-nasally. Intra-nasal 
administrations generally were shown to efficiently induce mucosal immune 
responses. 
Further, highly concentrated nanoparticle preparations, especially of the 
DEAEA-modification, exhibited in-situ aggregation upon injection into buffered 
medium. Most of the current in-situ forming devices are based on polymer 
solution in organic solvents. The possibility to inject an aqueous drug - 
nanoparticle dispersion, which self assembles to a polymeric implant represents 
a promising possible to develop organic solvent free in-situ implants.  
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ZUSAMMENFASSUNG 
 
In dieser Arbeit wurden mikropartikuläre und nanopartikuläre DNA-
Trägersysteme mit dem Ziel einer adjuvanten Anwendung für DNA-Impfstoffe 
entwickelt. 
Deren Eignung wurde anhand physikalisch-chemischer Parameter, unter 
anderem ihrer Partikelgrößen und ξ-Potentiale, sowie ihrer Verkapselungs- und 
Adsorptionseffizienzen bestimmt. Weiterhin wurde in-vitro die schützende 
Wirkung für DNA vor enzymatischem Abbau, die DNA-Bioaktivität nach deren 
Freisetzung und die Transfektionseffizienz charakterisiert. Eine optimierte 
Formulierung wurde schließlich als DNA-Trägersystem für die in-vivo DNA-
Immunisierung verwendet. 
In Kapitel 1 wurden die Grundlagen der DNA-Immunisierung, deren 
Möglichkeiten, der aktuelle Stand der Forschung und die Schwierigkeiten der 
Entwicklung eines effektiven Schutzes durch DNA-Impfstoffe dargestellt. Des 
weiteren wurden adjuvante Systeme vorgestellt, wobei besonders die 
Herstellung und Verwendung von bioabbaubaren Mikropartikeln und 
Nanopartikeln berücksichtigt wurde. 
In Kapitel 3 haben wir das Doppelemulsionsverfahren und die Sprühtrocknung 
zur Herstellung von DNA-Mikropartikeln untersucht. Um den möglichen Abbau 
der DNA während der Verkapselung zu verhindern wurden unterschiedliche 
Hilfsstoffe in der Formulierung verwendet. Die DNA wurde in Lösung, als 
Polyethylenimin (PEI) 25 kDa Komplex, sowie in lyophilisierter Form in 
Anwesenheit von Lyoprotektoren verkapselt. Folgende Methoden zur 
Herstellung der DNA Mikropartikel wurden verwendet: (1) ein modifiziertes 
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Doppelemulsions-verfahren (W/O/W), (2) ein Feststoff in Öl in Wasser 
Verfahren (S/O/W), (3) die Sprühtrocknung einer Wasser in Öl Dispersion 
(W/O) und (4) die Sprühtrocknung einer Feststoff in Öl Dispersion (S/O). Die 
resultierenden Partikel der Sprühtrocknung und des Doppelemulsionsverfahrens 
waren kleiner als 10 µm und entsprachen daher den Größenanforderungen für 
eine phagozytotische Aufnahme in Zellen. Die Partikel aus dem 
Doppelemulsions-verfahren setzten DNA kontinuierlich frei, wohingegen die 
DNA aus sprühgetrockneten Mikropartikeln primär schlagartig freigesetzt 
wurde. Durch die Komplexierung mit PEI konnte die DNA-Freisetzung in allen 
Zubereitungen erheblich verlangsamt werden. 
In Polyesterpartikel verkapselte DNA wird durch die sauren Hydrolyseprodukte 
des Polymers abgebaut.  
In Kapitel 4 haben wir daher DNA an Oberflächen von Mikropartikeln 
adsorbiert. Durch die Integration unterschiedlicher Anteile kationischer 
Moleküle PEI oder CTAB (Hexadecyl-trimethylammoniumbromid) in 
Polyestergerüste konnten wir Mikropartikel mit kationischen Oberflächen-
eigenschaften entwickeln. Partikel mit 10% PEI zeichneten sich durch besonders 
positive Eigenschaften, wie zum Beispiel einer geringen Partikelgröße, eines 
positiven ξ-Potentials von +47 mV und einer besonders guten DNA-
Adsorptionseffizienz über den physiologischen pH-Bereich, aus. Diese 
Formulierung war zudem in der Lage DNA vor enzymatischem Abbau zu 
schützen. Elektronenmikroskopische Aufnahmen bewiesen, dass CTAB Partikel 
stark aggregierten und daher erheblich größere Durchmesser als PEI 
Mikropartikel in der Laser Diffraktometrie aufwiesen. Im Gegensatz zu PEI - 
Partikeln waren CTAB - Partikel membrantoxisch. Konfokale Aufnahmen mit 
fluoreszenz-markierten PEI - Partikeln und DNA resultierten in diffuser 
Fluoreszenz im Zytoplasma von nicht-phagozytischen L929 Fibroblasten. Dies 
wurde auf das Herauslösen von PEI und der Bildung von Polyplexen 
zurückgeführt. Der Gen-Transfer der RG 502H+PEI 10% Partikel konnte des 
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weiteren durch die Transfektion mit dem Reportergen Luciferase bestätigt 
werden. Daher setzten wir diese Partikel als Trägersystem für die DNA-
Immunisierung von Mäusen gegen Listeria monocytogenes ein. Das System 
bewies dabei einen adjuvanten Effekt auf die DNA-Immunisierung, welches 
durch die Infektion mit einer letalen Dosis des Erregers untersucht wurde.  
Die Adsorption von DNA an kolloidale Systeme, wie kationische Mikropartikel, 
kann allerdings zu Instabilitäten und Ausflockung führen.  
In Kapitel 5 wurde daher die Entwicklung eines neuen Polymersystems für die 
Verkapselung von DNA beschreiben. Diese Polymere wurden  aus Poly-(vinyl-
alkohol) und Diamin-Substituenten (Diethylaminopropylamin (DEAPA), 
Dimethlyaminopropylamin (DMAPA) oder Diethylaminoethylamin (DEAEA) 
aufgebaut. Diese Polymer-Rückgrate wurden mit Seitenketten aus D,L-Laktid 
und Glykolid (50:50) aus 10 oder 20 Monomeren gepfropft. Diese neuartigen 
Polymere wurden über 1H-NMR, Gel-permeation-chromatographie und 
Differential Scanning Calorimetrie charakterisiert. Die amphiphilen Polymer-
eigenschaften ermöglichten es, ein neues Verfahren zu Verkapselung von DNA 
zu ohne Verwendung von Scherkräften zu entwickeln. Die DNA Nanopartikel 
zeigten hohe ξ-Potentiale sowie hohe Transfektionseffizienzen in-vitro. Diese 
waren vergleichbar mit PEI / DNA Komplexe mit einem N/P Verhältnis von 5. 
In Kapitel 6 wählten wir ein repräsentatives Polymer dieser neuen 
Polymerklasse, P(26)-10, um die Prozessparameter des Herstellungsverfahrens 
der DNA Nanopartikel zu charakterisieren. Die Partikelgröße war abhängig vom 
Volumen des organischen Lösungsmittels und der wässrigen Phase. Die 
Zusammensetzung des organischen Lösungsmittels bestimmte durch die 
Viskosität zusätzlich die Partikelgröße und die DNA Beladungseffizienz. Wir 
erklärten die Besonderheiten des Systems durch Polyelektrolyt-
Wechselwirkungen der DNA mit dem kationischen Polymer in dem Aceton / 
Wasser Lösungsmittel. Dieses Volumenverhältnis bestimmte daher die 
Koaleszenzeigenschaften des Polymers mit. 
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In Kapitel 7 wurden die neuartigen Polymersysteme durch die Formulierung 
von DNA Nanopartikeln in unterschiedlichen N/P Verhältnissen charakterisiert 
und in-vitro angewendet. Dabei waren die ξ-Potentiale der Partikel und die 
Partikelgröße von deren N/P Verhältnis abhängig. Die Raster-Kraft-Mikroskopie 
konnte die gemessenen Partikelgrößen bestätigen. Zudem wurde DNA durch 
Verkapselung in Partikel in Abhängigkeit des N/P Verhältnisses gegen 
enzymatischen Abbau geschützt. Die Freisetzung über 9 Tage zeigte, dass nur 
Polymere mit hohen Amindichten DNA vollständig verkapseln konnten. Durch 
Flow Cytometrie mit P(68)-10 DNA Nanopartikeln konnte gezeigt werden, dass 
die Partikelaufnahme in Zellen vom N/P Verhältnis abhängig ist. Der 
entsprechende Aufnahmemechanismus wurde mit Hilfe der konfokalen 
Mikroskopie verfolgt. Die Aufnahme der Partikel in das endo/lysosomale 
Kompartiment und eine Freisetzung des kovalent gebundenen Polymerlabels in 
das Cytosol konnte beobachtet werden. Wir nehmen daher eine Freisetzung der 
Formulierung aus Endosomen durch einen osmotischen Effekt der PLGA 
Abbauprodukte in Kombination mit polykationischen Eigenschaften des 
Rückgrates an. Die ausgesprochen gute Transfektionseffizienz eines der 
Polymere, P(68)-10, wurde in unterschiedlichen N/P Verhältnissen und in vier 
Zelllinien untersucht und war bei gleichen N/P Verhältnissen vergleichbar mit 
PEI / DNA Komplexen. 
 
AUSBLICK 
 
Die DNA Nanopartikel des aminmodifizierten Polyesters, P(68)-10 haben sich 
durch sehr gute Transfektionseffizienzen ausgezeichnet. Daher werden zur Zeit 
DNA-Immunisierungen durchgeführt. Dazu werden die Nanopartikel-
Zubereitungen Mäusen parallel intra-nasal und intra-muskulär verabreicht 
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werden. Die intra-nasale Immunisierung hat im Allgemeinen den Vorteil, dass 
durch sie eine verstärkte mukosale Immunantwort entsteht.  
Ein zweiter Ansatz verfolgt das Ziel lösungsmittelfreie In-Situ Implantate zu 
entwickeln. Hochkonzentrierte DNA Nanopartikelsuspensionen, im besonderen 
die DEAEA – aminmodifizierten Polyester, bilden bei der Injektion in 
Pufferlösungen Aggregate. Daher könnte die Injektion von wirkstoffhaltigen 
Nanopartikelsuspensionen in Wasser zur Bildung von bioabbaubaren Depots 
führen. 
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